Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3004119	vb-hb	g/l (g/l)	16961	61449	0.00%
3004119	vb-thb	g/l (g/l)	11253	31052	0.00%
3004119	vb-hb	— (—)	1162	2866	100.00%	Distribution not available
3004119	vb-hb-vt	g/l (g/l)	484	790	0.00%
3004119	vb-thb	— (—)	272	297	100.00%	Distribution not available
3004119	vb-hblask	g/l (g/l)	231	285	0.00%
3004119	vb-hb-vt	— (—)	218	273	100.00%	Distribution not available
3004119	vb-thb	g/L (g/l)	43	49	0.00%
3004119	vb-hb	G/L (g/l)	21	147	0.00%
3004119	vb-hb	g/L (g/l)	14	19	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other dialysis

468

708

10.42

321.74

13.8

4.2

106.25

130.51

g/l

84.01

461

691

Other diseases of intestines

5417

16957

1.84

320.66

4.4

3.3

128.76

130.99

g/l

9.16

5266

16509

Non-ischemic cardiomyopathy

2058

6603

2.69

319.19

4.6

2.7

124.45

130.25

g/l

21.33

1985

6418

Coronary atherosclerosis

3626

11445

2.11

317.47

4.5

2.7

124.17

130.95

g/l

49.54

3511

11165

Pain in limb

4553

15659

1.93

314.82

4.4

3.3

128.42

129.75

g/l

3.32

4428

15255

Asthma (only as main-diagnosis), excluding more controls

3308

8758

2.17

309.21

3.8

2.6

130.85

133.11

g/l

6.03

3212

8557

Heart failure and bmi 25plus

2377

6845

2.52

308.87

5.2

2.9

123.08

130.46

g/l

37.74

2291

6632

ILD medications

5912

18549

1.78

308.34

5.7

2.8

126.00

131.44

g/l

53.12

5756

18077

Insulin medication

4677

13829

3.08

307.65

5.1

3.2

124.92

130.55

g/l

45.02

4552

13448

ILD medications: prednisolone, methylprednisolone, prednisone

5833

18328

1.84

307.65

5.5

2.8

125.78

131.38

g/l

55.69

5669

17860

Symptoms and signs involving the digestive system and abdomen

5275

14277

1.92

307.65

4.3

3.2

129.47

130.35

g/l

1.75

5125

13903

Heart failure and antihypertensive medication

1942

2398

6.00

307.65

6.4

2.4

122.78

132.11

g/l

37.27

1878

2344

Renal failure

4923

12859

3.79

307.65

7.8

2.6

115.35

130.84

g/l

307.65

4790

12485

Heart failure, not strict

5932

13342

3.32

307.65

6.0

2.5

121.85

132.76

g/l

188.64

5757

13011

Caries of dentine

1688

5906

3.04

307.65

8.0

3.0

120.83

131.39

g/l

54.96

1647

5786

Bacterial pneumonia, not elsewhere classified

2665

9883

2.56

307.65

5.5

2.9

123.32

130.55

g/l

46.24

2575

9604

Diabetes mellitus

6116

15491

2.41

307.65

4.3

3.0

128.35

131.03

g/l

13.57

5953

15078

Persons encountering health services for specific procedures and health care

7115

16814

2.66

307.65

5.4

2.7

124.62

132.82

g/l

135.24

6935

16350

Insulin, combination of fast acting with intermediate-acting or long-acting

4689

17111

2.71

307.65

5.1

3.2

124.91

130.19

g/l

41.88

4564

16647

Care involving dialysis

1315

1783

11.38

307.65

14.9

2.9

105.96

132.54

g/l

255.09

1296

1718

Hyperlipidaemia, other/unspecified

2608

9956

2.55

307.65

4.3

2.8

128.31

129.31

g/l

1.37

2569

9680

Non-rheumatic valve diseases

3005

8101

2.86

307.65

5.0

2.8

122.14

129.93

g/l

52.59

2911

7894

Anaemias

1461

1027

10.06

307.65

8.0

1.9

115.42

140.74

g/l

175.20

1426

1005

All-cause Heart Failure

4318

12702

2.59

307.65

5.1

2.9

122.76

129.85

g/l

64.57

4172

12352

Implicit bacterial Sepsis

3773

10693

3.42

307.65

6.4

2.6

120.03

130.65

g/l

128.08

3647

10398

Cardiovascular diseases

2746

4602

3.32

307.65

4.7

2.8

130.99

135.91

g/l

18.68

2677

4480

Infections, IBD-co-morbidities

1090

1494

5.68

307.65

8.2

3.0

118.99

130.67

g/l

32.85

1060

1463

Condition for Implicit Sepsis (Organ dysfunction codes)

5917

16343

2.69

307.65

5.2

2.7

124.33

132.42

g/l

112.29

5725

15936

Bacterial Sepsis

4193

11618

3.35

307.65

6.3

2.6

120.20

131.01

g/l

145.25

4055

11302

Hypertensive heart and/or renal disease

1924

4382

3.56

307.65

5.6

2.5

123.67

130.32

g/l

24.21

1897

4255

Diabetes, insulin treatment (Kela reimbursement)

6371

17028

2.36

307.65

4.2

3.1

127.71

130.61

g/l

16.49

6209

16556

Cerebrovascular diseases (FINNGEN)

1861

2940

4.84

307.65

4.3

2.2

128.62

134.48

g/l

16.82

1811

2862

Certain infectious and parasitic diseases

5000

12350

2.11

307.65

4.5

2.5

127.26

133.18

g/l

53.26

4891

12018

Ischemic heart diseases

4894

13610

2.27

307.65

4.8

3.0

126.34

131.42

g/l

37.68

4743

13282

Emergency coronary revascularization (for ACS)

5338

15015

2.28

307.65

4.7

3.0

125.37

130.83

g/l

47.46

5173

14656

Diseases of arteries, arterioles and capillaries

4211

15956

2.05

307.65

5.4

3.0

121.98

129.94

g/l

82.72

4083

15536

Type 2 diabetes

5766

14966

2.35

307.65

4.3

2.8

128.15

130.96

g/l

13.97

5617

14562

Antihypertensive medication - note that there are other indications

2662

4940

2.94

307.65

4.7

2.6

130.64

134.77

g/l

13.25

2584

4825

Hypothyroidism, levothyroxine purchases

944

1039

5.34

307.65

4.2

1.8

132.20

141.34

g/l

22.17

923

1016

Erysipelas

3647

13933

2.41

307.65

4.7

2.6

125.34

132.42

g/l

58.53

3561

13540

Other heart diseases, wide

5508

12962

2.73

307.65

4.7

3.0

129.69

131.47

g/l

5.48

5359

12643

Covid-19 confirmed case

2895

10863

2.95

307.65

5.5

3.3

124.29

128.54

g/l

18.57

2819

10533

Glomerular diseases

1624

4922

3.86

307.65

10.6

3.2

113.50

130.69

g/l

151.38

1588

4780

Complications of medical and surgical care

4513

20186

2.12

307.65

5.0

3.1

123.44

130.12

g/l

66.25

4370

19658

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1779

3808

3.08

307.65

4.7

2.1

128.44

135.11

g/l

23.20

1731

3705

Pneumonia, organism unspecified

5737

17547

2.38

307.65

4.9

3.0

124.77

131.82

g/l

87.94

5579

17106

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5575

17985

2.05

307.65

5.9

2.8

123.16

132.08

g/l

133.59

5414

17537

Dental caries

1879

6552

2.97

307.65

8.5

3.1

120.66

131.20

g/l

61.80

1837

6409

Insulin, fast-acting

2789

9930

3.12

307.65

5.8

3.3

124.24

130.69

g/l

37.80

2710

9649

Angina pectoris

3694

10572

2.50

307.65

4.4

2.7

126.56

130.62

g/l

19.77

3585

10311

Heart failure and coronary heart disease

3200

8730

2.83

307.65

5.5

2.8

121.91

129.81

g/l

59.36

3095

8503

L04AD Calcineurin inhibitors

1284

2448

6.83

307.65

13.6

3.7

109.76

132.55

g/l

194.26

1265

2384

Other (not insulin) diabetes medications

5453

16026

2.09

307.65

3.7

3.0

128.82

130.56

g/l

5.75

5306

15586

Renal tubulo-interstitial diseases

6981

17292

3.25

307.65

6.1

2.5

120.31

132.78

g/l

314.97

6799

16825

Abdominal and pelvic pain

5218

14274

1.90

307.65

4.1

3.2

130.42

130.34

g/l

0.08

5080

13900

Nausea and vomiting

2018

6766

3.19

307.65

6.0

3.3

125.39

128.33

g/l

6.95

1965

6584

Provisional assignment of new diseases of uncertain etiology

4894

14719

3.73

307.65

4.6

3.3

129.07

129.22

g/l

0.16

4801

14292

Codes for special purposes

4898

14733

3.73

307.65

4.6

3.3

129.07

129.22

g/l

0.17

4805

14304

Transplanted organ and tissue status

1296

2222

7.93

307.65

13.5

3.1

108.52

133.49

g/l

231.55

1277

2162

Symptoms and signs involving cognition, perception, emotional state and behaviour

5302

19665

1.88

307.65

3.8

3.3

129.61

129.62

g/l

0.02

5149

19138

Diabetes, varying definitions

6073

15530

2.39

307.65

4.3

3.0

128.38

131.00

g/l

13.07

5914

15113

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3962

12938

2.62

307.65

4.3

3.1

125.69

129.17

g/l

15.81

3860

12571

Poisoning by medicine

1382

4618

3.28

307.65

3.4

3.5

132.09

131.50

g/l

0.44

1332

4498

Type 2 diabetes, definitions combined, including avohilmo

5138

14466

2.15

307.65

3.8

2.9

129.36

130.78

g/l

3.80

5010

14070

Type 1 diabetes, wide definition, subgroup 1

1451

4355

3.69

307.65

5.7

3.5

124.29

132.65

g/l

31.91

1407

4247

Malaise and fatigue

4001

10406

3.31

307.65

4.5

2.8

126.77

130.28

g/l

16.69

3901

10129

Intracranial trauma

2990

9268

2.28

307.65

3.6

3.4

130.35

129.40

g/l

1.35

2918

9038

Other bacterial diseases, including avohilmo

6979

17110

2.73

307.65

5.6

2.7

123.19

133.21

g/l

197.37

6800

16647

Symptoms and signs involving the circulatory and respiratory systems

4947

13112

1.96

307.65

4.0

3.1

130.86

130.11

g/l

1.30

4813

12783

5604

14086

2.47

307.65

4.8

2.8

124.89

131.23

g/l

67.13

5445

13725

All kidney diseases

7222

17402

3.01

307.65

5.9

2.5

122.27

133.21

g/l

242.05

7037

16927

Diabetes medication

6186

16805

2.26

307.65

4.2

3.1

128.11

130.75

g/l

13.57

6017

16353

Headache

3458

12127

2.31

307.65

3.7

2.8

131.54

g/l

0.00

3361

11814

Asthma, unspecified (mode), excluding more controls

2824

8373

2.54

307.65

3.9

2.6

130.08

132.77

g/l

7.43

2737

8184

Aplastic and other anaemias

3186

13944

2.25

307.65

6.1

3.1

111.54

130.18

g/l

307.65

3100

13540

Dialysis, with operation codes

1837

3091

8.38

307.65

14.2

2.8

107.19

133.28

g/l

307.65

1806

3007

Type 1 diabetes

1766

5520

3.53

307.65

5.8

3.5

124.10

132.00

g/l

33.66

1715

5371

Other disorders of fluid, electrolyte and acid-base balance

2882

8067

3.85

307.65

5.6

2.9

122.49

128.68

g/l

37.49

2798

7828

Pain in throat and chest

4856

12915

2.34

307.65

3.7

3.1

131.04

130.07

g/l

1.99

4713

12589

Bacterial pneumoniae

2812

10338

2.58

307.65

5.4

2.9

123.58

130.71

g/l

47.24

2720

10053

Pure hypercholesterolaemia

4339

13305

2.18

307.65

3.8

2.8

128.29

130.46

g/l

6.87

4208

12947

All pneumoniae

6452

18624

2.39

307.65

4.9

3.0

125.01

131.85

g/l

91.08

6261

18145

Complications of procedures, not elsewhere classified

4675

19814

1.99

307.65

4.5

3.1

123.83

130.83

g/l

72.73

4544

19297

Paroxysmal tachycardia

1216

2480

4.41

307.65

4.4

2.4

131.43

133.76

g/l

2.65

1188

2415

Syncope and collapse

2730

9747

2.49

307.65

3.7

2.8

128.32

130.22

g/l

4.03

2654

9489

Chronic kidney disease

3378

9609

3.99

307.65

9.4

2.7

113.16

130.30

g/l

307.65

3293

9321

Dialysis

614

844

11.26

307.65

15.5

3.6

106.45

132.48

g/l

119.93

606

824

Valvular heart disease excluding rheumatic fever

3041

8158

2.88

307.65

5.0

2.9

122.07

129.92

g/l

53.99

2947

7949

Fever of other and unknown origin

3948

11999

3.08

307.65

5.7

2.8

122.99

131.03

g/l

80.28

3849

11688

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6308

18810

2.37

307.65

4.9

3.1

124.87

131.75

g/l

91.31

6126

18325

Poisoning by drugs, medicaments and biological substances

1495

5185

3.14

307.65

3.4

3.5

132.01

131.44

g/l

0.43

1442

5057

Type 2 diabetes, definitions combined

5190

14625

2.16

307.65

3.8

2.8

129.18

130.84

g/l

5.01

5058

14226

Disorders of lipoprotein metabolism and other lipidaemias

5094

13820

2.38

307.65

4.0

2.9

128.87

130.68

g/l

5.63

4967

13447

Hypertension

4389

9450

2.78

307.65

5.1

2.6

127.91

133.16

g/l

32.81

4276

9191

Hypo-osmolality and hyponatraemia

1441

4685

3.46

307.65

4.9

2.8

122.12

127.94

g/l

18.46

1402

4557

Septicaemia

3638

11180

3.32

307.65

7.0

2.7

117.40

131.31

g/l

210.70

3532

10848

Hypothyroidism and >3 levothyroxin purchases

944

1039

5.34

307.65

4.2

1.8

132.20

141.34

g/l

22.17

923

1016

Metabolic disorders

6310

15057

2.69

307.65

4.6

3.0

127.90

130.91

g/l

17.08

6147

14652

Kidney transplant status

963

1134

14.77

307.65

14.3

3.8

106.84

132.61

g/l

156.34

954

1104

General symptoms and signs

6110

13391

2.40

307.65

4.2

2.8

128.97

131.60

g/l

12.90

5953

13048

Implicit Sepsis

5771

15788

2.93

307.65

5.4

2.7

123.63

131.97

g/l

116.95

5589

15384

Hypertensive diseases

4396

9452

2.78

307.65

5.1

2.6

127.93

133.16

g/l

32.63

4283

9193

Type 2 diabetes, wide definition

5578

13417

2.84

307.65

4.4

2.9

126.47

130.53

g/l

26.79

5429

13057

Type 1 diabetes, wide definition

1475

4748

3.41

307.65

5.7

3.5

124.23

132.23

g/l

30.15

1431

4629

Substance abuse, excluding more controls

3305

12653

2.31

307.65

3.7

3.3

130.34

130.50

g/l

0.14

3201

12317

Hypertensive diseases (excluding secondary)

2940

4176

4.41

307.65

5.6

2.4

128.19

135.74

g/l

39.96

2867

4067

Abnormalities of breathing

4931

13088

2.26

307.65

4.4

3.1

129.56

130.09

g/l

0.79

4779

12760

Diseases of arteries, arterioles and capillaries (FINNGEN)

1652

2232

5.70

307.65

6.4

2.1

121.81

134.30

g/l

57.88

1603

2176

Hypothyroidism (congenital or acquired)

968

1044

5.45

307.65

4.5

1.8

131.98

141.30

g/l

22.92

944

1021

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6087

19690

2.20

307.65

5.7

2.9

118.08

133.21

g/l

307.65

5924

19163

STROKE

3264

8034

2.93

307.65

4.1

2.5

128.84

132.71

g/l

14.80

3176

7837

Implicit bacterial Sepsis, including avohilmo

4052

11372

3.33

307.65

6.3

2.6

120.45

130.83

g/l

130.26

3911

11059

Insulin, intermediate and long-acting

4324

16158

2.84

307.65

4.9

3.2

125.35

130.26

g/l

33.87

4212

15716

Type 2 diabetes, strict (exclude DM1)

5210

14730

2.16

307.65

3.8

2.9

129.16

130.79

g/l

4.84

5078

14327

Insulin, fast-acting or short human

2798

10604

2.91

307.65

5.9

3.4

124.19

130.26

g/l

33.97

2719

10304

Explicit Sepsis, including avohilmo

3784

11657

3.28

307.65

6.9

2.7

117.64

131.02

g/l

203.75

3673

11335

Major coronary heart disease event excluding revascularizations

3600

11460

2.20

307.65

4.5

2.8

125.15

130.66

g/l

34.37

3481

11179

Other CVD (FINNGEN)

865

1166

6.48

307.65

4.8

2.0

125.01

132.02

g/l

12.15

840

1131

Asthma, unspecified (mode)

2935

9643

2.31

307.65

3.9

2.7

129.72

131.69

g/l

4.49

2845

9416

First line medication for Crohn's disease

5797

17715

1.82

307.65

5.5

2.9

125.49

131.97

g/l

72.97

5643

17262

Glomerular disorders in diseases classified elsewhere

1166

3047

4.66

307.65

10.8

3.1

111.34

130.57

g/l

135.91

1139

2955

Nephropathy related operations

1847

3152

8.50

307.65

14.3

3.0

107.18

131.67

g/l

307.65

1815

3064

Viral Sepsis

1853

5567

3.81

307.65

6.6

2.7

122.69

130.58

g/l

37.43

1782

5409

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5957

14871

2.53

307.65

4.2

3.0

127.83

130.95

g/l

17.39

5804

14469

Implicit viral Sepsis, including avohilmo

2426

8436

3.20

307.65

5.9

2.6

124.06

130.54

g/l

34.66

2339

8194

Covid-19 suspected case

2251

4517

5.99

307.65

4.0

3.3

134.66

130.86

g/l

12.16

2230

4383

Bacterial pneumonia (organism specified)

2963

12650

2.27

307.65

5.5

3.2

123.31

129.27

g/l

36.69

2869

12293

Implicit viral Sepsis

1850

5561

3.81

307.65

6.6

2.7

122.66

130.60

g/l

37.99

1779

5404

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1518

5114

3.14

307.65

3.3

3.2

131.44

131.50

g/l

0.04

1459

4994

Biguanides

5341

16833

2.00

307.65

3.6

3.2

128.97

129.98

g/l

2.26

5200

16369

Other septicaemia

3275

10366

3.34

307.65

7.3

2.7

116.98

131.12

g/l

196.42

3176

10051

Ischaemic heart disease, wide definition

4508

13819

2.12

307.65

4.5

2.9

126.06

130.79

g/l

31.09

4368

13463

Pneumonias (Asthma/COPD co-morbidities)

6414

18608

2.39

307.65

4.9

3.0

124.98

131.93

g/l

93.78

6228

18124

Complications of surgical and medical care, not elsewhere classified

5864

20364

2.01

307.65

4.7

3.1

123.83

130.97

g/l

92.25

5690

19831

Depression medications

1055

1096

5.05

307.65

3.6

1.7

134.49

141.94

g/l

16.38

1026

1073

Explicit Sepsis

3716

11501

3.28

307.65

6.9

2.7

117.58

130.93

g/l

199.87

3607

11183

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

5882

16324

2.59

307.65

5.1

2.7

124.98

132.70

g/l

101.52

5694

15920

GASTRO-related operations

3865

9032

2.23

307.65

4.2

2.5

127.65

135.36

g/l

67.47

3755

8830

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5604

14086

2.47

307.65

4.8

2.8

124.89

131.23

g/l

67.13

5445

13725

Dyspnoea

5653

19665

2.19

307.65

4.4

3.2

127.99

129.61

g/l

5.58

5483

19153

Heart failure,strict

4048

10278

3.04

307.65

5.3

2.5

122.98

132.10

g/l

93.87

3919

10010

Other septicaemia, including avohilmo

3337

10540

3.33

307.65

7.3

2.7

117.02

131.16

g/l

199.82

3236

10221

Other arrhythmias

3399

11090

2.41

307.65

3.7

2.7

132.39

130.75

g/l

3.79

3300

10820

Intestinal infectious diseases

5373

21632

1.93

307.65

5.3

3.1

127.00

130.22

g/l

19.40

5203

21073

Coronary revascularization (ANGIO or CABG)

4853

13316

2.36

307.65

4.8

3.0

125.59

131.34

g/l

47.03

4699

12997

Hypertensive Heart Disease

1688

4156

3.40

307.65

5.0

2.5

125.58

129.98

g/l

10.10

1666

4034

Speech therapy

2384

7161

3.87

307.65

4.0

3.5

129.32

128.25

g/l

1.46

2358

6954

Bleeding

5258

18028

2.17

307.65

4.7

3.2

123.84

130.67

g/l

71.87

5113

17555

Presence of cardiac and vascular implants and grafts

3182

10653

2.38

307.65

4.8

2.7

122.99

130.24

g/l

52.71

3074

10384

Asthma, excluding more controls

3612

8758

2.20

307.65

3.8

2.6

131.30

133.11

g/l

4.27

3512

8557

Bacterial infection, other or unspecified, including avohilmo

4807

13631

3.20

307.65

6.3

2.7

119.90

131.88

g/l

216.37

4672

13250

Atrial fibrillation and flutter

2362

2759

6.22

307.65

4.6

2.0

134.13

135.15

g/l

0.92

2303

2687

Diarrhoea and gastroenteritis of presumed infectious origin

4161

18652

2.09

307.65

5.4

3.1

127.47

130.31

g/l

12.22

4030

18170

Erysipelas, including avohilmo

4505

15278

2.32

307.65

4.5

2.6

125.81

132.92

g/l

70.55

4386

14856

Cardiovascular diseases (excluding rheumatic etc)

3194

5271

3.67

307.65

4.9

2.8

130.19

135.84

g/l

27.24

3107

5134

Percutaneous Coronary Intervention

4875

13311

2.37

307.65

4.8

3.0

125.58

131.33

g/l

47.47

4721

12992

Major coronary heart disease event

5107

14259

2.27

307.65

4.7

3.0

125.81

131.17

g/l

43.53

4948

13918

Bacterial infection, other or unspecified

4478

13001

3.23

307.65

6.5

2.7

119.47

131.59

g/l

208.76

4358

12632

Atrial fibrillation and flutter with reimbursement

2054

2169

6.83

307.65

4.0

2.1

134.84

133.78

g/l

0.86

2007

2116

Any reimbursement code in KELA

2491

4189

3.11

307.65

4.2

2.0

130.91

137.01

g/l

25.96

2430

4079

All chronic kidney diseases

4914

12136

3.63

307.65

7.6

2.5

117.00

132.12

g/l

307.65

4791

11797

Care involving use of rehabilitation procedures

4694

15264

3.01

307.65

4.5

2.7

127.51

132.22

g/l

35.77

4576

14843

Acute tubulo-interstitial nephritis

4212

14416

2.65

307.65

5.1

2.5

123.24

131.85

g/l

103.16

4093

13999

Tramadol

4405

13192

2.10

307.65

4.1

3.0

127.30

131.75

g/l

26.69

4280

12883

Heart failure, strict

4398

12877

2.60

307.65

5.2

2.9

122.89

129.91

g/l

63.97

4250

12526

Secondary hypertension

728

958

9.03

307.65

10.3

2.8

113.83

133.87

g/l

71.14

714

934

Influenza and pneumonia

6640

18132

2.39

307.65

4.9

3.0

125.49

131.94

g/l

83.23

6445

17674

Hypertension, essential

4356

9253

2.83

307.65

4.4

2.5

128.99

133.14

g/l

20.86

4246

8994

Other medical care

3013

11417

2.36

307.65

4.6

2.7

119.24

130.96

g/l

131.62

2919

11078

Extracorporeal dialysis

995

1540

10.25

307.65

16.5

3.1

105.93

130.79

g/l

187.83

982

1494

Other bacterial diseases

7069

17310

2.93

307.65

5.7

2.7

122.35

132.91

g/l

222.07

6899

16832

Any gastric operation

3865

9032

2.23

307.65

4.2

2.5

127.65

135.36

g/l

67.47

3755

8830

Hard cardiovascular diseases

5007

12905

2.44

307.65

4.6

3.0

126.70

131.71

g/l

36.74

4861

12590

Cardiac arrhythmias

3441

6055

3.91

307.65

4.1

2.8

133.67

132.43

g/l

1.94

3351

5905

Other heart diseases

3100

4307

5.12

307.65

5.3

2.7

130.01

135.66

g/l

23.50

3019

4196

Implicit Sepsis, including avohilmo

5952

16392

2.80

307.65

5.2

2.7

124.18

132.24

g/l

112.87

5767

15977

L04AA Selective immunosuppressants

1555

5481

3.15

307.65

10.1

3.1

114.18

131.35

g/l

148.20

1523

5323

Acute renal failure

2291

6563

4.15

307.65

7.7

2.6

115.48

130.87

g/l

159.54

2221

6358

Endocrine, nutritional and metabolic diseases

3917

8094

2.55

307.65

4.3

2.8

130.30

132.77

g/l

7.28

3808

7884

Non-invasive ventilation

1719

2608

6.32

307.65

6.0

2.7

121.64

131.50

g/l

41.47

1584

2555

Abnormalities of heart beat

2113

8675

2.51

305.48

3.7

2.9

131.60

128.60

g/l

7.68

2051

8443

Diseases of oesophagus, stomach and duodenum

5622

19263

1.79

303.33

4.0

3.3

126.50

130.83

g/l

33.02

5461

18761

Dizziness and giddiness

4209

17759

1.93

302.27

3.7

3.3

129.43

128.98

g/l

0.62

4091

17287

Parasetamol

3473

8555

2.13

302.05

3.8

3.0

129.68

133.03

g/l

11.96

3377

8353

Other anaemias

2917

13354

2.19

298.26

5.7

3.1

111.48

130.10

g/l

307.65

2838

12963

Preparatory care for dialysis

572

1130

7.15

296.96

12.4

3.4

105.90

129.94

g/l

116.89

566

1101

Other and unspecified anaemias

2893

13289

2.19

295.66

5.8

3.1

111.37

130.10

g/l

307.65

2814

12899

Diverticular disease of intestine

4081

13561

1.96

294.98

3.8

3.0

127.52

129.87

g/l

7.92

3978

13204

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1538

2533

3.17

294.21

3.6

2.4

131.96

133.73

g/l

1.69

1497

2466

Asthma

3814

10062

2.03

294.08

3.8

2.7

131.01

132.04

g/l

1.75

3706

9822

Oedema, not elsewhere classified

1964

8015

2.56

293.86

4.6

2.8

125.26

129.88

g/l

14.66

1903

7797

Personality disorders, excluding more controls

1341

4637

3.08

290.53

3.3

3.2

132.30

132.34

g/l

0.02

1306

4536

Convulsions, not elsewhere classified

1416

5004

3.01

290.18

4.4

3.0

129.37

131.88

g/l

3.51

1378

4872

Mental and behavioural disorders due to psychoactive substance use

3398

16130

2.03

289.67

3.7

3.5

130.31

130.75

g/l

0.49

3291

15708

Other nutritional deficiencies

3568

17145

1.99

289.49

4.2

3.4

130.41

129.90

g/l

0.63

3469

16683

Examination and observation for other reasons

3220

8902

2.13

287.11

4.0

2.8

126.80

131.31

g/l

19.64

3170

8651

Other soft tissue disorders, not elsewhere classified

4925

15908

1.83

283.74

4.4

3.3

129.11

129.86

g/l

1.38

4784

15494

ILD medications: immunosuppressive drugs

3482

16566

1.99

283.41

7.5

2.8

120.90

131.84

g/l

133.82

3400

16138

Substance abuse

3305

15915

2.03

282.46

3.7

3.5

130.34

130.77

g/l

0.46

3201

15498

COPD/asthma related infections

4972

14086

1.83

280.44

4.4

2.8

127.35

131.23

g/l

24.26

4836

13725

COPD/asthma/ILD related infections

4972

14086

1.83

280.44

4.4

2.8

127.35

131.23

g/l

24.26

4836

13725

Pain, not elsewhere classified

1588

6204

2.73

274.32

4.7

2.8

129.06

130.83

g/l

2.28

1540

6038

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5837

18605

1.72

272.74

4.4

3.2

128.94

129.99

g/l

2.63

5726

18077

Hypothyroidism, drug reimbursement

542

625

6.41

271.55

3.9

1.8

129.02

139.84

g/l

18.33

521

612

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3459

18173

1.96

270.19

5.1

3.1

122.69

129.95

g/l

60.25

3341

17699

Cerebrovascular diseases

4266

16629

1.87

269.31

4.0

3.3

127.26

128.97

g/l

4.70

4154

16165

Disorders resulting from impaired renal tubular function

481

889

7.65

267.86

13.6

3.7

108.02

128.89

g/l

72.50

472

868

GI-bleeding

2224

10278

2.34

267.50

5.0

3.3

118.14

129.32

g/l

77.28

2167

9976

Diseases of the digestive system

2875

14470

2.09

267.26

5.0

3.4

119.79

129.52

g/l

80.58

2790

14068

Other diseases of the digestive system

2215

10233

2.34

266.79

5.0

3.3

117.97

129.37

g/l

79.89

2156

9929

Cardiodefibrillation

2424

11604

2.27

266.64

4.0

3.4

135.46

127.52

g/l

49.18

2373

11263

Disorders of gallbladder, biliary tract and pancreas

5225

19243

1.75

266.58

4.1

3.2

127.78

129.67

g/l

6.78

5082

18734

Hypokalaemia

954

2896

3.75

266.16

5.2

2.9

124.62

128.56

g/l

5.62

928

2820

Sub-endpoint used in defining T1D endpoints

1856

7810

2.51

265.27

5.7

3.6

123.89

130.27

g/l

25.19

1800

7607

Obesity

3317

16552

1.97

264.52

4.2

3.3

130.57

129.88

g/l

0.94

3227

16114

Obesity and other hyperalimentation

3329

16617

1.97

263.96

4.2

3.3

130.55

129.87

g/l

0.92

3239

16177

Asthma (only as main-diagnosis)

3469

10062

2.00

262.30

3.8

2.7

130.48

132.04

g/l

3.33

3371

9822

Myocardial infarction

2814

9717

2.15

262.23

4.6

2.7

123.46

130.78

g/l

47.08

2720

9477

Valvular operations

1041

3364

3.48

261.27

5.5

3.0

115.93

129.84

g/l

58.08

990

3270

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1034

3320

3.42

259.67

3.5

3.4

132.94

131.94

g/l

0.75

994

3239

Asthma-related infections

3337

17477

1.95

257.44

4.3

3.5

129.06

129.01

g/l

0.04

3236

17008

Asthma, hospital admission 2, infections

3337

17477

1.95

257.44

4.3

3.5

129.06

129.01

g/l

0.04

3236

17008

Fall on same level

5694

18381

1.70

256.08

4.0

3.4

128.39

130.87

g/l

12.01

5560

17877

Concussion

2490

9200

2.19

255.98

3.5

3.4

131.12

129.38

g/l

3.29

2429

8970

Asthma (mode)

3657

10187

1.95

255.29

3.6

2.7

131.06

132.11

g/l

1.80

3556

9945

Injuries to the head

5736

20822

1.69

254.34

3.5

129.34

129.77

g/l

0.70

5598

20251

All influenza

1669

6951

2.59

254.25

5.6

3.1

126.58

131.00

g/l

12.17

1605

6764

Oxycodone

2477

10264

2.19

253.55

4.4

3.0

120.21

130.48

g/l

83.81

2393

10017

Obesity due to excess calories

2518

12403

2.14

251.67

4.3

3.3

130.17

130.04

g/l

0.10

2453

12081

Intestinal infectious diseases, including avohilmo, including avohilmo

5920

20332

1.67

251.12

4.6

3.1

127.60

130.04

g/l

12.14

5741

19807

Unspecified kidney failure

927

2890

3.73

250.59

7.7

2.7

114.46

129.83

g/l

78.09

905

2806

Symptoms and signs involving the urinary system

4252

18454

1.81

250.44

4.4

3.2

127.24

129.60

g/l

8.92

4128

17969

Pacemaker

2501

11528

2.18

248.01

5.2

3.2

123.63

127.81

g/l

16.02

2394

11206

3243

15552

1.95

247.45

3.7

3.5

129.33

130.81

g/l

2.79

3143

15145

Other neurological diseases

4081

18113

1.83

246.83

3.8

3.3

128.81

128.58

g/l

0.26

3969

17621

Opioids

4680

13969

1.78

246.73

4.0

3.0

128.46

132.00

g/l

18.66

4545

13639

3355

15865

1.93

244.93

3.7

3.5

129.44

130.78

g/l

2.43

3250

15452

Paralytic ileus and intestinal obstruction

1718

7385

2.51

244.22

4.3

3.2

125.86

128.67

g/l

5.12

1655

7173

Unstable angina pectoris

2255

8393

2.26

241.97

4.4

2.7

126.22

129.85

g/l

10.77

2173

8178

Adjustment and management of implanted device

1314

5035

2.89

241.64

4.6

2.7

128.03

129.84

g/l

2.07

1287

4877

Codeine

4436

13793

1.79

240.46

3.6

3.0

129.66

131.96

g/l

7.98

4269

13468

Oral corticosteroids

5413

19434

1.69

238.80

4.1

3.1

127.76

130.44

g/l

13.14

5236

18945

Statin medication

3009

8644

2.03

238.46

4.4

2.8

129.41

132.24

g/l

7.98

2922

8417

Mental and behavioural disorders due to alcohol

2873

14355

2.00

238.27

3.7

3.5

130.14

130.86

g/l

0.84

2785

13976

Any mental disorder

5361

16284

1.70

236.35

3.9

3.4

129.83

129.53

g/l

0.39

5218

15854

Continuous positive airway pressure

864

2105

3.65

236.23

5.1

3.5

130.27

130.81

g/l

0.24

836

2063

Autoimmune diseases excluding thyroid diseases

5315

17571

1.69

233.78

4.6

3.2

126.48

131.15

g/l

36.48

5173

17120

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1518

6270

2.57

233.11

3.3

3.4

131.44

131.46

g/l

0.01

1459

6111

Alcohol use disorder, Swedish definition

3060

14977

1.95

232.48

3.7

3.5

129.08

130.90

g/l

3.71

2960

14591

Other functional intestinal disorders

2587

11976

2.06

231.23

4.5

3.4

127.26

129.21

g/l

4.51

2500

11645

Asthma-related pneumonia

2289

11249

2.16

230.48

4.6

3.5

126.46

127.78

g/l

1.95

2219

10935

Asthma-related pneumonia or sepsis

2292

11269

2.16

230.45

4.6

3.5

126.47

127.80

g/l

1.97

2222

10954

Asthma, hospital admissions 3, pneumonia

2292

11269

2.16

230.45

4.6

3.5

126.47

127.80

g/l

1.97

2222

10954

Mood disorders, excluding more controls

4558

15825

1.75

229.97

3.7

3.3

130.41

129.71

g/l

1.20

4420

15404

Low back pain

3984

15447

1.80

229.24

3.4

3.3

130.06

129.58

g/l

0.64

3868

15068

Inflammatory bowel disease treatment related agents

5708

19806

1.65

228.18

4.7

3.2

127.57

130.52

g/l

16.35

5535

19311

Autoimmune diseases excluding thyroid diseases, strict definition

5136

17019

1.69

227.10

4.6

3.1

126.45

131.08

g/l

34.55

5003

16589

Suicide or other Intentional self-harm

1374

5514

2.68

225.87

3.5

3.4

131.31

131.40

g/l

0.05

1322

5371

Any death

3627

14436

1.85

221.61

5.2

2.9

118.79

131.83

g/l

181.20

3534

14020

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2519

12959

2.03

217.96

3.7

3.5

129.86

131.08

g/l

1.66

2438

12616

Other disorders of urethra and urinary system

3626

14342

1.83

217.92

4.3

3.1

125.65

129.13

g/l

16.77

3532

13928

Nutritional anaemias

2907

15054

1.94

217.44

4.7

3.3

115.41

129.58

g/l

185.42

2824

14618

Neurological diseases, wide definition

1197

2050

3.05

215.69

4.0

3.4

132.93

131.49

g/l

1.08

1168

2004

Myocardial infarction, strict

2547

9282

2.05

212.28

4.5

2.7

123.91

130.70

g/l

37.74

2462

9052

Lower back pain or/and sciatica

5414

21298

1.63

211.56

3.4

130.01

129.54

g/l

0.77

5255

20738

Alcohol abuse, main dg, excluding more controls

954

3297

3.17

211.17

3.5

3.4

132.65

131.88

g/l

0.43

932

3218

Stroke, including SAH

3559

14660

1.83

211.05

4.0

3.2

127.45

128.46

g/l

1.68

3466

14245

Gastrointestinal diseases

2518

6258

2.08

208.25

4.0

2.5

129.64

133.96

g/l

14.96

2449

6093

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

5091

20471

1.64

208.00

4.6

3.1

128.45

130.04

g/l

4.95

4936

19944

Volume depletion

772

2400

3.66

207.65

5.4

3.1

122.77

127.67

g/l

6.59

743

2332

Other pulmonary diagnosis

3607

10157

1.84

207.31

4.0

2.7

128.99

132.08

g/l

11.25

3507

9915

Polyarthropathies

3493

12745

1.83

207.09

4.7

3.3

124.50

130.42

g/l

38.60

3389

12446

Persons encountering health services in other circumstances, wide

5709

18740

1.61

205.94

4.4

3.2

129.20

129.93

g/l

1.43

5574

18209

Hyperkalaemia

564

1446

4.69

205.22

8.8

2.9

116.52

127.85

g/l

24.76

543

1411

Iron deficiency anaemia

2520

13137

1.99

203.12

4.8

3.2

114.82

129.45

g/l

172.24

2450

12766

Schizophrenia or delusion, excluding more controls

1514

6547

2.41

202.73

3.1

3.3

131.02

130.93

g/l

0.05

1479

6388

Alcohol use disorder, ICD-based

2325

12056

2.04

202.30

3.8

3.5

130.08

131.10

g/l

1.20

2252

11741

Constipation

4631

19429

1.67

202.24

3.8

3.5

127.74

129.38

g/l

5.26

4472

18942

Infections of the skin and subcutaneous tissue

3098

17264

1.84

201.25

5.2

3.4

126.53

130.94

g/l

20.73

3017

16804

Falls/tendency to fall

5009

15586

1.65

200.67

3.8

3.4

129.24

130.70

g/l

4.02

4890

15151

Excluding asthma or asthma-COPD overlap

3579

10157

1.82

200.46

4.0

2.7

129.19

132.08

g/l

9.88

3481

9915

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3115

17706

1.84

199.72

5.0

3.2

122.75

129.55

g/l

48.41

3007

17237

Dorsalgia

4816

15779

1.66

199.49

3.4

3.3

130.76

129.65

g/l

2.54

4675

15392

Pain (limb, back, neck, head abdominally)

3447

9696

1.84

199.03

4.0

3.3

130.33

129.70

g/l

0.77

3355

9445

Certain infectious and parasitic diseases, including avohilmo

3326

9264

1.85

197.93

3.9

2.5

128.23

132.98

g/l

23.83

3239

9014

Medical observation and evaluation for suspected diseases and conditions

3196

8993

1.88

197.89

4.4

2.8

129.71

131.19

g/l

2.72

3118

8740

Haemorrhage from respiratory passages

1963

8500

2.16

196.27

4.6

3.1

125.82

128.40

g/l

4.89

1894

8274

Other disorders of kidney and ureter

985

3658

3.04

194.73

9.3

3.4

116.56

129.09

g/l

51.90

965

3551

Stroke, excluding SAH

3382

14155

1.81

193.96

4.1

3.3

127.35

128.31

g/l

1.50

3294

13750

COPD differential diagnosis

3560

10189

1.80

193.90

4.0

2.7

129.16

132.11

g/l

10.19

3461

9947

Peripheral artery disease

2682

11555

1.94

193.62

5.6

3.0

119.53

129.13

g/l

82.00

2600

11228

Intestinal stricture

1927

9545

2.16

193.06

4.4

3.5

125.07

128.27

g/l

7.13

1861

9273

ILD differential diagnosis

3554

10187

1.80

192.55

4.0

2.7

129.15

132.11

g/l

10.23

3455

9945

Unspecified mental disorder

2035

10239

2.09

191.62

3.4

3.5

130.99

130.80

g/l

0.15

1985

9980

Bronchitis

5387

20863

1.59

191.52

4.3

3.1

129.04

129.59

g/l

0.95

5247

20293

Hernia of abdominal wall, postoperative

1083

4163

2.77

191.34

5.0

2.5

124.63

134.92

g/l

34.38

1059

4067

Disorders of thyroid, IBD co-morbidities

762

1549

3.54

190.65

3.6

2.5

132.93

130.24

g/l

2.11

742

1515

Gout

1858

7785

2.20

188.71

5.5

3.2

121.59

129.23

g/l

32.61

1800

7590

Amiodarone users

842

2953

3.33

187.83

4.9

3.3

135.06

128.27

g/l

12.47

828

2865

5496

17999

1.59

187.76

4.2

3.1

128.90

129.44

g/l

0.91

5345

17522

Personality disorders

1341

5781

2.46

187.22

3.3

3.4

132.30

132.06

g/l

0.15

1306

5634

Conduction disorders

1601

5859

2.32

187.06

4.6

2.9

126.20

129.39

g/l

6.32

1546

5694

Anxiety disorders, excluding more controls

3799

14506

1.72

186.83

4.0

3.3

131.38

129.87

g/l

3.60

3698

14127

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3612

18885

1.73

186.80

4.1

3.3

126.37

129.08

g/l

10.06

3523

18364

Other or unspecified ileus, impaction or obstruction

1228

5168

2.58

184.00

4.2

3.2

125.33

128.35

g/l

4.23

1182

5025

Other antidepressants

5019

16339

1.61

181.91

3.6

3.3

130.30

129.47

g/l

1.62

4877

15928

Disorders of adult personality and behaviour

1385

6136

2.38

181.19

3.3

3.5

132.00

132.08

g/l

0.05

1344

5984

Asthma (diagnoses ohter than nonallergic)

4360

22224

1.63

181.10

3.8

3.4

129.99

129.34

g/l

1.10

4235

21635

Problems related to lifestyle

688

2171

3.50

178.38

4.1

3.1

133.34

132.64

g/l

0.30

669

2112

AV-block

1131

3903

2.67

178.34

4.4

2.8

124.30

128.59

g/l

7.89

1086

3794

Diabetic nephropathy, excluding more controls

1174

3987

2.70

176.69

9.0

3.2

115.09

131.34

g/l

96.52

1139

3883

Other disorders of skin and subcutaneous tissue

3800

19768

1.68

176.41

4.9

3.2

123.40

129.64

g/l

53.53

3695

19235

2311

12398

1.93

175.12

4.4

3.7

130.48

129.41

g/l

1.44

2242

12080

Substance use, excluding alcohol

1094

4474

2.62

172.89

3.9

3.5

132.57

132.00

g/l

0.33

1057

4356

COPD (mode)

1749

6655

2.17

172.60

4.4

2.6

127.49

130.57

g/l

5.78

1689

6489

Other reaction to severe stress, and adjustment disorders

1641

7908

2.16

172.36

4.1

3.3

129.94

131.14

g/l

1.27

1592

7713

Codeine or tramadol medication

5394

19290

1.56

172.06

3.6

3.2

129.23

129.93

g/l

1.28

5200

18830

Neurological diseases

3798

11485

1.71

171.34

3.7

3.5

131.65

128.92

g/l

9.81

3696

11194

Exposure to unspecified factor

4993

22240

1.57

170.87

3.8

3.5

129.32

129.71

g/l

0.54

4876

21622

Used for control exclusion in common control thyroid runs

5011

16324

1.59

170.85

4.4

3.1

128.65

131.06

g/l

9.96

4873

15910

Nerve, nerve root and plexus disorders

5209

20617

1.56

169.25

3.8

3.2

129.36

129.55

g/l

0.23

5035

20095

Intracranial injury

3066

16909

1.75

168.75

3.5

3.6

129.29

129.50

g/l

0.20

2987

16438

Persons encountering health services for specific procedures, not carried out

589

1752

3.75

168.53

4.2

2.7

128.98

133.92

g/l

5.34

584

1696

Obesity, other/unspecified

1655

8096

2.15

168.50

4.2

3.3

130.54

130.06

g/l

0.36

1613

7893

Insulin, fast-acting (human)

822

2964

3.01

167.82

6.5

3.0

122.02

132.60

g/l

29.10

799

2881

Ulcer of lower limb, not elsewhere classified

1076

4483

2.67

167.61

7.2

3.2

116.00

128.94

g/l

61.68

1062

4361

Specific personality disorders

1147

4857

2.50

166.84

3.3

3.5

132.00

131.86

g/l

0.07

1114

4732

Glucagon-like peptide-1 (GLP-1) analogues

1585

7678

2.18

166.73

4.1

3.3

132.81

131.03

g/l

2.24

1547

7469

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1585

7678

2.18

166.73

4.1

3.3

132.81

131.03

g/l

2.24

1547

7469

Myocardial infarction, without ST-elevation

2468

12500

1.89

166.41

4.7

3.2

122.28

128.49

g/l

34.08

2377

12164

Ischaemic Stroke, excluding all haemorrhages

3131

13695

1.76

165.11

4.0

3.2

127.30

128.13

g/l

1.15

3049

13298

Glomerulonephritis

717

2451

3.32

164.91

11.0

3.5

116.35

129.79

g/l

41.91

707

2379

Atherosclerosis, excluding cerebral and coronary sclerosis

2489

10953

1.89

164.73

5.5

3.0

119.53

128.89

g/l

72.46

2415

10640

Other acute lower respiratory infections

2859

15976

1.77

163.35

4.6

3.5

128.30

129.27

g/l

1.49

2786

15548

Diabetic maculopathy, excluding more controls

713

2429

3.25

163.04

6.2

2.8

117.69

131.49

g/l

43.14

692

2358

Episodal and paroxysmal disorders

5067

16829

1.57

162.85

3.8

3.4

131.66

128.65

g/l

15.98

4926

16376

Coronary artery bypass grafting

1573

5593

2.24

162.54

4.7

2.7

117.98

130.01

g/l

69.37

1508

5451

Depression

4480

19345

1.59

162.52

3.8

3.3

130.87

129.91

g/l

1.98

4342

18839

Anxiety (asthma-related co-morbidities)

2616

11246

1.82

161.66

4.0

3.5

132.61

130.97

g/l

3.15

2549

10965

Psychiatric diseases

4555

14605

1.60

161.52

3.8

3.4

130.07

129.50

g/l

0.84

4425

14222

Mood disorders

4854

20403

1.56

161.23

3.7

3.3

130.62

129.75

g/l

1.83

4705

19871

Misadventures to patients during surgical and medical care

932

3677

2.78

161.15

5.3

2.9

122.91

129.59

g/l

15.15

910

3575

Cholelithiasis, broad definition with cholecystitis

4224

17981

1.61

160.42

3.6

3.2

128.73

129.15

g/l

0.56

4109

17501

Transient ischemic attack

2884

13524

1.78

159.66

3.7

3.2

128.49

128.00

g/l

0.53

2816

13125

Mood [affective] disorders

4834

20387

1.56

159.44

3.7

3.3

130.64

129.75

g/l

1.89

4686

19855

Viral pneumonia

839

3157

2.91

159.02

6.2

3.2

124.94

131.15

g/l

11.35

805

3070

Viral hepatitis, IBD co-morbidity

303

561

5.94

158.46

4.2

2.6

130.23

134.06

g/l

1.52

294

549

Vocal cord dysfunction

541

1341

3.74

158.24

3.7

2.7

128.70

132.15

g/l

2.46

516

1306

Genitourinary diseases

2655

7413

1.85

157.78

5.0

2.7

129.45

134.93

g/l

22.66

2588

7236

Unspecified haematuria

2433

11170

1.86

157.52

4.7

3.2

126.07

129.56

g/l

10.67

2381

10840

Other special examinations and investigations of persons without complaint or reported diagnosis

3055

8996

1.77

157.42

4.3

2.8

128.94

131.18

g/l

5.44

2976

8743

Benign neoplasm of colon, rectum, anus and anal canal

3427

17947

1.68

157.08

4.0

3.2

125.49

128.98

g/l

14.99

3344

17456

Autoimmune diseases

5231

17649

1.54

156.98

4.5

3.2

127.78

131.15

g/l

19.72

5090

17196

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

558

1086

3.88

156.80

5.2

2.9

126.29

129.02

g/l

1.55

536

1063

Abnormal findings on examination of blood, without diagnosis

2647

13937

1.80

156.43

5.0

3.4

124.95

129.86

g/l

21.01

2573

13556

Calcific aortic valvular stenosis, operated

1929

9916

2.00

155.38

4.9

3.2

119.08

127.76

g/l

49.91

1873

9614

Calcific aortic valvular stenosis

1929

9916

2.00

155.38

4.9

3.2

119.08

127.76

g/l

49.91

1873

9614

Other and unspecified iron deficiency

1945

10373

1.97

154.95

4.6

3.2

115.16

129.35

g/l

130.42

1895

10077

Calcific aortic valvular stenosis, diagnosis (helper)

1925

9898

2.00

154.90

4.9

3.2

119.08

127.75

g/l

49.67

1869

9597

Operations 2 for CAVS

1925

9898

2.00

154.90

4.9

3.2

119.08

127.75

g/l

49.67

1869

9597

Gout, FINNGEN

1858

9787

2.01

153.36

5.5

3.2

121.59

129.45

g/l

35.72

1800

9510

Calcific aortic valvular stenosis, including rheumatic fever

1926

9930

1.99

153.12

4.9

3.2

119.10

127.75

g/l

49.45

1870

9628

Chronic lower respiratory diseases

5643

20208

1.51

153.02

3.8

3.4

130.37

129.62

g/l

1.53

5476

19679

Alcohol abuse, main dg

954

3901

2.66

152.38

3.5

3.6

132.65

131.63

g/l

0.65

932

3799

Retention of urine

2056

9016

1.95

151.41

4.2

3.2

125.25

129.37

g/l

12.66

1992

8739

Emotionally unstable personality disorder

624

2044

3.29

150.40

3.4

3.1

132.99

133.10

g/l

0.05

605

1991

Disorders of other endocrine glands

2256

12501

1.85

150.13

6.5

3.4

125.24

129.20

g/l

13.50

2191

12173

Implicit fungal Sepsis, including avohilmo

541

1661

3.72

149.08

7.7

2.5

119.79

130.30

g/l

19.34

522

1608

Other dorsopathies, not elsewhere classified

4638

15801

1.56

148.76

3.5

3.3

130.83

129.65

g/l

2.76

4493

15414

Benzodiazepine use

4826

21805

1.53

148.73

3.4

129.49

129.63

g/l

0.16

4679

21245

Cholelithiasis

4023

17695

1.60

148.56

3.5

3.2

128.73

129.08

g/l

0.42

3915

17220

Osteopathies and chondropathies

2902

16029

1.72

147.81

5.0

3.2

124.48

129.34

g/l

26.54

2814

15611

Kela-code for severe mental illness

1764

9279

1.99

146.22

3.2

3.5

130.76

130.87

g/l

0.07

1716

9043

Sciatica+with lumbago

2550

13193

1.77

145.78

3.4

3.3

130.30

129.35

g/l

1.29

2480

12862

Obesity related asthma

1798

9545

1.98

145.67

4.5

3.4

131.43

129.51

g/l

2.97

1750

9285

Other CVD

1359

6612

2.22

144.36

4.5

3.2

124.39

127.02

g/l

4.54

1312

6432

External causes of morbidity and mortality

2783

8079

1.77

144.27

3.5

3.3

129.08

131.27

g/l

4.90

2701

7868

Explicit bacterial Sepsis, including avohilmo

721

2642

3.00

144.19

5.6

2.7

118.75

131.38

g/l

34.11

703

2560

Combinations of oral blood glucose lowering drugs

1544

7846

2.09

143.62

3.3

3.2

129.00

129.96

g/l

0.86

1514

7612

General examination and investigation of persons without complaint and reported diagnosis

2920

8968

1.74

142.40

4.4

2.8

128.77

131.23

g/l

6.18

2834

8715

Other retinal disorders

3429

16449

1.64

142.40

4.8

3.2

125.09

128.99

g/l

18.92

3325

16009

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

469

1348

3.93

142.23

4.0

3.8

132.51

130.99

g/l

0.76

456

1313

Streptococcal septicaemia, including avohilmo

644

2259

3.18

140.64

5.5

2.7

118.66

131.42

g/l

31.09

629

2188

Explicit bacterial Sepsis

703

2579

3.00

140.30

5.5

2.7

118.69

131.33

g/l

34.24

685

2498

Other diseases of urinary system

4602

17204

1.54

140.25

4.3

3.3

127.30

130.17

g/l

13.68

4474

16742

Other external causes of accidental injury

3534

11033

1.65

139.71

3.6

3.5

129.41

130.18

g/l

1.09

3441

10727

Cardiomyopathy

945

3994

2.54

139.18

5.3

2.9

128.58

130.56

g/l

1.57

914

3880

Factors influencing health status and contact with health services

1341

3056

2.28

138.77

3.5

2.1

129.54

135.67

g/l

14.10

1306

2988

Benign neoplasm: Colon

2939

17045

1.69

138.75

4.1

3.2

125.52

128.70

g/l

10.98

2867

16575

Acute alcohol intoxication, ICD10

1152

5318

2.32

138.41

3.7

3.6

132.70

131.59

g/l

0.85

1122

5183

Streptococcal septicaemia

628

2194

3.20

138.16

5.3

2.8

118.50

131.42

g/l

31.76

613

2123

Venous thromboembolism

2847

16843

1.69

137.61

4.2

3.2

126.11

128.51

g/l

6.56

2775

16360

Alcohol dependence

1473

7473

2.09

137.30

4.0

3.5

130.33

130.69

g/l

0.23

1437

7272

Unspecified fall

2682

15946

1.71

136.92

4.1

3.5

128.25

128.97

g/l

0.89

2611

15517

Other anxiety disorders

1983

9302

1.87

136.34

3.7

3.4

132.28

131.37

g/l

1.02

1937

9073

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

434

1216

3.97

135.70

3.6

3.3

135.31

135.85

g/l

0.18

420

1191

Disorders of lens

3276

12717

1.65

135.26

5.0

3.2

124.97

130.62

g/l

33.28

3181

12410

Other bacterial intestinal infections

1084

4933

2.36

135.23

7.0

3.0

120.01

128.86

g/l

28.69

1048

4792

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

926

3810

2.54

135.08

7.9

4.5

121.16

131.14

g/l

28.81

906

3704

Neurotic, stress-related and somatoform disorders

3980

18041

1.56

133.35

4.0

3.4

131.37

130.04

g/l

3.12

3878

17559

Epilepsy

1610

8463

1.99

132.71

4.1

3.7

129.11

128.19

g/l

0.89

1573

8234

All anxiety disorders

2655

12392

1.71

132.23

4.0

3.4

132.61

131.01

g/l

3.12

2588

12072

Schizophrenia or delusion

1514

7834

2.03

131.90

3.1

3.4

131.02

131.26

g/l

0.16

1479

7632

Acute peritonitis

508

1626

3.62

131.88

10.7

3.2

113.75

128.34

g/l

34.86

502

1580

Early onset COPD, excluding more controls

1058

4795

2.34

131.77

4.6

2.7

130.19

132.01

g/l

1.61

1024

4678

Fungal Sepsis

367

951

4.60

131.59

9.0

2.4

116.31

129.88

g/l

21.17

356

921

Acute alcohol intoxication

1400

7080

2.09

131.42

3.7

3.5

131.56

130.51

g/l

0.91

1362

6886

Schizophrenia, schizotypal and delusional disorders

1521

7898

2.02

131.14

3.1

3.4

131.01

131.20

g/l

0.13

1485

7697

Anxiety disorders

4017

18238

1.55

130.95

4.0

3.4

131.43

129.99

g/l

3.59

3912

17751

Sequelae of external causes of morbidity and mortality

1457

7504

2.06

130.48

4.7

3.4

123.01

129.13

g/l

19.56

1423

7290

Disorders of mineral metabolism

558

1880

3.30

130.47

7.1

3.0

120.67

129.60

g/l

15.91

545

1824

Disorders of choroid and retina

4051

18877

1.55

130.26

4.6

3.2

125.95

129.60

g/l

19.26

3930

18384

Accidents

3483

11033

1.62

129.73

3.6

3.5

129.53

130.18

g/l

0.85

3389

10727

Cholecystectomy

3413

18777

1.59

128.27

3.6

3.3

129.53

128.31

g/l

2.47

3323

18265

Disorders of calcium metabolism

461

1407

3.72

127.93

7.4

2.7

118.77

129.17

g/l

18.13

451

1363

Cutaneous abscess, furuncle and carbuncle

1353

6845

2.08

126.39

5.8

3.4

126.06

131.15

g/l

11.83

1321

6668

Gastroduodenal ulcer

1511

7941

2.01

126.02

4.6

3.2

118.66

128.76

g/l

45.47

1476

7713

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

959

4139

2.41

125.69

7.7

4.5

121.37

130.94

g/l

27.71

937

4020

Hypotension

1184

5790

2.21

124.36

4.5

3.1

124.85

126.88

g/l

2.63

1155

5631

Soft tissue disorders

4604

16036

1.50

123.90

4.4

3.3

129.84

129.89

g/l

0.05

4480

15619

Type 1 diabetes, definitions combined

489

1559

3.38

122.88

4.3

4.8

131.41

135.16

g/l

3.02

475

1521

Type 1 diabetes, strict (exclude DM2)

485

1541

3.39

122.60

4.4

5.0

131.45

135.03

g/l

2.80

471

1502

Spondylopathies

3689

14330

1.56

121.53

3.3

128.99

129.15

g/l

0.16

3562

13980

Implicit fungal Sepsis

336

866

4.63

121.40

9.2

2.4

116.63

130.08

g/l

19.22

326

838

Diseases of liver

1808

10205

1.86

120.69

4.5

3.4

123.34

129.97

g/l

24.33

1756

9923

Cardiac arrest

356

769

4.28

120.63

6.5

2.3

123.53

133.34

g/l

10.63

333

752

Hypertensive Renal Disease

298

702

4.96

120.16

8.2

2.4

111.45

129.55

g/l

31.62

291

686

Other bacterial intestinal infections, including avohilmo

1267

6387

2.10

119.98

6.5

3.0

121.22

129.09

g/l

27.09

1225

6208

Cystic kidney disease

300

727

5.10

118.88

9.8

4.0

111.78

129.61

g/l

31.63

295

713

Pulmonary heart disease, diseases of pulmonary circulation

1783

10081

1.86

118.86

4.3

3.3

126.31

127.79

g/l

1.88

1729

9793

Gout, idiopatic and unspecified

1533

8366

1.96

116.37

5.5

3.3

122.15

129.24

g/l

23.97

1486

8111

Asthma, hospital admissions , main diagnosis only

3773

22160

1.52

116.32

3.8

3.5

130.11

129.41

g/l

1.11

3667

21565

DVT of lower extremities and pulmonary embolism

2231

13430

1.73

116.05

4.0

3.2

126.66

128.20

g/l

2.50

2178

13039

Liquid cancers, including Hilmo

1925

9814

1.81

115.84

4.9

3.3

119.38

131.01

g/l

82.13

1870

9544

Other headache syndromes

1853

10593

1.80

115.09

3.6

3.1

131.61

128.15

g/l

9.68

1794

10315

Cystic kidney disease, including avohilmo

310

792

4.76

114.14

9.6

3.9

112.00

129.56

g/l

32.27

304

776

Superficial injury of head

1320

6877

2.02

113.15

3.4

3.5

128.51

128.99

g/l

0.33

1284

6680

Congenital malformations of the urinary system

414

1284

3.68

112.41

9.3

4.7

114.79

130.53

g/l

33.07

406

1247

Other disorders of glucose regulation and pancreatic internal secretion

559

2057

3.01

111.61

5.8

4.0

124.21

129.67

g/l

6.35

543

1996

Autoimmune diseases related-to ILD

3897

22270

1.50

111.59

4.2

3.3

128.28

129.95

g/l

4.57

3789

21683

Unspecified acute lower respiratory infection

903

4127

2.35

111.58

5.6

3.3

127.51

130.53

g/l

3.55

884

4020

Asthma/COPD (KELA code 203)

4352

20187

1.47

111.31

3.7

3.4

130.37

129.62

g/l

1.31

4231

19658

Bacterial intestinal infections, IBD co-morbidities

1078

5290

2.18

111.03

7.0

3.2

120.13

128.74

g/l

27.50

1040

5139

Diseases of the respiratory system

2730

8474

1.66

110.74

3.7

2.7

128.36

131.24

g/l

7.89

2644

8278

Hernia

4285

19743

1.48

110.45

3.9

3.4

127.42

130.02

g/l

10.27

4186

19201

Urinary track infection

2187

6399

1.76

110.21

4.3

2.9

126.29

129.17

g/l

7.83

2129

6219

Viral and other specified intestinal infections, including avohilmo

1237

6081

2.03

110.21

6.2

3.2

128.53

132.26

g/l

6.54

1188

5921

Use of hypnotics and sedatives

4852

19596

1.45

109.61

3.9

3.3

128.45

130.13

g/l

5.39

4718

19080

Asthma, including avohilmo

5391

21333

1.42

109.55

3.6

3.5

130.97

129.33

g/l

5.73

5241

20767

Other diseases of pleura

2453

13331

1.67

109.40

5.0

3.3

124.05

128.44

g/l

16.59

2368

12952

Nonorganic sleeping disorders, excluding more controls

901

4123

2.29

108.78

3.8

3.3

132.66

130.99

g/l

1.48

885

4022

Delirium, not induced by alcohol and other psychoactive substances

843

3796

2.42

108.73

4.5

3.2

125.07

126.48

g/l

1.00

827

3682

Abnormal findings on diagnostic imaging of lung

2531

15174

1.64

108.38

4.2

3.2

125.88

128.68

g/l

7.87

2470

14737

Chronic pancreatitis

770

3348

2.51

108.28

4.9

3.3

123.31

130.43

g/l

13.53

747

3264

Open wound of head

2738

16543

1.60

108.04

3.5

3.6

128.37

129.64

g/l

2.16

2674

16082

Other intervertebral disc disorders

3705

14900

1.52

107.61

3.5

3.3

130.41

129.37

g/l

1.89

3573

14535

Other symptoms and signs involving cognitive functions and awareness

2400

13278

1.66

107.39

3.4

3.3

128.45

128.10

g/l

0.33

2335

12894

Hydronephrosis

675

2768

2.64

107.33

5.3

2.5

118.15

131.90

g/l

42.37

657

2682

Panic disorder

648

2582

2.65

107.28

3.7

3.2

133.52

132.21

g/l

0.77

628

2517

Congenital malformations of the urinary system, including avohilmo

428

1394

3.48

107.03

9.0

4.6

115.12

130.39

g/l

32.61

419

1351

Viral and other specified intestinal infections

964

4450

2.21

106.54

7.3

3.2

127.73

132.43

g/l

8.02

929

4335

Cough

1798

9732

1.78

106.20

4.4

3.2

129.23

128.97

g/l

0.19

1752

9481

Diabetic retinopathy, excluding more controls

1596

4910

1.94

106.05

6.1

3.1

122.43

131.20

g/l

37.69

1555

4780

Other/unspecified dorsalgia

1779

10205

1.79

106.00

3.5

3.3

129.72

128.63

g/l

1.26

1730

9947

COPD

2375

12026

1.67

105.97

4.4

3.3

127.99

128.08

g/l

0.06

2297

11695

Non-allergic asthma (mode), excluding more controls

866

3915

2.30

105.35

3.6

2.7

129.22

131.46

g/l

2.08

847

3826

Injuries to the thorax

2384

14998

1.65

104.93

3.9

3.4

128.55

129.28

g/l

0.82

2331

14589

Amputation

703

2986

2.60

104.92

7.9

3.1

113.79

128.45

g/l

52.56

686

2905

Acute bronchitis

2058

12254

1.71

104.22

4.6

3.5

128.57

128.59

g/l

0.01

2001

11926

Enterocolitis due to Clostridium difficile

710

3032

2.56

104.19

7.9

3.0

116.34

127.63

g/l

31.37

680

2942

Finngen Rheumatological endpoints

4164

16379

1.47

104.02

3.9

3.3

129.13

130.89

g/l

4.88

4028

15985

Other and unspecified nonorganic psychotic disorders

880

4073

2.27

103.82

3.0

3.4

132.80

132.56

g/l

0.11

863

3963

Disorder of lipoprotein metabolism, unspecified

765

3373

2.45

103.50

4.5

2.8

127.11

128.63

g/l

1.00

753

3280

Pulmonary embolism

1603

9153

1.84

103.37

4.2

3.3

126.02

127.90

g/l

2.53

1558

8892

Peripheral artery operations in Hilmo

808

3653

2.40

103.22

7.1

2.9

114.47

129.07

g/l

60.17

791

3555

Senile cataract

2954

11702

1.58

102.52

4.6

3.1

125.14

130.19

g/l

24.71

2865

11425

Elevated blood glucose level

553

2117

2.89

102.40

7.3

3.5

125.56

130.06

g/l

4.32

532

2051

Injuries to the abdomen, lower back, lumbar spine and pelvis

2088

12610

1.69

102.35

3.8

3.4

127.36

128.83

g/l

2.22

2037

12263

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

548

2085

2.88

102.06

5.7

3.1

125.89

129.95

g/l

3.92

531

2032

Persons encountering health services for examination and investigation

2816

8996

1.61

101.92

3.7

2.8

129.74

131.18

g/l

2.42

2741

8743

Pulmonary heart disease

1603

9191

1.83

101.91

4.2

3.3

126.02

127.91

g/l

2.57

1558

8929

Anaemia in chronic diseases classified elsewhere

248

588

5.35

101.87

12.9

2.9

106.86

130.09

g/l

51.58

240

569

Hypoglycaemia, other or unspecified

462

1616

3.20

101.67

6.0

4.2

123.79

129.55

g/l

5.74

450

1572

Acute upper respiratory infections of multiple and unspecified sites

3433

16953

1.51

101.55

4.4

3.3

130.08

129.52

g/l

0.73

3351

16492

Disorders of parathyroid gland

1164

5982

2.04

101.54

7.2

3.0

119.83

126.70

g/l

23.15

1130

5802

ILD medications: azathioprine

741

3234

2.44

101.41

9.9

2.8

121.87

132.74

g/l

28.88

722

3148

Bipolar affective disorders

818

3709

2.32

101.30

2.9

3.2

131.80

131.73

g/l

0.03

796

3622

Dorsopathies

4464

15887

1.45

100.97

3.8

3.4

130.94

129.64

g/l

3.13

4334

15498

Dysphagia

1256

6709

1.96

99.93

3.8

3.0

126.36

128.49

g/l

2.65

1207

6515

Hyperparathyroidism

1056

5286

2.11

99.85

7.3

3.0

119.48

126.74

g/l

22.90

1026

5127

Cytomegaloviral disease, including avohilmo

226

505

5.58

99.27

13.2

3.4

109.32

130.71

g/l

35.71

216

494

Vascular disorders of the intestines

495

1826

3.03

98.95

5.4

3.0

115.60

127.72

g/l

23.72

480

1775

Cytomegalovirus infection, IBD co-morbidity

223

499

5.64

98.14

13.4

3.5

109.05

130.88

g/l

36.98

213

490

Other/unspecified cytomegaloviral diseases

202

419

6.23

97.68

14.2

3.7

108.02

130.43

g/l

37.31

197

410

Other infectious diseases, including avohilmo

590

2389

2.72

97.40

6.0

3.2

122.99

128.52

g/l

6.84

582

2320

Cytomegaloviral disease

223

501

5.55

97.35

13.4

3.5

109.05

130.58

g/l

36.15

213

490

Diabetic nephropathy

1181

6260

2.05

97.21

9.0

3.5

115.11

129.05

g/l

79.00

1145

6100

Injuries to the hip and thigh

2509

14548

1.60

96.59

3.9

3.3

125.01

128.84

g/l

14.12

2449

14129

Peripheral arterial reconstruction

1061

5486

2.08

95.42

6.0

3.3

116.39

127.44

g/l

47.40

1027

5329

Cystitis

3680

15101

1.48

95.28

4.2

3.2

127.55

129.38

g/l

5.32

3578

14672

Gout, strict definition

1130

5974

2.03

95.23

5.8

3.3

122.02

128.85

g/l

17.13

1096

5802

Transport accidents

1960

9912

1.69

95.16

3.2

3.3

131.36

130.58

g/l

0.77

1903

9630

Intestinal adhesions without obstruction

548

2168

2.78

94.74

3.6

3.2

127.87

128.69

g/l

0.36

526

2106

Sequelae with surgical and medical care as external cause

1123

5914

2.02

94.63

4.9

3.3

121.92

128.80

g/l

18.98

1096

5746

Other chronic obstructive pulmonary disease

2257

11699

1.64

94.52

4.4

3.2

128.00

128.05

g/l

0.03

2181

11380

Sulfonylureas

1744

8252

1.75

92.82

4.4

3.1

121.96

127.81

g/l

21.72

1704

7997

Dermatitis

2934

19369

1.52

92.78

4.1

3.3

127.16

129.40

g/l

6.09

2847

18858

Azathioprine

741

3369

2.34

92.10

9.9

3.2

121.87

131.70

g/l

24.06

722

3279

Diseases of peritoneum

620

2633

2.57

92.09

9.4

3.1

116.25

128.69

g/l

32.04

608

2558

Gout, unspecified

1224

6714

1.94

91.59

5.5

3.3

122.02

129.11

g/l

19.42

1184

6517

Congenital malformations, deformations and chromosomal abnormalities

2407

14773

1.58

91.59

5.3

3.4

127.53

131.21

g/l

12.05

2344

14390

Diseases of the skin and subcutaneous tissue

4333

15470

1.43

91.43

4.2

3.1

128.36

130.79

g/l

9.23

4217

15052

Neoplasms

3076

10762

1.53

91.33

4.9

3.3

128.69

133.74

g/l

24.65

2997

10501

Status post-ami

1354

5724

1.89

90.40

4.2

2.7

125.52

129.86

g/l

9.52

1316

5582

Other viral diseases

1278

7048

1.88

90.13

7.2

3.9

126.09

131.62

g/l

14.03

1246

6868

Organic, including symptomatic, mental disorders

2710

12644

1.56

90.08

3.5

3.3

127.39

127.54

g/l

0.13

2644

12266

Type 1 diabetes, strict definition, subgroup 1

336

1030

3.49

90.00

4.1

5.3

133.08

137.01

g/l

2.47

326

1008

Other cataract

2145

10036

1.64

89.99

5.0

3.2

124.45

129.82

g/l

21.00

2082

9787

Functional dyspepsia

1260

6959

1.89

89.97

3.9

3.1

131.01

129.50

g/l

1.71

1225

6780

Benign neoplasms

4284

16657

1.43

89.82

4.0

3.4

129.44

130.69

g/l

2.76

4165

16231

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1051

5516

2.03

89.68

3.5

3.2

118.64

130.47

g/l

56.38

1030

5351

Other and unspecified drugs and medicaments

526

2097

2.76

89.57

5.7

3.2

125.86

129.38

g/l

3.03

510

2039

Failure and rejection of transplanted organs and tissues

154

271

7.63

89.45

14.6

3.6

106.64

133.35

g/l

33.06

154

266

Ascites

475

1802

2.91

89.43

6.7

2.8

113.78

129.17

g/l

35.76

464

1745

Injury, poisoning and certain other consequences of external causes

2152

6648

1.66

88.96

3.6

3.3

129.05

130.97

g/l

3.16

2086

6466

Symptoms and signs concerning food and fluid intake

568

2346

2.59

87.89

5.5

2.9

125.60

130.44

g/l

5.28

536

2274

Cardiomyopathies, Primary/intrinsic

625

2703

2.48

87.89

6.0

2.9

128.63

130.42

g/l

1.00

603

2628

Other gastritis (incl. Duodenitis)

1160

6309

1.94

87.88

4.3

3.3

123.95

129.29

g/l

11.88

1136

6134

Cellulitis

1141

6174

1.94

87.67

5.3

3.4

124.75

130.50

g/l

13.65

1104

6011

Malignant neoplasm of digestive organs, including Hilmo

2192

10272

1.63

87.54

3.3

120.43

130.95

g/l

76.48

2144

9994

Depression or dysthymia

2881

10490

1.54

87.03

3.7

3.4

130.64

129.16

g/l

2.64

2773

10225

Malignant neoplasm, wide definition

3724

15245

1.45

86.78

4.6

3.4

125.28

132.31

g/l

57.78

3633

14848

Acute pancreatitis

1038

5476

2.00

86.63

4.6

3.3

127.49

129.83

g/l

2.33

1001

5319

Shoulder lesions

3418

14209

1.48

86.51

3.5

3.1

130.57

129.50

g/l

1.84

3307

13835

Type 1 diabetes, strict definition

350

1130

3.30

86.02

4.3

5.5

132.98

136.84

g/l

2.46

340

1106

Cardiomyopathy (excluding other)

644

2848

2.42

85.98

5.9

2.9

128.60

130.57

g/l

1.18

621

2766

Malignant neoplasm, including Hilmo

3708

15222

1.45

85.37

4.6

3.4

125.22

132.33

g/l

58.80

3616

14826

Spinal stenosis

2479

12039

1.57

84.92

3.3

3.2

126.99

128.24

g/l

1.92

2399

11744

Osteoporosis

1424

7619

1.80

84.80

5.1

3.0

123.15

126.72

g/l

8.68

1376

7398

Other viral diseases, including avohilmo

1567

9252

1.73

84.54

6.3

3.8

127.51

131.70

g/l

10.25

1523

9014

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

245

647

4.30

84.33

8.6

3.0

119.46

136.03

g/l

19.49

239

632

Non-allergic asthma (mode)

866

4271

2.10

84.15

3.6

2.8

129.22

130.21

g/l

0.62

847

4168

Non-selective monoamine reuptake inhibitors

1724

10171

1.68

82.90

3.9

3.2

127.94

128.23

g/l

0.22

1662

9908

Symptoms and signs involving the skin and subcutaneous tissue

3238

21475

1.46

82.55

4.3

3.4

129.42

129.21

g/l

0.22

3134

20906

Enlarged lymph nodes

709

3304

2.25

82.32

4.1

2.9

126.98

131.15

g/l

4.78

690

3215

Other and unspecified dermatitis

2413

16087

1.54

81.57

3.9

3.3

127.28

129.32

g/l

4.32

2342

15660

Tobacco use

348

1176

3.31

81.50

3.6

3.2

133.11

130.98

g/l

0.82

340

1148

Post-traumatic stress disorder

348

1160

3.17

81.00

4.3

3.1

132.25

132.86

g/l

0.20

334

1136

All influenza (not pneumonia)

724

3433

2.23

80.87

6.2

3.0

127.84

132.75

g/l

7.08

691

3345

Other chronic obstructive pulmonary disease, including avohilmo

2680

14960

1.52

80.82

4.2

3.3

128.56

128.42

g/l

0.11

2592

14561

Intentional self-harm by unspecified means

128

204

7.87

80.69

4.0

4.6

132.83

133.83

g/l

0.19

123

199

Mental and behavioural disorders due to sedatives or hypnotics

388

1399

3.04

80.10

3.5

3.2

132.10

132.59

g/l

0.15

379

1361

KRA_PSY_EATING, excluding more controls

293

875

3.49

80.03

5.8

3.3

128.86

131.47

g/l

1.26

285

850

Focal epilepsy

1070

5849

1.92

79.64

3.9

3.8

129.52

129.51

g/l

0.00

1048

5684

Malignant neoplasm

3612

15034

1.44

79.61

4.6

3.4

124.89

132.23

g/l

61.80

3525

14640

Mycoses

1342

7859

1.78

78.73

5.3

3.4

125.68

129.65

g/l

8.14

1300

7642

Gastric ulcer

971

5179

1.98

78.56

4.8

3.1

118.28

128.57

g/l

32.51

945

5030

COPD related to multimorbidity

2063

11333

1.60

77.94

4.6

3.2

127.75

127.84

g/l

0.06

1995

11013

Ventral hernia

1213

6937

1.83

77.81

4.1

3.3

125.52

128.97

g/l

5.57

1179

6738

Other and unspecified effects of external causes

1182

6684

1.84

77.75

3.7

3.8

131.42

130.72

g/l

0.50

1150

6512

Spondylosis

2492

13111

1.53

77.44

3.1

3.3

129.87

128.87

g/l

1.37

2412

12792

Malignant neoplasm

3595

15026

1.43

77.34

4.6

3.4

124.86

132.23

g/l

61.97

3507

14633

Other specified and unspecified personality disorders

442

1731

2.74

77.00

3.1

3.2

131.71

132.48

g/l

0.29

430

1687

Acute sinusitis

2142

12758

1.56

76.84

4.6

3.2

131.01

130.24

g/l

0.83

2082

12422

Iron deficiency anaemia secondary to blood loss (chronic)

893

4672

2.03

76.84

5.5

3.1

111.42

129.15

g/l

80.51

864

4546

Migraine

1873

9215

1.62

76.40

3.2

3.3

133.43

129.10

g/l

15.58

1813

8983

Schizophrenia

752

3699

2.15

76.36

3.1

3.4

130.96

131.98

g/l

0.61

733

3600

Noninfective enteritis and colitis

2057

13428

1.57

76.29

4.8

3.6

127.51

129.84

g/l

4.69

2004

13067

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

837

4309

2.08

76.09

5.0

3.5

116.93

130.19

g/l

40.78

820

4198

Gastro-oesophageal reflux disease

2982

17615

1.46

76.02

3.9

3.3

128.48

130.50

g/l

5.17

2867

17159

Acute upper respiratory infections

4591

20497

1.37

75.99

4.1

3.2

129.69

129.06

g/l

1.07

4462

19942

Schizoaffective disorder

395

1475

2.90

75.97

3.0

3.1

130.93

132.65

g/l

0.90

384

1433

Recurrent or chronic depression

1545

6449

1.71

75.49

3.6

3.3

132.90

130.58

g/l

3.60

1504

6301

Amputation of toe

493

2082

2.64

75.27

8.4

3.1

113.60

128.28

g/l

39.25

482

2019

Traumatic subdural haemorrhage

753

3479

2.15

75.14

4.0

3.2

125.81

126.55

g/l

0.39

732

3380

Decubitus ulcer and pressure area

445

1793

2.77

75.02

7.0

3.1

116.74

127.86

g/l

19.10

435

1740

Selective serotonin reuptake inhibitors

4294

16420

1.38

75.01

3.5

3.4

130.71

129.47

g/l

2.82

4174

16009

Assault

603

2738

2.32

74.94

3.4

3.6

133.80

134.43

g/l

0.26

589

2676

Fracture of rib(s), sternum and thoracic spine

1589

9880

1.68

74.38

4.0

3.4

128.86

129.04

g/l

0.11

1553

9592

Certain disorders involving the immune mechanism

926

4955

1.97

74.02

9.1

3.5

123.11

130.15

g/l

15.71

904

4810

Hernia of abdominal wall

2156

14361

1.55

73.87

4.3

3.4

127.29

129.66

g/l

4.80

2102

13968

Diseases of the eye and adnexa

3158

11050

1.46

73.77

4.2

3.3

129.76

131.99

g/l

5.62

3067

10805

Viral infections characterized by skin and mucous membrane lesions

1925

12499

1.59

73.61

5.5

3.5

127.73

129.63

g/l

3.20

1862

12171

Thiazolidinediones

636

2999

2.29

73.58

4.1

3.2

126.09

129.03

g/l

2.34

624

2918

Endocarditis

245

713

3.91

73.47

7.6

3.1

113.74

130.19

g/l

16.75

237

694

Solid cancers, including Hilmo

3584

15033

1.42

73.25

4.1

3.4

125.64

132.25

g/l

50.68

3502

14641

Visual disturbances

2225

14942

1.53

72.94

4.4

3.3

130.32

128.88

g/l

2.40

2151

14536

Unspecified misadventure during surgical and medical care

384

1460

2.95

72.84

5.9

3.0

123.74

128.78

g/l

4.11

374

1417

Sequelae of cerebrovascular disease

1876

10354

1.61

72.75

4.1

3.3

125.81

127.80

g/l

3.28

1824

10045

Myalgia

1033

5734

1.87

72.32

3.8

3.1

131.91

129.51

g/l

3.11

1004

5596

Mental and behavioural disorders due to opioids

222

608

4.06

72.09

3.6

3.3

131.31

135.37

g/l

1.57

212

592

Other metabolic disorders

564

2531

2.35

71.99

4.9

3.0

129.56

129.83

g/l

0.10

546

2459

Other diseases of pericardium

284

917

3.46

71.85

7.2

3.1

116.71

129.57

g/l

16.37

274

889

Later onset COPD, excluding more controls

1111

4774

1.87

71.82

4.3

2.6

125.85

129.00

g/l

4.27

1072

4637

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2572

16157

1.48

71.72

5.1

3.4

127.86

131.04

g/l

9.81

2503

15715

Migraine with aura

902

4797

1.94

71.61

2.9

3.2

134.25

129.29

g/l

10.73

876

4682

Visual disturbances and blindness

2398

16413

1.50

70.98

4.5

3.4

129.75

128.76

g/l

1.40

2314

15969

Cervicobrachial syndrome

974

5350

1.90

70.79

3.1

3.2

132.21

129.13

g/l

4.37

951

5217

Acidosis

183

451

4.91

70.73

6.1

3.9

122.61

130.08

g/l

3.67

175

439

Acute pancreatitis (for exclusion)

1038

5843

1.87

70.65

4.6

3.3

127.49

129.74

g/l

2.20

1001

5679

Noninfectious colitis NAS

702

3478

2.14

70.29

5.2

3.4

126.16

129.26

g/l

3.08

688

3376

Any event in cancer register

3766

16095

1.39

69.57

4.6

3.4

125.28

132.04

g/l

55.54

3675

15677

COPD, early/later onset

2266

12903

1.52

69.56

4.4

3.2

128.01

128.13

g/l

0.08

2190

12547

Other noninfective gastroenteritis and colitis

1164

6780

1.79

69.39

5.3

3.6

125.65

129.13

g/l

5.90

1141

6594

Other diseases of anus and rectum

1417

8670

1.69

69.02

4.1

3.1

125.48

128.98

g/l

6.48

1371

8418

Diaphragmatic hernia

1711

11014

1.61

68.90

3.5

3.1

124.31

128.40

g/l

10.97

1679

10688

Other viral diseases, not elsewhere classified

837

4423

1.97

68.25

7.1

3.7

127.76

130.81

g/l

3.36

820

4304

Hypocalcemia

198

533

4.47

67.95

9.2

3.5

119.47

129.15

g/l

7.05

193

522

Postprocedural endocrine and metabolic disorders, not elsewhere classified

521

2318

2.37

67.94

4.3

2.8

129.99

129.71

g/l

0.11

504

2249

COPD, hospital admissions

2236

12815

1.52

67.74

4.5

3.2

128.04

128.12

g/l

0.06

2162

12456

Allergic asthma (mode), excluding more controls

795

4023

1.98

67.67

3.6

2.7

131.96

133.32

g/l

0.92

775

3941

Other and unspecified injuries of head

449

1895

2.58

67.61

3.3

3.6

129.54

129.17

g/l

0.12

443

1840

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

827

4405

1.99

67.57

3.6

3.3

120.89

130.99

g/l

30.09

809

4274

Other and unspecified local infections of skin and subcutaneous tissue

539

2459

2.35

67.34

6.9

3.5

123.79

130.08

g/l

7.60

529

2384

Diseases of the musculoskeletal system and connective tissue

2114

6962

1.55

66.90

4.3

3.5

130.40

131.44

g/l

1.15

2059

6807

Injuries to the shoulder and upper arm

3839

22064

1.37

66.59

3.7

3.4

129.52

129.62

g/l

0.09

3717

21495

Malignant neoplasm of digestive organs

1938

9793

1.56

66.48

3.3

120.26

130.79

g/l

69.26

1892

9527

Focal epilepsy, strict definition

974

5472

1.87

66.44

3.9

3.8

129.62

129.36

g/l

0.13

956

5320

Solid cancers

3464

14787

1.40

66.25

4.0

3.4

125.30

132.16

g/l

53.40

3382

14401

Speech and linguistic disorders, excluding more controls

343

1182

2.87

66.13

6.9

6.1

130.55

130.90

g/l

0.10

333

1151

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

445

1896

2.56

65.75

5.1

2.9

121.69

128.36

g/l

7.50

437

1836

Focal epilepsy, mode (most common among epilepsy diagnosis)

926

5146

1.89

65.52

3.6

3.7

129.70

129.40

g/l

0.16

909

5004

Other complications of surgical and medical care, not elsewhere classified

500

2234

2.39

65.38

4.8

2.9

126.58

130.10

g/l

2.70

480

2174

Other degenerative diseases of the nervous system

1267

5512

1.73

65.31

3.1

3.0

128.99

127.11

g/l

2.22

1237

5365

Other infectious diseases

458

1985

2.52

65.22

6.6

3.1

123.54

128.33

g/l

4.32

450

1929

Other and unspecified mood [affective] disorders

311

1105

2.99

64.98

2.8

3.2

131.55

133.06

g/l

0.58

304

1078

Polyneuropathies and other disorders of the peripheral nervous system

1140

6756

1.77

64.95

5.5

3.4

125.02

128.85

g/l

6.86

1110

6553

ILD, hospital admission 2, with pulmonary infections

549

2562

2.30

64.94

5.3

2.6

125.05

129.31

g/l

4.38

531

2486

Other local infections of skin and subcutaneous tissue

561

2640

2.27

64.81

6.7

3.5

124.11

130.04

g/l

7.12

551

2560

Other diseases of intestine

783

4150

1.99

64.50

5.3

3.2

122.88

129.43

g/l

10.73

754

4042

Undetermined asthma, excluding more controls

563

2636

2.24

64.49

4.6

2.6

131.16

131.49

g/l

0.13

544

2569

Disturbances of skin sensation

1145

6771

1.75

64.35

3.2

3.3

132.74

130.31

g/l

3.49

1103

6594

Myocarditis

200

547

3.92

64.09

5.9

2.4

130.18

136.64

g/l

3.24

194

536

Conductive and sensorineural hearing loss

3584

17594

1.38

64.04

3.6

3.4

127.77

129.06

g/l

2.72

3461

17147

Other and unspecified polyneuropathies, also in other diseases

1016

5859

1.83

64.03

5.0

3.3

124.78

128.66

g/l

6.46

987

5685

Migraine without aura

685

3449

2.05

63.95

3.7

3.5

132.95

130.16

g/l

2.90

662

3362

Lumbar disc prolapse

2688

14075

1.44

63.75

3.5

3.3

130.44

129.56

g/l

1.17

2594

13723

Nonischemic cardiomyopathy

518

2375

2.33

63.67

5.0

2.9

128.99

130.80

g/l

0.89

493

2320

Injuries to the knee and lower leg

5110

21386

1.31

63.22

3.6

3.4

129.86

129.57

g/l

0.38

4975

20804

Left ventricular outflow tract obstruction (LVOTO), broad definition

523

2421

2.32

63.10

6.8

4.3

123.52

132.42

g/l

12.55

512

2360

Mixed and other personality disorders

368

1453

2.71

63.03

3.1

3.2

132.31

133.65

g/l

0.52

359

1414

Sensorineural hearing loss

3453

16978

1.38

62.87

3.5

3.4

127.75

128.92

g/l

2.24

3332

16553

Phobic anxiety disorders

489

2179

2.33

62.59

4.7

3.2

133.10

133.60

g/l

0.18

478

2132

Irritable bowel syndrome

1094

6433

1.76

62.56

3.4

3.0

132.20

129.91

g/l

3.24

1065

6267

Candidiasis

682

3487

2.06

62.40

6.3

3.1

122.66

129.23

g/l

11.29

663

3387

Pain in joint

2209

9217

1.50

62.25

3.5

3.2

130.41

129.89

g/l

0.47

2137

8973

Other diseases of arteries and capillaries

498

2275

2.35

62.16

8.7

3.0

117.73

129.27

g/l

22.21

483

2211

Early onset COPD

1058

6215

1.78

61.95

4.6

3.4

130.19

129.58

g/l

0.36

1024

6040

Presence of other functional implants

2666

12944

1.44

61.84

4.2

2.7

125.40

130.22

g/l

22.63

2578

12622

Toxic effects of substances chiefly nonmedicinal as to source

556

2652

2.22

61.66

3.4

3.6

132.86

131.18

g/l

1.03

545

2582

Other blood glucose lowering drugs, excl. Insulins

786

4239

1.96

61.62

4.1

3.2

126.00

128.68

g/l

2.54

758

4108

Mental and behavioural disorders due to use of other stimulants, including caffeine

167

418

4.46

61.58

3.4

3.7

135.38

137.55

g/l

0.57

162

409

Nonorganic sleeping disorders

901

5045

1.85

61.47

3.8

3.5

132.66

130.77

g/l

1.88

885

4912

Cardiomyopathy, other and unspecified

387

1591

2.62

61.23

5.0

2.7

128.25

129.70

g/l

0.56

381

1545

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

999

5690

1.79

61.06

6.8

3.4

128.26

131.15

g/l

3.92

967

5536

Other respiratory disorders and diseases

1067

6316

1.77

60.92

5.5

3.5

127.03

127.69

g/l

0.39

1015

6138

Other diseases of the respiratory system

1067

6316

1.77

60.92

5.5

3.5

127.03

127.69

g/l

0.39

1015

6138

Other viral diseases, not elsewhere classified, including avohilmo

1088

6404

1.74

60.61

6.1

4.0

129.45

131.33

g/l

1.92

1061

6238

Other diseases of pancreas

480

2188

2.38

60.60

5.4

3.2

122.30

129.02

g/l

7.96

469

2123

Somatoform disorder

687

3554

2.02

60.26

3.6

3.3

131.36

129.65

g/l

1.28

663

3460

Exclusions for E4_PCOS_BROAD

789

4283

1.93

59.90

7.0

4.0

130.06

130.27

g/l

0.09

762

4164

Vascular diseases of the intestine

277

999

3.13

58.33

5.3

2.7

118.04

127.77

g/l

9.54

269

972

Periodontitis

4272

20901

1.32

58.27

4.2

3.2

128.54

129.86

g/l

3.15

4150

20343

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4155

20090

1.33

58.04

4.1

3.3

128.13

129.68

g/l

4.04

4039

19560

COPD, hospital admission 2, with asthma infections

1628

9244

1.57

57.80

5.0

3.2

127.29

127.95

g/l

0.54

1575

8973

Chronic ulcer of skin, not elsewhere classified

424

1878

2.47

57.62

7.2

2.9

118.34

128.66

g/l

16.46

416

1818

Other disorders of ear

3970

19544

1.33

57.40

3.7

3.5

128.83

129.46

g/l

0.94

3845

19051

Pain in thoracic spine

679

3559

1.99

57.35

3.2

131.08

129.31

g/l

1.28

661

3464

Liquid cancers

1409

8552

1.62

57.31

5.4

3.4

119.05

130.59

g/l

58.99

1367

8311

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

532

2585

2.21

56.87

5.6

3.1

120.80

129.13

g/l

12.52

517

2508

Viral pneumonia (unknown virus, not influenza)

373

1569

2.57

56.49

6.1

3.5

125.36

130.34

g/l

3.77

362

1525

Allergic asthma (mode)

795

4277

1.86

56.13

3.6

2.8

131.96

132.51

g/l

0.28

775

4183

ILD, hospital admissions 3, with pneumonia sepsis

483

2277

2.28

55.97

5.7

2.7

123.79

128.96

g/l

5.70

466

2207

Fibrosis and cirrhosis of liver

451

2075

2.36

55.88

5.6

3.2

115.52

129.05

g/l

25.91

442

2013

Chronic periodontitis, including avohilmo

4248

20911

1.32

55.86

4.2

3.2

128.51

129.88

g/l

3.32

4126

20352

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1420

9192

1.59

55.49

4.2

3.5

131.95

128.88

g/l

5.72

1362

8963

Injuries to the ankle and foot

2881

18075

1.39

55.39

4.1

3.5

130.32

130.58

g/l

0.25

2805

17577

Aortic valve malfunction, age under 60 years

477

2246

2.28

55.23

6.7

3.8

122.65

132.49

g/l

13.85

467

2186

Fracture of femur

1420

8287

1.60

55.16

4.2

3.3

121.42

127.01

g/l

17.86

1389

8046

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1392

9001

1.60

54.75

4.4

3.4

129.16

130.05

g/l

0.78

1352

8761

Additional codes for the location of defect, injury or illness

340

1398

2.66

54.52

3.9

3.3

132.54

128.80

g/l

2.34

335

1354

Chronic gastritis

1262

8034

1.63

53.51

3.8

3.1

123.30

128.08

g/l

10.68

1227

7807

Osteomyelitis

384

1685

2.49

53.34

8.2

3.4

115.49

129.64

g/l

28.51

377

1640

Aortic aneurysm

1162

7128

1.66

53.16

4.2

3.1

126.55

130.01

g/l

5.01

1125

6932

Undetermined asthma

563

2838

2.07

53.07

4.6

2.7

131.16

130.53

g/l

0.29

544

2761

Vitreous haemorrhage

551

2784

2.12

52.99

6.3

3.2

120.79

128.90

g/l

11.95

529

2698

Other arthritis (FG)

1326

8543

1.60

52.88

4.1

3.3

125.86

129.97

g/l

8.77

1290

8329

Systemic connective tissue disorders

1546

10312

1.55

52.78

4.7

3.2

125.11

127.92

g/l

5.74

1499

10024

Candidiasis, including avohilmo

1258

8011

1.62

52.78

5.1

3.2

126.31

129.11

g/l

4.41

1225

7791

Cirrhosis of liver, NAS

354

1515

2.59

52.65

6.1

3.1

113.39

129.28

g/l

27.94

348

1472

Other viral hepatitis

301

1180

2.74

52.62

4.9

3.3

130.32

134.52

g/l

2.18

292

1154

Fracture of lower leg, including ankle

2356

16676

1.42

52.26

3.8

3.4

127.58

129.50

g/l

3.86

2292

16229

Colectomy operation

851

4957

1.81

51.83

4.0

3.3

120.80

128.66

g/l

17.05

834

4816

Fracture of lumbar spine and pelvis

1149

7206

1.66

51.70

3.9

3.3

125.59

127.40

g/l

1.92

1120

7001

Alcohol withdrawal state with delirium

392

1760

2.43

51.62

4.7

3.6

128.46

130.84

g/l

1.07

379

1717

Benign neoplasm: Colon, unspecified

1238

7953

1.62

50.94

4.5

3.3

126.10

128.29

g/l

2.73

1203

7723

Carpal tunnel syndrome

2552

16184

1.39

50.76

3.5

3.2

129.00

129.04

g/l

0.04

2480

15778

Congenital malformations of heart and great arteries

577

2906

2.03

50.34

6.1

5.0

126.10

131.00

g/l

5.16

564

2828

COPD, hospital admissions 3, with asthma pneumonia sepsis

1380

7760

1.58

50.31

5.2

3.2

126.02

127.52

g/l

1.58

1335

7525

Abnormal findings on examination of urine, without diagnosis

270

1037

2.89

50.16

6.3

3.7

120.70

129.39

g/l

7.47

263

1010

Other problems related to primary support group, including family circumstances

436

1983

2.24

50.09

11.1

3.4

127.38

131.89

g/l

4.28

425

1931

Intentional self-harm by sharp object

149

400

4.15

49.99

3.8

3.9

131.65

134.15

g/l

0.77

143

387

Rotator cuff syndrome

2659

13449

1.39

49.98

3.5

3.1

130.28

129.35

g/l

1.24

2574

13098

Abnormal findings on diagnostic imaging of other body structures

693

3838

1.90

49.92

4.5

3.3

125.37

128.75

g/l

3.55

678

3717

Other viral hepatitis, including avohilmo

307

1249

2.63

49.61

4.8

3.3

130.59

134.72

g/l

2.16

298

1220

Unspecified dementia

649

3156

1.95

49.37

3.7

3.2

126.09

124.47

g/l

1.29

638

3060

Haemorrhage, not elsewhere classified

238

863

3.04

49.16

5.7

2.6

119.28

129.27

g/l

8.35

232

842

Other eating disorders

197

633

3.30

49.09

4.5

129.59

131.12

g/l

0.48

191

622

Sleep apnoea

3945

19355

1.30

48.50

4.0

3.3

132.96

129.04

g/l

21.77

3829

18841

Unspecified privation

523

2670

2.07

48.48

4.7

3.3

126.52

129.95

g/l

2.54

512

2584

Arthropathies

3579

13829

1.33

47.96

3.8

3.4

130.22

130.84

g/l

0.84

3471

13503

Congenital malformations of the circulatory system

630

3327

1.93

47.65

6.2

4.7

126.91

130.95

g/l

3.97

615

3233

Cervicalgia

896

5389

1.72

47.62

3.9

3.3

130.59

128.47

g/l

2.02

863

5254

Diseases of the ear and mastoid process

4648

18440

1.28

47.52

3.6

3.4

130.67

129.82

g/l

1.65

4518

17973

Other specified/unspecified arthritis

1153

7383

1.61

47.34

4.1

3.3

125.94

129.48

g/l

5.83

1121

7199

Other skin changes

963

5928

1.69

47.30

4.9

3.3

126.22

128.36

g/l

2.21

935

5757

Artificial opening status

319

1362

2.56

47.26

5.6

3.0

121.80

130.26

g/l

7.62

312

1319

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1148

7137

1.62

47.20

3.1

3.4

118.20

130.77

g/l

61.65

1125

6930

Idiopathic gout

546

2875

2.04

47.05

5.7

3.2

122.98

129.06

g/l

6.59

531

2797

Disorders of eyelid, lacrimal system and orbit

3690

21014

1.31

47.01

3.7

3.3

128.67

129.08

g/l

0.52

3575

20464

Assault by bodily force

339

1475

2.43

46.96

3.2

3.6

133.96

135.32

g/l

0.51

328

1441

Soft tissue disorders related to use, overuse and pressure

1200

7772

1.59

46.95

3.5

3.0

129.89

128.88

g/l

0.84

1177

7563

Coxarthrosis [arthrosis of hip](FG)

2455

12384

1.39

46.92

3.3

3.1

127.90

129.45

g/l

2.68

2382

12090

Abnormal serum enzyme levels

1478

9673

1.53

46.82

4.1

3.5

126.83

130.26

g/l

6.38

1444

9399

Type1 diabetes, definitions combined, early onset

261

1005

2.74

46.49

4.8

6.3

132.18

135.52

g/l

1.57

255

981

Alcohol-induced chronic pancreatitis

351

1576

2.42

46.22

4.5

3.6

125.79

131.32

g/l

3.62

338

1539

Acute and transient psychotic disorders

495

2517

2.06

46.02

2.9

3.2

131.00

131.85

g/l

0.35

481

2447

Generalized anxiety disorder

544

2847

1.97

45.44

3.0

3.2

133.50

131.91

g/l

0.94

530

2777

Chronic viral hepatitis

244

928

2.83

45.39

4.3

3.3

130.69

135.37

g/l

2.11

235

908

Duodenal ulcer

573

3095

1.96

45.02

4.2

3.3

117.52

128.99

g/l

20.53

561

3008

Diabetic neuropathy

738

4322

1.83

44.90

6.3

3.9

121.61

128.34

g/l

13.32

717

4210

Diagnoses used for exclusion with ILD

1169

7633

1.58

44.44

4.5

3.3

126.68

128.68

g/l

2.23

1128

7419

Other diseases of liver

799

4761

1.75

44.32

3.8

3.4

127.14

130.32

g/l

3.28

780

4629

Undefined dementia

659

3430

1.86

44.22

3.7

3.0

126.01

124.88

g/l

0.78

648

3339

Zoster [herpes zoster]

885

5426

1.70

44.20

4.4

3.2

126.12

127.74

g/l

1.37

857

5269

Other respiratory diseases principally affecting the interstitium

910

5629

1.69

44.17

5.2

3.3

123.96

127.64

g/l

5.03

881

5458

Adrenocortical insufficiency

219

807

3.01

44.11

11.4

3.8

127.04

129.22

g/l

0.69

211

784

COPD, hospital admissions 1, only main diagnosis

1641

9841

1.48

43.97

4.8

3.2

128.78

127.72

g/l

1.06

1589

9546

Pneumonitis due to solids and liquids

471

2408

2.09

43.94

4.9

3.2

124.73

127.69

g/l

2.12

450

2342

Event of undetermined intent

321

1411

2.44

43.91

4.2

3.4

131.68

132.48

g/l

0.25

315

1374

Open wound of lower leg

720

4186

1.80

43.82

4.8

3.4

126.20

129.34

g/l

2.99

700

4075

Disorders of psychological development

461

2140

2.08

43.77

5.4

132.30

132.20

g/l

0.03

448

2090

Diabetic retinopathy

1997

8926

1.45

43.75

5.8

3.6

122.50

128.64

g/l

26.06

1940

8689

Disorders of the thyroid gland

3883

19834

1.29

43.63

3.7

3.4

129.27

129.24

g/l

0.03

3759

19328

Fitting and adjustment of other devices

1524

9241

1.49

43.38

3.6

2.6

127.30

130.10

g/l

5.59

1486

8957

Viral hepatitis

327

1454

2.39

43.36

4.7

3.3

130.53

133.41

g/l

1.30

318

1416

Migraine with aura and triptan purchases

536

2845

1.94

43.24

2.6

3.5

134.61

130.27

g/l

5.81

520

2766

Sleep disorders (combined)

4591

19195

1.27

43.24

3.6

3.4

131.80

128.60

g/l

17.00

4448

18686

Open wound of ankle and foot

493

2565

2.03

43.16

5.1

3.3

124.14

131.02

g/l

8.29

488

2490

Amputation of foot

194

686

3.26

43.02

8.2

3.2

112.32

128.14

g/l

19.93

188

665

Superficial injury of lower leg

1084

6998

1.59

42.94

3.7

3.4

129.31

129.43

g/l

0.06

1062

6813

Eating disorder

296

1254

2.46

42.92

5.8

3.9

129.00

131.60

g/l

1.35

288

1223

Obsessive-compulsive disorder

249

976

2.67

42.89

4.8

3.7

132.14

133.15

g/l

0.31

242

958

Arthrosis

2936

12194

1.34

42.89

3.3

3.2

130.61

130.36

g/l

0.22

2836

11906

Other diseases of biliary tract

461

2365

2.08

42.48

4.8

3.3

120.08

127.83

g/l

11.10

447

2298

Fracture of skull and facial bones

912

5675

1.66

42.43

4.2

3.6

130.70

130.94

g/l

0.11

877

5523

Coagulation defects, purpura and other haemorrhagic conditions

856

5253

1.69

42.38

5.7

3.4

120.42

129.43

g/l

22.35

834

5111

Coxarthrosis

2228

10535

1.39

42.32

3.4

3.2

128.11

129.42

g/l

1.83

2161

10295

severe traumatic brain injury, does not include concussion

1098

7158

1.59

42.29

3.8

3.4

126.55

128.30

g/l

1.80

1072

6946

Other symptoms and signs involving general sensations and perceptions

248

993

2.74

42.21

3.9

3.3

128.50

127.16

g/l

0.42

242

966

Gonarthrosis [arthrosis of knee](FG)

3150

13938

1.32

41.96

3.1

130.16

130.10

g/l

0.05

3047

13605

Viral hepatitis, including avohilmo

333

1513

2.33

41.86

4.7

3.4

130.78

133.59

g/l

1.28

324

1473

Other disorders of adrenal gland

248

996

2.71

41.82

10.6

3.9

127.89

129.31

g/l

0.44

240

972

Shock, not elsewhere classified

182

5.87

41.36

11.2

2.9

113.90

128.73

g/l

5.55

176

Adverse effects, not elsewhere classified

757

4520

1.73

41.33

4.0

3.7

130.37

129.91

g/l

0.23

739

4396

Maltreatment syndromes

225

860

2.79

41.26

2.9

3.3

134.37

134.56

g/l

0.04

219

839

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

787

4765

1.72

41.17

3.2

3.8

131.08

129.56

g/l

1.08

773

4626

Periapical abscess

1881

13621

1.41

41.07

4.0

3.5

131.56

130.34

g/l

1.52

1822

13270

Chronic apical periodontitis

4579

20713

1.26

40.77

3.7

3.3

128.98

129.97

g/l

2.08

4442

20174

533

2886

1.91

40.71

6.8

3.0

125.59

130.61

g/l

5.13

520

2794

Primary_lymphoid and hematopoietic malignant neoplasms

1131

7487

1.57

40.64

6.0

3.4

117.88

128.77

g/l

44.65

1102

7268

Tubulo-interstitial nephritis, not specified as acute or chronic

327

1495

2.33

40.62

5.0

2.5

122.79

130.74

g/l

8.37

321

1451

Thoracic aortic aneurysm

714

4244

1.77

40.61

4.3

3.1

127.85

131.03

g/l

2.88

692

4131

Dermatitis and eczema

4660

22330

1.25

40.61

4.0

3.4

128.61

129.84

g/l

3.17

4523

21739

L04AX Other immunosuppressants

2225

16554

1.37

40.59

5.9

3.4

125.22

130.03

g/l

19.67

2161

16108

Emotional disorders starting during childhood or adolecense, excluding more controls

152

451

3.43

40.59

5.3

6.8

134.59

132.27

g/l

0.61

146

439

COPD-related respiratory insufficiency

614

3505

1.85

40.47

6.6

3.1

126.31

127.71

g/l

0.73

579

3407

Hyperkinetic disorders, excluding more controls

333

1408

2.26

40.45

5.4

4.6

133.54

134.52

g/l

0.34

320

1381

Exclusions for E4_PCOS_CONSORTIUM

2588

12169

1.35

40.26

4.0

3.4

128.69

128.85

g/l

0.13

2498

11860

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

701

4143

1.77

40.23

3.0

3.9

131.15

129.60

g/l

1.04

692

4018

Second line medication for Crohn's disease

2277

17019

1.36

40.13

5.8

3.4

125.33

130.14

g/l

19.96

2212

16565

Diabetic retinopathy, strict definition

982

5632

1.64

39.99

7.5

3.7

118.74

129.60

g/l

41.00

954

5476

Benign neoplasm of other and ill-defined parts of digestive system

819

5058

1.69

39.90

4.1

3.2

124.12

128.27

g/l

5.58

794

4905

Respiratory insufficiency

405

2018

2.12

39.88

5.3

2.7

131.94

128.77

g/l

1.86

380

1961

Cholecystitis

669

3920

1.78

39.72

4.2

3.1

126.33

128.16

g/l

1.17

655

3809

Psychotic depression

260

1086

2.53

39.55

3.2

3.1

132.67

129.40

g/l

1.59

252

1055

Injuries to the neck

926

5880

1.62

39.53

2.8

3.5

131.69

130.71

g/l

0.65

900

5729

Pericarditis

187

670

3.04

39.33

5.9

2.4

123.65

130.19

g/l

3.18

182

648

Phlebitis and thrombophlebitis (not including DVT)

996

6455

1.60

39.21

4.7

3.3

127.58

129.07

g/l

1.31

975

6288

Fentanyl

523

2863

1.91

38.96

4.3

3.1

118.64

128.72

g/l

21.31

506

2793

Amenorrhoea

239

963

2.59

38.94

7.1

3.0

126.38

129.15

g/l

1.16

233

943

Heartburn

462

2428

1.98

38.91

4.1

3.0

130.49

130.19

g/l

0.10

447

2357

Sleep apnoea, including avohilmo

4052

19648

1.26

38.66

3.9

3.3

133.15

128.93

g/l

25.77

3924

19135

Isolated proteinuria

173

606

3.20

38.46

6.9

3.7

119.13

130.45

g/l

7.35

168

591

Other arthrosis

2234

11158

1.37

38.22

3.3

3.2

129.39

130.06

g/l

0.69

2165

10902

Follow-up examination after treatment for conditions other than malignant neoplasms

1611

7568

1.44

38.11

3.3

2.8

128.23

130.54

g/l

3.71

1560

7352

Other systemic involvement of connective tissue (FG)

1072

6972

1.55

37.74

3.9

3.1

126.42

128.11

g/l

1.87

1037

6805

Diseases of the myoneural junction and muscle

599

3462

1.82

37.66

5.7

3.4

128.81

128.50

g/l

0.12

581

3358

Acute gastritis

372

1846

2.14

37.60

4.1

2.9

126.65

129.26

g/l

1.37

356

1789

Paralytic ileus

223

900

2.72

37.43

5.2

2.9

125.72

129.64

g/l

1.61

211

876

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

646

3279

1.76

37.33

4.6

4.7

133.50

134.20

g/l

0.35

624

3211

Hypercalcemia

265

1163

2.51

37.29

6.2

3.0

118.05

128.07

g/l

11.12

260

1126

Eating disorders

357

1732

2.14

37.27

5.0

3.6

129.33

131.01

g/l

0.79

347

1690

Pleural effusion

772

4785

1.69

37.26

5.0

3.2

118.16

127.97

g/l

27.63

751

4639

Aneurysms, operations, SAH

721

4384

1.71

37.23

3.4

3.2

127.44

128.16

g/l

0.36

707

4260

Status epilepticus

215

855

2.76

37.21

5.6

3.8

126.01

127.73

g/l

0.49

207

832

Total colectomy operation

226

920

2.68

37.17

5.1

3.2

125.03

130.60

g/l

2.63

221

898

Total colectomy

226

920

2.68

37.17

5.1

3.2

125.03

130.60

g/l

2.63

221

898

Symptoms and signs involving the nervous and musculoskeletal systems

2417

18472

1.33

36.81

4.1

3.5

129.92

128.82

g/l

1.66

2334

17991

Left ventricular outflow tract obstruction, narrow definition

257

1114

2.50

36.70

6.4

5.2

122.73

132.07

g/l

7.82

249

1087

Other and unspecified myopathies

462

2495

1.97

36.67

6.0

3.1

128.06

128.52

g/l

0.16

447

2424

Gonarthrosis

2660

11527

1.32

36.12

3.1

130.33

129.97

g/l

0.34

2574

11257

Other pleural conditions

533

3022

1.86

36.03

6.3

3.1

118.49

127.57

g/l

16.49

513

2928

Any dementia, excluding more controls

1717

8543

1.42

35.89

3.3

3.2

127.62

126.46

g/l

1.40

1679

8276

Cholangitis (primary sclerosing, PSC)

324

1557

2.23

35.85

5.9

3.3

119.64

128.83

g/l

10.55

315

1517

Hypothyroidism, strict autoimmune

2794

14207

1.31

35.84

3.7

3.0

127.87

130.05

g/l

5.72

2703

13853

Urolithiasis

1413

10017

1.45

35.44

4.1

3.5

131.36

129.28

g/l

2.69

1381

9724

Other embolism and thrombosis

599

3523

1.78

35.26

4.9

3.2

124.66

128.69

g/l

4.19

584

3426

Exposure to other specified factors

3202

21817

1.28

35.24

3.6

3.5

130.28

130.04

g/l

0.23

3115

21227

Use of disulfiram, acamprosate or naltrexone

393

2035

2.04

35.09

3.7

3.5

133.31

133.57

g/l

0.07

381

1985

Speech and linguistic disorders

354

1683

2.11

34.99

7.8

5.9

130.52

131.44

g/l

0.33

344

1640

Subjective visual disturbances

1045

7014

1.53

34.81

3.6

3.2

130.89

129.15

g/l

1.76

1003

6829

Oesophagitis

286

1326

2.32

34.78

5.2

3.1

122.72

129.83

g/l

5.38

281

1290

Other specific joint derangements/joint disorders

2752

13311

1.31

34.50

3.4

3.3

131.05

130.98

g/l

0.06

2664

12997

Superficial injury of abdomen, lower back and pelvis

663

4020

1.71

34.42

4.0

3.4

129.81

130.09

g/l

0.12

644

3907

Fall on and from stairs and steps

1107

7539

1.51

34.34

3.4

3.5

128.56

129.21

g/l

0.43

1075

7337

Superficial injury of hip and thigh

712

4404

1.68

34.33

3.9

3.3

126.53

128.54

g/l

1.60

696

4276

Polyuria

995

6646

1.55

34.20

3.9

3.2

129.86

129.31

g/l

0.33

968

6434

Blood alcohol or alcohol intoxication level

139

459

3.36

34.11

5.0

3.7

136.02

132.90

g/l

0.80

134

445

Disorders of vestibular function (Vertigo)

1979

14487

1.36

34.09

3.2

3.3

130.78

127.83

g/l

8.33

1923

14077

Type of accident

1210

8399

1.48

33.90

4.3

3.5

128.70

129.96

g/l

1.23

1176

8181

Migraine without aura and triptan purchases

508

2862

1.82

33.89

3.6

133.55

130.73

g/l

2.43

492

2784

Colorectal cancer, including Hilmo

1221

7918

1.48

33.72

3.0

3.3

121.59

130.22

g/l

29.57

1193

7697

Lung diseases due to external agents

672

4125

1.70

33.66

4.4

3.2

125.87

127.76

g/l

1.36

647

4007

Hypothyroidism, other/unspecified

3485

18395

1.26

33.41

3.7

3.3

128.66

128.91

g/l

0.26

3361

17927

Suppurative and necrotic conditions of lower respiratory tract

303

1465

2.23

33.28

5.5

3.2

120.03

129.02

g/l

8.04

292

1421

Parkinson's disease, excluding more controls

585

3176

1.76

33.27

3.3

3.1

128.02

126.47

g/l

1.02

570

3092

Superficial injury of thorax

672

4130

1.69

33.27

3.9

3.4

128.81

129.96

g/l

0.64

656

4014

Persistent mood disorders

724

4521

1.65

33.23

3.9

3.1

129.68

129.62

g/l

0.02

698

4402

Diseases of pulp and periapical tissues, including avohilmo

4259

18003

1.24

33.18

3.6

3.4

129.49

129.28

g/l

0.24

4137

17546

Congenital malformations of aortic and mitral valves

218

920

2.57

33.15

6.2

4.6

121.85

132.46

g/l

8.32

211

897

Vitamin deficiency, wide

245

1087

2.42

33.07

5.0

3.1

128.19

128.11

g/l

0.02

235

1052

Vitamin deficiency

245

1087

2.42

33.07

5.0

3.1

128.19

128.11

g/l

0.02

235

1052

Injuries to the wrist and hand

4078

22104

1.24

33.03

3.4

3.5

131.59

129.47

g/l

7.30

3964

21515

Injuries to unspecified part of trunk, limb or body region

478

2690

1.86

32.91

4.6

3.5

125.34

129.26

g/l

3.12

464

2615

Other disorders of skin and subcutaneous tissue, not elsewhere classified

647

3954

1.70

32.89

5.9

3.2

119.78

129.46

g/l

22.27

625

3840

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1312

9153

1.44

32.72

3.8

3.7

132.70

131.71

g/l

0.88

1272

8912

Alcoholic liver disease

485

2755

1.86

32.56

4.1

3.4

118.54

130.86

g/l

18.88

472

2691

Arterial embolism and thrombosis

309

1514

2.18

32.54

7.0

2.8

119.78

128.34

g/l

8.24

296

1473

Alzheimer disease, excluding more controls

789

3219

1.64

32.53

2.8

3.0

128.86

126.00

g/l

2.99

768

3132

Nontraumatic intracranial haemmorrhage

914

6061

1.56

32.53

3.8

3.3

127.18

127.47

g/l

0.14

894

5886

Vascular syndromes of brain in cerebrovascular disorders

260

1198

2.37

32.53

3.5

3.1

127.34

126.46

g/l

0.25

255

1165

Chronic periodontitis, complicated

2357

17799

1.31

32.51

4.6

3.3

127.68

129.80

g/l

4.35

2295

17313

Calculus of kidney and ureter

1292

9158

1.45

32.50

4.0

3.5

131.23

129.35

g/l

2.10

1264

8892

Impacted teeth

608

3107

1.72

32.43

4.1

3.6

134.88

133.95

g/l

0.52

596

3035

Purpura and other haemorrhagic conditions

603

3633

1.73

32.41

5.7

3.5

119.19

129.33

g/l

20.13

589

3526

Cerebral palsy and other paralytic syndromes

492

2803

1.83

32.36

4.5

3.7

130.06

129.18

g/l

0.37

478

2714

Disorders of skin appendages

1833

13681

1.35

31.72

4.6

3.4

129.22

130.44

g/l

1.52

1788

13313

Appendectomy

2376

17562

1.31

31.71

3.4

131.09

130.27

g/l

1.02

2317

17088

Other diseases of blood and blood-forming organs, wide

924

6179

1.54

31.59

6.3

3.4

121.97

129.33

g/l

14.56

894

5995

Vascular dementia

519

2920

1.80

31.47

3.5

3.2

125.93

124.28

g/l

0.97

509

2836

Other congenital malformations of the digestive system

217

930

2.49

31.19

10.6

6.2

124.38

129.54

g/l

2.62

212

906

Disorders of vitreous body and globe

2155

15694

1.32

31.11

4.0

3.3

127.90

128.36

g/l

0.42

2086

15246

Diseases of inner ear

2263

16779

1.31

31.10

3.2

3.3

130.87

128.24

g/l

7.33

2190

16316

Hypothyreosis and Thyroxine purchase for inclusion criteria

3601

19171

1.24

30.87

3.7

3.3

128.61

128.96

g/l

0.42

3473

18687

Extreme obesity with alveolar hypoventilation

219

958

2.48

30.86

4.8

2.9

134.13

129.25

g/l

2.13

207

932

Inflammatory bowel disease

1192

8398

1.45

30.70

4.3

3.6

129.30

130.78

g/l

1.39

1150

8182

Cerebral cysts

259

1211

2.27

30.58

4.7

3.6

130.18

129.86

g/l

0.07

245

1177

Disorders of vitreous body

2096

15339

1.33

30.55

3.9

3.3

128.10

128.38

g/l

0.23

2028

14900

Other diseases of stomach and duodenum

316

1597

2.10

30.51

4.5

2.8

121.59

129.26

g/l

6.61

305

1550

Dementia, including avohilmo

2163

11346

1.33

30.42

3.0

3.3

127.95

126.69

g/l

1.93

2107

10992

Other necrotizing vasculopathies

363

1930

2.00

30.41

6.6

3.0

120.76

127.96

g/l

7.51

354

1872

Hepatic failure, not elsewhere classified

214

935

2.50

30.39

7.5

3.0

115.59

129.06

g/l

10.34

202

910

DVT of lower extremities

847

5613

1.56

30.37

3.9

3.3

127.25

128.52

g/l

0.91

835

5462

Cervical disc disorders

1408

10230

1.41

30.33

3.4

3.2

130.29

129.11

g/l

1.16

1352

9971

Parkinson's disease, strict definition, excluding more controls

547

3037

1.74

30.30

3.3

3.1

128.50

126.42

g/l

1.57

533

2956

Alzheimer’s disease (Atypical or mixed), excluding more controls

460

1935

1.86

30.07

2.9

129.31

124.17

g/l

5.14

449

1891

Abnormal involuntary movements

591

3613

1.70

30.04

4.6

3.4

129.79

128.88

g/l

0.46

578

3508

Complications of internal orthopaedic prosthetic devices, implants and grafts

990

6789

1.50

29.94

3.8

3.0

123.02

128.25

g/l

10.57

956

6595

Viral pneumonia (known virus, not influenza)

172

687

2.77

29.81

10.1

4.5

123.63

127.01

g/l

1.04

164

673

Malignant neoplasm of bladder, including Hilmo

588

3561

1.70

29.63

4.3

3.3

124.55

130.40

g/l

7.52

573

3454

Somnolence, stupor and coma

219

972

2.42

29.59

5.9

3.2

123.60

128.28

g/l

2.20

210

944

Fracture of shoulder and upper arm

1512

11155

1.38

29.41

3.8

3.5

125.89

128.80

g/l

5.46

1466

10862

Benign neoplasm: Ascending colon

661

4186

1.65

29.39

4.3

3.2

125.59

128.29

g/l

2.20

649

4064

Malignant neoplasm of urinary organs, including Hilmo

556

3375

1.73

29.34

4.6

3.3

120.31

130.52

g/l

19.85

547

3277

Cyst of kidney

368

1990

1.97

29.34

4.9

3.0

123.52

128.46

g/l

3.88

358

1925

Benign paroxysmal vertigo

1228

8788

1.43

29.27

3.1

3.3

131.18

127.56

g/l

7.76

1190

8546

Other and unspecified visual disturbances

466

2699

1.80

29.05

4.8

3.2

133.28

129.29

g/l

4.05

458

2621

Other ulcerative colitis

258

1232

2.22

28.92

5.1

3.2

128.70

132.02

g/l

1.46

247

1196

Arthropathies in other diseases classified elsewhere

193

824

2.54

28.72

7.2

3.2

120.01

129.50

g/l

6.09

188

806

Other joint disorders

3275

13791

1.25

28.62

3.6

3.4

131.36

130.87

g/l

0.59

3164

13465

Injuries to the elbow and forearm

2800

19233

1.26

28.50

3.6

3.5

128.68

129.62

g/l

1.45

2734

18714

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

348

1858

1.98

28.50

3.4

3.0

127.96

127.00

g/l

0.34

341

1807

Operations for atrial fibrillation

115

387

3.52

28.33

4.8

3.2

126.98

129.07

g/l

0.38

108

379

Infective dermatitis

497

2951

1.76

28.31

4.5

3.2

125.46

129.80

g/l

4.16

484

2862

Missing teeth due to accident, extraction or parodontitis

2615

18629

1.27

28.23

3.9

3.3

126.78

129.12

g/l

5.96

2514

18156

Diabetic maculopathy

704

4328

1.62

28.21

6.2

3.7

117.49

129.67

g/l

38.31

683

4210

Asthma and allergy, excluding more controls

359

1898

1.91

28.14

4.2

2.9

134.94

134.09

g/l

0.30

353

1853

Disorders of synovium and tendon

2007

13122

1.32

28.05

3.6

3.1

129.89

129.74

g/l

0.11

1941

12775

Neuromuscular dysfunction of bladder

403

2263

1.87

28.02

5.7

3.0

127.73

129.65

g/l

0.91

384

2193

Social phobias

267

1296

2.13

28.00

3.8

3.5

133.47

133.94

g/l

0.12

262

1274

Viral warts

397

2216

1.87

27.94

7.7

3.3

126.34

130.61

g/l

2.93

382

2154

Smoking dependency

381

2107

1.90

27.88

4.5

3.3

130.36

130.61

g/l

0.07

364

2051

Other arterial embolism and thrombosis

158

627

2.76

27.60

7.1

2.8

117.56

127.31

g/l

5.43

152

609

Mental and behavioural disorders due to tobacco

381

2114

1.89

27.59

4.5

3.3

130.36

130.60

g/l

0.07

364

2059

Deforming dorsopathies

1043

7316

1.46

27.50

4.0

3.4

128.74

128.78

g/l

0.02

1011

7129

Other symptoms and signs involving the digestive system and abdomen

597

3729

1.64

27.41

5.2

3.0

124.05

128.37

g/l

5.00

568

3630

Benign neoplasm: Sigmoid colon

847

5758

1.52

27.02

3.7

3.4

125.12

128.48

g/l

3.92

833

5595

Immunodeficiencies

222

1033

2.30

26.81

11.6

4.4

125.85

128.90

g/l

1.18

216

1001

Other pulmonary heart/vessel disease

250

1226

2.20

26.63

5.5

3.5

129.36

126.33

g/l

1.16

240

1187

Colorectal cancer

1069

7283

1.45

26.60

2.9

3.2

121.53

130.21

g/l

26.83

1043

7074

ILD, hospital admissions

713

4699

1.58

26.59

4.7

3.3

126.37

127.84

g/l

0.98

691

4558

Crohn disease

493

2966

1.72

26.50

4.8

3.4

128.71

131.04

g/l

1.43

477

2878

Any dementia

1863

9914

1.33

26.30

3.2

127.32

126.34

g/l

1.20

1823

9596

Dental operations

2595

10616

1.27

26.20

3.7

3.2

128.25

129.36

g/l

1.56

2513

10386

Familial hypercholesterolemia

624

4000

1.61

26.07

3.7

3.0

125.02

128.22

g/l

2.73

606

3883

Interstitial lung disease endpoints

722

4798

1.56

25.90

4.8

3.3

126.40

127.82

g/l

0.94

700

4652

Interstitial lung disease

722

4798

1.56

25.90

4.8

3.3

126.40

127.82

g/l

0.94

700

4652

Fracture of foot, except ankle

891

6145

1.48

25.84

4.7

3.5

128.65

130.67

g/l

1.90

871

5978

Secondary right heart disease

230

1107

2.25

25.81

5.6

3.1

128.41

126.11

g/l

0.72

220

1072

Other interstitial pulmonary diseases

722

4802

1.56

25.80

4.8

3.3

126.40

127.85

g/l

0.97

700

4655

Other congenital malformations of the digestive system, including avohilmo

236

1131

2.20

25.80

10.0

6.2

124.93

129.27

g/l

2.13

231

1102

ILD, hospital admissions 1, main diag only

642

4168

1.61

25.72

4.6

3.2

126.96

127.85

g/l

0.46

624

4045

Polycystic ovarian syndrome, consortium definition

2321

10490

1.28

25.64

3.8

2.9

127.64

127.85

g/l

0.17

2239

10221

Myocardial infarction, with ST-elevation

810

5518

1.52

25.60

4.6

3.4

124.92

128.15

g/l

3.76

784

5357

Dilated cardiomyopathy

544

3407

1.67

25.47

5.7

3.4

128.94

129.07

g/l

0.04

525

3312

Attention to artificial openings

206

951

2.32

25.46

5.2

2.8

121.12

131.29

g/l

9.05

201

911

Fall on same level involving ice and snow

2283

18166

1.27

25.35

3.4

129.29

g/l

0.00

2229

17661

Bicuspidal aortic valve syndrome

186

826

2.43

25.31

5.0

4.5

120.96

132.35

g/l

8.28

179

805

Diplopia

558

3512

1.65

25.30

4.8

3.1

129.87

129.15

g/l

0.33

539

3408

Psoriasis

1106

7971

1.42

25.25

3.7

3.4

129.85

130.10

g/l

0.13

1083

7752

Diseases of oral cavity, salivary glands and jaws

2460

10065

1.28

25.22

3.8

3.1

128.23

129.11

g/l

1.08

2379

9842

Malignant neoplasm of bladder

356

1993

1.88

25.20

4.5

3.3

123.67

129.22

g/l

4.32

347

1935

Emphysema

354

1980

1.88

25.15

4.0

3.2

129.60

127.86

g/l

0.68

344

1922

Postprocedural disorders of digestive system, not elsewhere classified

175

760

2.50

25.15

5.5

3.4

121.30

129.31

g/l

3.73

168

740

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

475

2886

1.72

25.08

4.6

3.3

120.07

130.66

g/l

18.01

468

2806

Other necrotizing vasculopathies (FG)

300

1598

2.00

25.06

5.9

3.0

122.52

128.86

g/l

5.05

291

1561

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3580

23186

1.21

25.02

4.1

3.5

129.14

129.80

g/l

0.97

3472

22579

Osteoporosis with pathological fracture (FG)

370

2105

1.86

24.99

4.7

2.9

121.93

126.31

g/l

3.86

353

2058

Asthma and allergy

359

1971

1.84

24.98

4.2

3.1

134.94

133.43

g/l

0.64

353

1922

Other aneurysm

273

1411

2.06

24.94

5.3

3.0

122.00

128.90

g/l

4.51

263

1370

Leisure time condition

737

4945

1.53

24.86

4.2

3.4

129.42

129.55

g/l

0.06

718

4809

Radiculopathy

658

4312

1.57

24.83

4.0

3.3

129.58

127.62

g/l

1.35

634

4204

Thyroiditis, ILD-related definition

421

2472

1.76

24.81

3.5

3.3

130.71

129.14

g/l

0.85

414

2398

Gonarthrosis,primary

3713

18669

1.21

24.61

3.0

3.4

129.56

128.74

g/l

1.36

3592

18184

Ovarian cyst

1124

4587

1.43

24.56

3.3

3.0

128.63

126.93

g/l

1.92

1083

4493

Other symptoms and signs involving the circulatory and respiratory systems

260

1319

2.06

24.55

4.8

3.0

129.22

128.57

g/l

0.17

246

1277

Other disorders of bone

709

4726

1.54

24.53

3.8

3.2

131.22

131.24

g/l

0.01

685

4606

Malignant neoplasm of urinary organs

468

2850

1.72

24.52

4.7

3.3

119.33

130.59

g/l

19.79

459

2770

Hypopituitarism

309

1667

1.94

24.48

5.9

4.1

133.55

133.09

g/l

0.12

295

1622

Superficial injury of wrist and hand

741

4982

1.52

24.48

3.4

3.7

132.10

130.52

g/l

1.15

728

4852

Other systemic involvement of connective tissue

1090

7881

1.42

24.48

4.1

3.1

126.48

127.69

g/l

1.15

1055

7660

Other shoulder lesions

374

2134

1.82

24.45

3.0

132.31

130.27

g/l

0.98

366

2068

Benign neoplasm: Adrenal gland

361

2052

1.86

24.41

3.6

3.1

128.34

128.71

g/l

0.11

345

1990

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1983

10463

1.30

24.39

3.6

3.3

126.76

130.70

g/l

12.44

1920

10175

Papulosquamous disorders

1532

11668

1.34

24.34

3.6

3.4

129.42

129.44

g/l

0.01

1499

11355

Dislocation, sprain and strain of joints and ligaments at neck level

530

3314

1.64

24.33

2.7

3.3

134.74

131.54

g/l

2.67

515

3217

Abnormalities of gait and mobility

568

3634

1.63

24.28

4.9

3.5

127.65

127.81

g/l

0.06

549

3535

Dementia

1986

10648

1.30

24.20

3.0

3.3

128.24

126.65

g/l

2.71

1936

10308

Degeneration of macula and posterior pole

2133

13045

1.28

24.14

3.7

3.2

126.53

127.62

g/l

1.43

2071

12669

Bulimia nervosa (incl. atypical)

105

356

3.09

24.07

3.5

3.0

127.67

131.35

g/l

0.91

100

349

Umbilical hernia

1094

7939

1.41

24.05

4.6

3.3

129.29

130.90

g/l

1.45

1072

7722

Intestinal malabsorption

217

1045

2.21

24.02

8.3

3.0

123.18

131.23

g/l

5.43

209

1014

Primary hyperparathyroidism

472

2895

1.70

23.96

3.7

3.0

126.44

127.44

g/l

0.47

454

2807

Benign neoplasm of other and unspecified endocrine glands

547

3477

1.63

23.84

3.5

3.2

128.87

129.26

g/l

0.14

520

3374

Pyothorax

228

1128

2.17

23.75

5.7

3.2

119.64

129.26

g/l

6.80

220

1101

Benign neoplasm: Transverse colon

508

3198

1.66

23.38

4.1

3.2

124.57

128.55

g/l

3.23

501

3105

Malignant neoplasm of pancreas, including Hilmo

415

2483

1.75

23.30

3.1

120.14

129.76

g/l

16.63

406

2418

Volvulus

149

624

2.59

23.24

6.5

2.8

122.24

128.76

g/l

2.52

144

604

Fibromyalgia

305

1659

1.90

23.22

2.7

2.6

131.63

129.56

g/l

1.05

295

1616

Malignant neoplasm of skin, including Hilmo

2131

11328

1.28

23.14

3.6

3.3

126.82

131.06

g/l

14.73

2065

11031

Trochanteric bursitis

567

3661

1.60

22.89

2.9

129.25

127.43

g/l

1.21

551

3560

Other and unspecified tonsillitis

1054

6328

1.41

22.76

4.6

3.5

135.09

133.39

g/l

1.55

1017

6176

Pulmonary oedema

118

449

2.94

22.74

7.2

2.9

112.35

125.73

g/l

7.92

113

435

Cerebral aneurysm, nonruptured

366

2127

1.80

22.74

3.6

3.0

127.61

129.47

g/l

0.80

360

2059

Other other unspecified disorders of the circulatory system

187

872

2.31

22.74

4.8

3.4

120.99

128.56

g/l

4.76

169

849

Nonalcoholic fatty liver disease

402

2400

1.74

22.51

3.4

131.54

131.06

g/l

0.15

392

2333

Amputation of thigh

176

806

2.37

22.49

6.7

2.9

112.26

125.54

g/l

11.53

171

782

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1903

10160

1.29

22.40

3.5

3.3

126.63

130.49

g/l

11.46

1841

9876

Malignant neoplasm of colon, including Hilmo

821

5730

1.47

22.30

3.1

3.2

120.69

129.88

g/l

21.68

803

5566

Coxarthrosis, primary

2561

17363

1.24

22.29

3.3

127.94

127.99

g/l

0.04

2487

16887

Irregular menses

1367

7727

1.35

22.29

4.5

2.9

128.91

129.05

g/l

0.08

1325

7520

Haemorrhoids and perianal venous thrombosis

1303

9752

1.35

22.18

3.5

3.0

128.17

129.16

g/l

0.89

1264

9476

Thyrotoxicosis

916

6539

1.43

22.15

3.6

3.2

131.36

128.13

g/l

4.59

886

6356

Contact with and exposure to communicable diseases

398

6497

0.60

22.14

6.9

3.8

130.40

132.34

g/l

0.94

376

6330

Pyogenic arthritis

306

1702

1.89

22.14

6.4

3.4

121.84

129.25

g/l

6.10

294

1663

Malignant neoplasm of kidney, except renal pelvis

421

2564

1.72

22.12

4.7

3.3

119.21

130.67

g/l

18.34

414

2488

Disorders of muscles

403

2426

1.72

21.78

4.7

3.2

128.93

130.08

g/l

0.47

389

2363

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

251

1326

2.02

21.72

4.3

3.0

118.25

130.42

g/l

14.41

239

1283

Specific development disorders of speech and language

234

1154

2.04

21.54

5.9

6.9

130.52

130.33

g/l

0.04

226

1122

Appendicitis, broad definition

2706

19999

1.23

21.47

3.4

132.00

130.13

g/l

4.22

2636

19457

Ulcer of oesophagus

321

1834

1.84

21.39

4.4

3.0

121.72

129.51

g/l

6.76

311

1779

Ulcerative colitis

884

6311

1.43

21.35

4.2

3.4

128.67

131.13

g/l

2.45

848

6149

Childhood asthma (age<16), excluding more controls

300

1278

1.87

21.35

4.2

3.3

134.79

138.14

g/l

1.76

294

1254

Malignant neoplasm of skin

2026

10929

1.27

21.33

3.5

3.3

126.84

130.89

g/l

12.94

1955

10634

Acute appendicitis

2530

19243

1.23

21.22

3.3

3.4

132.23

130.27

g/l

4.33

2463

18726

Non-Hodgkin lymphoma, all, including Hilmo

569

3754

1.57

21.13

4.6

3.3

120.86

130.41

g/l

17.94

560

3643

Other disorders of eye and adnexa

531

3441

1.59

21.13

3.8

3.6

130.02

129.57

g/l

0.18

514

3340

Other disorders of eyelid

1855

13905

1.28

21.12

3.8

3.3

127.73

127.52

g/l

0.16

1812

13507

Abnormal findings on diagnostic imaging of central nervous system

212

1061

2.11

21.09

3.0

3.5

131.95

130.28

g/l

0.49

205

1031

Diseases of appendix

2725

20129

1.22

20.96

3.4

131.99

130.11

g/l

4.30

2655

19584

Panniculitis affecting regions of neck and back

161

731

2.34

20.67

4.0

2.9

128.18

128.92

g/l

0.15

156

711

Postprocedural disorders of nervous system

233

1208

2.00

20.66

5.4

3.1

133.97

131.34

g/l

1.18

227

1174

Dermatophytosis

581

3870

1.55

20.58

4.1

3.4

129.34

129.94

g/l

0.25

560

3757

Other and unspecified nerve root and plexus disorders, also in other diseases

763

5346

1.46

20.57

3.6

3.3

131.89

130.36

g/l

1.12

725

5211

Polyarthrosis

841

5393

1.44

20.48

3.4

3.2

126.39

127.23

g/l

0.53

806

5275

Other or ill-defined heart diseases

202

1002

2.10

20.38

5.5

3.1

127.81

130.98

g/l

1.05

197

970

Other sleep disorders

435

2718

1.65

20.30

3.7

3.3

129.96

129.17

g/l

0.33

419

2648

Other bursopathies

518

3375

1.58

20.22

3.4

3.2

127.02

129.46

g/l

1.67

509

3279

Disorders of sclera, cornea, iris and ciliary body

2076

16800

1.25

20.10

4.4

3.3

127.92

129.81

g/l

3.34

2013

16352

Emotional disorders and disorders of social functioning with onset specific to childhood

164

737

2.26

20.05

5.8

6.9

133.89

133.01

g/l

0.20

158

719

Need for other prophylactic measures

253

1371

1.94

20.03

7.7

3.6

124.90

130.49

g/l

3.27

253

1328

Childhood asthma (age<16)

300

1307

1.82

19.91

4.2

3.5

134.79

137.62

g/l

1.35

294

1284

Psoriatic and enteropathic arthropathies

437

2748

1.64

19.87

4.0

3.3

130.16

130.90

g/l

0.28

426

2685

Cardiac murmurs and other cardiac sounds

317

1808

1.78

19.84

5.5

4.1

126.00

128.65

g/l

1.13

305

1760

Open wound of wrist and hand

1674

12793

1.28

19.68

3.5

3.6

132.94

131.11

g/l

2.62

1631

12453

Right hemicolectomy

282

1593

1.87

19.68

4.2

2.9

117.88

127.45

g/l

9.57

275

1549

malignant neoplasm of female genital organs, including Hilmo

655

4288

1.50

19.61

3.0

121.56

128.16

g/l

13.01

646

4166

Examination and encounter for administrative purposes

355

2133

1.73

19.55

3.3

2.9

130.39

130.31

g/l

0.02

343

2062

Paracetamol or NSAID medication

613

2041

1.54

19.53

4.3

4.1

129.87

130.47

g/l

0.24

598

1986

Multiple myeloma, including Hilmo

229

1217

2.01

19.50

5.2

2.9

111.66

130.09

g/l

26.37

223

1177

Pneumonia derived septicemia

167

791

2.26

19.49

7.3

3.9

120.62

128.31

g/l

4.38

162

767

Other disorders of nervous system

294

1682

1.84

19.48

4.4

3.0

126.19

129.21

g/l

1.33

279

1636

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

348

2087

1.74

19.44

5.1

2.9

115.84

127.90

g/l

20.09

339

2025

Other epidermal thickening

210

1082

2.06

19.42

4.9

3.3

125.01

128.99

g/l

1.74

202

1053

Adhesive capsulitis of shoulder

623

4254

1.50

19.35

3.7

3.2

128.72

129.00

g/l

0.11

605

4145

Intracerebral haemorrhage

564

3784

1.54

19.33

4.2

3.1

126.99

127.03

g/l

0.02

552

3679

Allergic contact dermatitis

454

2896

1.61

19.32

3.6

3.2

131.61

129.89

g/l

1.13

444

2815

Lesion of ulnar nerve

535

3546

1.55

19.30

3.6

3.3

130.56

130.50

g/l

0.02

521

3455

Sequelae of injuries, of poisoning and of other consequences of external causes

863

6250

1.41

19.27

3.4

3.5

129.56

131.00

g/l

1.02

837

6084

Urticaria and erythema

1237

9444

1.33

19.26

4.4

3.6

129.73

129.59

g/l

0.08

1198

9209

Other Crohn's disease

255

1399

1.90

19.17

4.1

3.3

127.94

132.77

g/l

2.68

248

1360

Psoriasis vulgaris

711

4993

1.46

19.09

3.8

3.4

129.61

130.36

g/l

0.37

695

4851

Car occupant injured in other and unspecified transport accidents

650

4482

1.48

19.08

3.2

3.3

133.06

130.99

g/l

1.50

632

4364

Abdominal aortic aneurysm (AAA)

444

2813

1.62

19.04

4.3

3.1

122.50

127.92

g/l

4.62

430

2735

Toxic effect of carbon monoxide

103

401

2.84

18.99

2.9

3.2

131.78

129.37

g/l

0.50

103

392

Benign neoplasm: Descending colon

331

1978

1.76

18.91

4.4

3.1

124.32

128.11

g/l

2.13

325

1918

Thyrotoxicosis, other and/or unspecified

708

4971

1.46

18.89

3.5

3.2

132.10

128.32

g/l

4.57

681

4843

!Aliquae complicationes praecoces traumatis

207

1072

2.05

18.89

4.3

3.1

127.04

130.44

g/l

1.20

200

1044

Early complications of trauma

207

1072

2.05

18.89

4.3

3.1

127.04

130.44

g/l

1.20

200

1044

Other mental disorders due to brain damage and dysfunction and to physical disease

535

3579

1.55

18.74

4.1

3.2

126.03

126.90

g/l

0.40

526

3467

Agranulocytosis

440

2818

1.62

18.70

6.3

3.4

116.02

129.22

g/l

26.30

426

2727

Artrosis, including avohilmo

3203

14773

1.20

18.68

3.1

3.5

131.50

129.36

g/l

5.74

3101

14411

Malignant neoplasm of colon

672

4697

1.47

18.67

3.0

3.2

120.26

129.72

g/l

19.65

657

4563

Hypothyroidism, strict autoimmune, 3 medication purchases required

3100

17548

1.20

18.65

3.5

3.3

127.87

128.71

g/l

1.34

2999

17092

Benign neoplasm: Skin of other and unspecified parts of face

442

2838

1.62

18.63

4.1

3.1

127.65

128.03

g/l

0.14

432

2756

Embedded and impacted teeth

754

4321

1.44

18.62

4.5

3.6

133.28

133.58

g/l

0.15

735

4211

Basal cell carcinoma, including Hilmo

1878

10217

1.26

18.56

3.3

126.58

130.56

g/l

11.82

1812

9931

Abnormal blood-pressure reading, without diagnosis

172

835

2.15

18.50

3.5

3.2

131.31

129.34

g/l

0.47

167

810

Congenital malformations of cardiac septa

258

1393

1.87

18.42

5.8

6.5

129.64

130.28

g/l

0.16

252

1355

Basal cell carcinoma

1824

9972

1.27

18.39

3.4

3.2

126.54

130.46

g/l

11.15

1761

9693

Other enthesopathies

1029

7711

1.36

18.31

3.3

3.1

130.84

129.47

g/l

1.16

998

7517

Budesonide

502

3316

1.55

18.31

3.3

3.0

128.94

131.05

g/l

1.30

476

3221

Haemolytic anaemias

170

832

2.19

18.30

8.5

3.9

114.75

128.50

g/l

8.54

165

814

Other diseases of oesophagus

397

2497

1.65

18.24

3.6

3.1

124.51

129.02

g/l

3.33

385

2422

Lichen simplex chronicus and prurigo

278

1596

1.83

18.22

5.2

3.0

123.19

129.60

g/l

4.80

273

1545

Injury of unspecified body region

330

1985

1.73

18.20

4.9

3.6

125.45

128.99

g/l

2.03

319

1924

Open wound of forearm

391

2451

1.65

18.16

4.3

3.3

128.17

129.96

g/l

0.87

385

2383

Invasive ventilation

313

1859

1.76

18.15

4.7

3.5

122.37

129.07

g/l

4.88

301

1801

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1123

8544

1.34

18.13

3.8

3.5

131.84

130.86

g/l

0.73

1092

8315

Superficial injury of ankle and foot

422

2690

1.61

18.03

4.3

3.5

131.37

131.26

g/l

0.03

405

2615

Rheumatoid arthritis

1186

8036

1.33

18.00

3.5

3.1

123.96

128.54

g/l

10.69

1151

7837

Malnutrition

123

534

2.52

17.99

6.9

5.5

122.27

127.57

g/l

1.84

113

520

Extrapyramidal and movement disorders

1569

12482

1.28

17.97

3.4

3.3

128.97

128.10

g/l

0.90

1530

12112

Anorexia (incl.atypical)

185

930

2.06

17.91

5.8

3.6

128.60

130.41

g/l

0.58

179

907

Emotional disorders starting during childhood or adolescence

153

710

2.22

17.88

5.2

6.9

134.49

132.91

g/l

0.40

147

692

Diseases of male genital organs

2071

8459

1.25

17.82

4.3

3.8

132.00

132.26

g/l

0.17

2011

8265

Symptoms and signs involving speech and voice

1262

9789

1.31

17.71

4.1

3.4

129.44

128.24

g/l

1.19

1227

9508

Benign thyroid growths and nodules

1221

8751

1.32

17.68

3.1

129.52

127.06

g/l

3.88

1187

8524

Secondary uncertain malignant neoplasm

564

3855

1.51

17.66

3.6

3.2

119.84

130.41

g/l

24.63

555

3741

Dependent personality disorder

391

2.76

17.61

3.5

2.8

129.05

130.29

g/l

0.21

384

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

588

4015

1.50

17.59

4.1

3.1

124.49

129.06

g/l

5.60

574

3897

Ocular pain

315

1884

1.73

17.59

3.5

3.4

130.98

129.86

g/l

0.44

307

1829

Hyperplasia of prostate

1554

6905

1.29

17.57

4.0

3.5

130.29

130.52

g/l

0.13

1499

6749

Zoster [herpes zoster], including avohilmo

2053

16246

1.24

17.56

3.6

3.3

127.92

128.47

g/l

0.54

1983

15804

Acute appendicitis, no complications

1896

15324

1.24

17.48

3.4

3.5

133.13

130.64

g/l

5.14

1852

14925

Traumatic subarachnoid haemorrhage

170

844

2.13

17.45

5.4

3.0

124.97

127.25

g/l

0.60

165

824

Need for immunization against other single viral diseases

107

443

2.66

17.41

8.3

3.2

114.18

132.22

g/l

11.42

107

433

Disorders of speech understanding and production

187

941

2.05

17.40

5.2

6.9

130.12

129.20

g/l

0.22

181

917

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1200

7997

1.32

17.35

4.0

2.9

127.02

129.10

g/l

2.80

1168

7779

Subarachnoid haemorrhage

421

2718

1.60

17.33

3.3

3.0

127.38

128.38

g/l

0.40

412

2639

Inflammatory disease of uterus

393

2485

1.62

17.31

2.6

3.0

129.88

128.86

g/l

0.43

381

2422

Pruritus

436

2833

1.58

17.29

5.2

3.0

124.56

128.80

g/l

3.88

424

2752

Corns and callosities

285

1673

1.78

17.27

5.4

3.1

122.40

129.43

g/l

5.61

274

1626

Endovascular or surgical operations to intracerebral aneurysms

260

1488

1.83

17.27

3.8

3.0

126.57

129.05

g/l

0.97

260

1443

Hypothermia

106

439

2.66

17.24

4.7

3.4

124.61

128.09

g/l

0.74

101

428

Benign neoplasm: Caecum

470

3122

1.56

17.15

4.3

3.2

124.29

127.88

g/l

2.63

464

3027

Speech disturbances, not elsewhere classified

398

2547

1.62

17.14

4.4

3.1

128.98

127.71

g/l

0.57

388

2470

Background retinopathy and retinal vascular changes

116

503

2.51

16.99

6.3

3.0

120.42

128.74

g/l

3.06

110

493

Stomatitis and related lesions

714

5122

1.42

16.96

6.2

3.4

127.85

129.83

g/l

1.59

696

4965

Retinal vascular occlusion

540

3697

1.51

16.95

4.4

3.1

123.80

127.42

g/l

3.23

527

3577

Pneumococcal septicemia

159

782

2.17

16.90

6.9

4.0

120.90

127.97

g/l

3.60

154

763

Injuries involving multiple body regions

167

834

2.12

16.89

4.9

3.2

127.45

130.39

g/l

0.89

159

809

Acute posthaemorrhagic anaemia

170

857

2.11

16.86

5.1

2.7

110.56

129.04

g/l

15.55

163

831

Malignant neoplasm of pancreas

326

2003

1.70

16.69

3.1

3.0

119.93

129.73

g/l

13.26

319

1946

Unspecified jaundice

211

1146

1.93

16.60

4.4

3.0

120.70

128.17

g/l

4.50

206

1110

1355

9178

1.29

16.60

3.4

3.1

125.25

126.61

g/l

1.54

1309

8893

Multiple myeloma and malignant plasma cell neoplasms

236

1335

1.88

16.57

5.3

2.9

112.00

127.77

g/l

20.64

227

1295

Other and unspecified epidermal thickening

130

597

2.34

16.50

4.8

3.6

124.92

129.44

g/l

1.47

125

587

Familial hypercholesterolemia, with ischemic heart disease

389

2499

1.62

16.50

4.1

2.7

123.70

128.92

g/l

4.48

378

2431

Orchitis and epididymitis

398

2568

1.61

16.47

5.0

3.6

130.48

130.91

g/l

0.12

386

2504

Reimbursement for rheumatic diseases

2082

17101

1.22

16.46

4.0

3.4

125.67

129.28

g/l

11.29

2020

16636

Other disorders of optic [2nd] nerve and visual pathways

265

1548

1.79

16.37

5.2

3.8

127.21

129.27

g/l

0.74

258

1503

Retinal vascular disorders

544

3756

1.50

16.34

4.4

3.1

123.70

127.49

g/l

3.52

531

3635

Excessive, frequent and irregular menstruation

1178

4817

1.32

16.28

4.1

3.0

127.77

127.02

g/l

0.59

1148

4711

Disorders of ocular muscles, binocular movement, accommodation and refraction

1653

13247

1.25

16.16

5.1

3.6

129.85

130.24

g/l

0.30

1603

12896

Dislocation, sprain and strain of joint and ligaments of hip

176

913

2.05

16.11

3.5

3.0

127.20

128.32

g/l

0.27

171

887

Asthma and opportunity respiratory infection

210

1156

1.92

16.04

3.3

3.1

126.38

126.72

g/l

0.08

204

1118

Cervicocranial syndrome

382

2451

1.60

16.01

4.4

3.1

131.69

128.29

g/l

2.64

372

2379

Seborrhoeic keratosis

1002

7654

1.34

15.95

3.7

3.1

127.26

128.64

g/l

1.23

978

7435

Use of biperiden

216

1199

1.89

15.92

3.0

3.2

127.06

130.74

g/l

1.71

210

1168

Other fall from one level to another

835

6206

1.37

15.90

4.0

3.9

130.17

130.73

g/l

0.30

814

6049

Herpesviral [herpes simplex] infections

423

2784

1.56

15.86

4.9

3.2

127.08

129.44

g/l

1.36

413

2701

Inflammatory diseases of the central nervous system

321

1987

1.67

15.81

3.9

3.4

125.77

129.93

g/l

2.79

313

1929

Discitis, unspecified

408

2.64

15.81

6.2

2.9

117.60

127.32

g/l

3.86

397

Neuralgia and neuritis, unspecified

208

1143

1.90

15.76

3.8

2.9

129.84

130.13

g/l

0.06

195

1112

Pregnancy hypertension

1042

7129

1.32

15.64

4.2

2.9

127.24

129.35

g/l

2.53

1015

6930

Disorders of optic nerve and visual pathways

343

2166

1.64

15.51

5.5

3.6

129.24

129.78

g/l

0.17

332

2105

Multiple myeloma

150

749

2.16

15.49

5.1

2.8

108.32

129.07

g/l

21.79

145

727

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

150

749

2.16

15.49

5.1

2.8

108.32

129.07

g/l

21.79

145

727

Benign neoplasm: Stomach

403

2649

1.58

15.47

4.4

3.0

122.36

128.01

g/l

5.29

391

2572

Disorders of lacrimal system

1626

12981

1.25

15.45

4.1

3.3

128.43

128.34

g/l

0.05

1564

12623

Benign neoplasm: Rectum

745

5489

1.39

15.34

3.6

3.4

125.27

128.52

g/l

3.32

725

5338

Redundant prepuce, phimosis and paraphimosis

804

5883

1.37

15.32

4.6

3.6

132.57

133.40

g/l

0.44

780

5745

Presence of other devices

545

7590

0.69

15.24

3.7

2.7

125.48

128.72

g/l

2.60

508

7385

Sequelae of injuries of head

214

1200

1.87

15.23

3.9

3.5

129.90

131.54

g/l

0.49

207

1167

Gingivitis and periodontal diseases

3937

17699

1.16

15.13

3.7

3.3

128.90

129.60

g/l

1.09

3803

17260

Conjunctivitis (acute, non atopic)

980

7474

1.33

15.10

4.3

4.0

131.44

129.83

g/l

1.49

957

7279

Fracture of neck

280

1702

1.72

15.08

3.1

3.2

125.52

128.70

g/l

1.43

273

1653

Arthropod-borne viral fevers and viral haemorrhagic fevers

368

2382

1.60

15.08

3.7

3.2

130.44

130.20

g/l

0.07

356

2312

Diseases of salivary glands

1150

9019

1.30

14.84

3.3

3.4

129.87

129.13

g/l

0.56

1117

8780

Disorders of continuity of bone

353

2269

1.60

14.76

4.5

3.1

125.80

130.55

g/l

3.59

343

2206

Fall involving bed

180

974

1.98

14.72

5.9

3.6

123.10

125.93

g/l

1.03

173

950

Special screening examination for neoplasms

252

1493

1.75

14.68

3.3

2.9

131.61

130.95

g/l

0.15

244

1449

Exposure to other and unspecified inanimate mechanical forces

291

1795

1.68

14.56

4.0

3.7

129.65

130.98

g/l

0.42

284

1745

Struck by thrown, projected or falling objec

210

1187

1.85

14.55

5.0

3.5

130.22

132.05

g/l

0.57

203

1158

Conotruncal defects

246

3.04

14.46

7.5

12.3

125.60

130.61

g/l

1.00

241

Faecal incontinence

330

2100

1.62

14.45

3.3

2.7

126.92

127.11

g/l

0.06

315

2041

Other general symptoms and signs

164

847

1.98

14.42

3.2

3.4

126.74

130.51

g/l

1.23

155

824

Other diseases of lip and oral mucosa

1510

12284

1.25

14.16

3.8

3.4

129.31

g/l

0.00

1465

11952

Postmenopausal osteoporosis with pathological fracture

300

1888

1.66

14.14

3.9

2.7

122.43

125.72

g/l

2.06

288

1838

Vitamin B12 deficiency anaemia

428

2901

1.52

14.12

4.3

3.0

118.71

128.70

g/l

15.65

414

2825

Fracture at wrist and hand level

1229

9743

1.27

14.09

3.9

3.6

129.87

130.86

g/l

0.83

1201

9488

Diabetes mellitus in pregnancy

679

3121

1.40

14.08

3.5

3.2

130.48

130.88

g/l

0.19

660

3038

Non-follicular lymphoma

401

2693

1.54

13.98

5.2

3.2

119.69

128.13

g/l

10.10

396

2610

Crohn's disease NAS

233

1372

1.76

13.93

5.3

3.5

128.17

131.82

g/l

1.56

224

1334

Burns and corrosions

486

3378

1.47

13.93

3.5

3.8

129.76

131.78

g/l

1.07

474

3288

Chronic sinusitis

1492

12124

1.24

13.90

3.7

3.4

131.15

129.38

g/l

2.43

1442

11798

Retinal detachments and breaks

1402

11351

1.25

13.90

4.2

3.2

126.53

128.69

g/l

3.01

1365

11026

Nontoxic multinodular goitre

717

5330

1.37

13.85

3.1

3.0

129.09

126.50

g/l

2.85

698

5179

Other noninflammatory disorders of uterus, except cervix

760

3766

1.37

13.85

2.8

3.1

126.50

125.63

g/l

0.55

734

3691

Use of pramipexole

845

6436

1.34

13.85

5.3

3.2

126.13

127.93

g/l

1.59

820

6251

Viral haemorrhagic fevers, not elsewhere classified/unspecified

300

1892

1.64

13.81

3.6

3.2

130.60

130.35

g/l

0.07

293

1838

Collagenous colitis

352

2304

1.58

13.73

5.4

3.2

124.41

128.95

g/l

3.40

344

2236

Spondylolisthesis/Spondylolysis

639

4670

1.40

13.69

3.6

3.3

128.97

128.70

g/l

0.11

617

4550

Diseases of pulp and periapical tissues and dental caries

2681

11721

1.18

13.69

3.8

3.3

128.23

128.84

g/l

0.67

2602

11439

Lung cancer and mesothelioma

724

4562

1.37

13.69

3.6

2.6

122.74

129.83

g/l

13.95

705

4443

5-aminosalicylic acid

687

5073

1.38

13.68

4.1

3.1

130.46

132.19

g/l

1.14

663

4948

Benign neoplasm: Rectum, anus and anal canal

811

6157

1.35

13.67

3.6

3.4

125.37

128.45

g/l

3.33

788

5979

IBD patients in KELA-register

749

5606

1.36

13.66

3.9

3.5

130.81

131.80

g/l

0.54

722

5453

Recurrent and persistent haematuria

173

3.45

13.63

6.7

2.7

128.00

130.51

g/l

0.32

167

Trigger finger

497

3490

1.46

13.45

3.7

3.0

128.00

129.39

g/l

0.69

480

3395

Psoriatic arthropathies

358

2359

1.56

13.44

3.9

3.2

129.85

130.56

g/l

0.23

351

2305

Fibroblastic disorders

876

6729

1.33

13.41

3.4

3.2

128.31

128.68

g/l

0.18

850

6531

Hyperfunction of pituitary gland

167

901

1.93

13.40

4.4

3.3

126.13

131.14

g/l

2.28

162

881

Melanocytic naevi

1048

8238

1.29

13.32

4.3

3.5

128.22

129.91

g/l

1.64

1023

8019

Other diseases of gallbladder

184

1031

1.87

13.23

3.8

2.9

127.88

127.72

g/l

0.03

178

1003

Abscess of anal and rectal regions

299

1899

1.62

13.23

3.9

3.3

128.71

133.12

g/l

2.53

288

1850

Persistent delusional disorders

291

1841

1.64

13.22

2.6

3.1

131.07

129.50

g/l

0.60

283

1787

Secondary and unspecified malignant neoplasm of lymph nodes

339

2222

1.58

13.21

3.7

3.1

120.62

131.05

g/l

13.46

332

2153

Thrombocytopenia, unspecified

299

1907

1.63

13.20

5.8

3.3

115.22

129.03

g/l

17.63

291

1848

Septal defects

230

1342

1.74

13.19

5.7

7.3

130.00

129.96

g/l

0.01

224

1307

Acute suppurative otitis media

753

5272

1.35

13.15

5.9

3.7

131.10

133.21

g/l

1.76

734

5138

Fissure and fistula of anal and rectal regions

802

6098

1.34

13.14

3.4

3.1

130.07

130.44

g/l

0.17

771

5937

Lesion of lateral popliteal nerve

205

1189

1.80

13.12

3.7

3.1

127.78

129.68

g/l

0.56

199

1157

Superficial injury of forearm

348

2290

1.56

13.12

3.2

3.5

133.85

130.38

g/l

2.31

343

2231

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

942

7317

1.31

13.11

3.2

3.6

133.45

131.09

g/l

2.61

905

7134

Generalized epilepsy

152

804

1.97

13.03

4.6

5.3

128.85

130.68

g/l

0.43

144

783

Disturbance of activity and attention

327

2066

1.57

13.00

5.3

4.6

133.17

134.19

g/l

0.37

314

2021

malignant neoplasm of female genital organs

552

3890

1.42

12.96

2.9

3.0

121.44

127.94

g/l

10.53

543

3784

Hemiplegia

201

1162

1.80

12.96

3.7

3.1

129.30

128.02

g/l

0.36

195

1127

Intentional self-harm by smoke, fire and flames

7.94

12.93

4.7

5.2

129.24

129.17

g/l

0.00

Barrett oesophagus

219

1302

1.76

12.90

3.6

3.3

125.14

130.67

g/l

2.54

210

1263

Mycoses, including avohilmo

3467

23128

1.15

12.88

3.8

3.4

129.44

129.86

g/l

0.50

3363

22514

Recurrent aphthous stomatitis , including avohilmo

515

3673

1.43

12.86

7.0

3.3

127.57

129.24

g/l

1.01

500

3562

Carbimazole or st.post thyroidectomy, condition for graves disease

673

5007

1.37

12.86

3.2

132.23

128.74

g/l

3.83

644

4869

Squamous cell neoplasms and carcinomas of the skin

466

3275

1.47

12.83

4.0

3.1

124.47

129.01

g/l

4.50

455

3175

Arterial embolism and thrombosis of lower extremity artery

163

892

1.93

12.76

6.9

3.0

121.86

128.10

g/l

2.67

154

869

Nontoxic goitre/thyroid nodule

1034

8169

1.29

12.74

3.1

129.46

126.92

g/l

3.62

1008

7924

Lupus nephritis

5.43

12.74

8.8

5.0

118.29

127.30

g/l

1.02

Fracture of forearm

2014

15259

1.20

12.72

3.6

3.4

127.93

129.00

g/l

1.37

1965

14848

Problems related to social environment

124

619

2.11

12.66

4.0

2.9

121.53

127.92

g/l

2.47

118

600

Personal history of other diseases and conditions

305

1951

1.59

12.65

8.2

3.2

126.06

132.48

g/l

5.32

299

1899

1752

13171

1.21

12.53

3.6

3.2

126.56

126.96

g/l

0.34

1698

12785

Acute pharyngitis

459

3182

1.45

12.52

5.1

3.8

132.77

132.79

g/l

0.01

442

3108

Superficial injuries involving multiple body regions

113

548

2.18

12.51

5.5

3.2

130.21

130.50

g/l

0.05

107

531

Hypertrophic cardiomyopathy

186

1068

1.84

12.48

5.6

3.4

130.36

128.55

g/l

0.40

180

1040

Atypical facial pain

199

1161

1.79

12.45

2.7

2.8

131.42

128.49

g/l

1.20

190

1131

Sarcoidosis

474

3356

1.45

12.42

4.4

3.1

128.22

129.99

g/l

0.88

459

3257

Colorectal adenocarcinoma

835

6367

1.32

12.38

2.7

3.3

121.85

130.14

g/l

19.45

812

6183

Urticaria

941

7365

1.29

12.36

4.5

3.6

130.51

129.93

g/l

0.35

913

7171

ILD-related respiratory insufficiency

167

936

1.90

12.29

6.2

3.1

123.56

126.97

g/l

1.06

152

911

Strabismus

879

6821

1.30

12.17

5.4

3.9

129.91

129.99

g/l

0.04

852

6637

Bell's palsy

423

2947

1.47

12.10

3.6

3.2

128.53

129.39

g/l

0.31

409

2867

Other enthesopathy of foot (+metatarsalgia)

340

2266

1.54

12.10

3.3

3.1

130.74

129.35

g/l

0.55

330

2201

Pre-eclampsia or eclampsia

532

3846

1.40

12.09

4.1

3.0

126.09

129.40

g/l

2.97

514

3740

Other disorders of the musculoskeletal system and connective tissue

558

4083

1.40

12.07

2.9

3.3

127.82

128.85

g/l

0.48

542

3959

Suppurative and unspecified otitis media

1091

7702

1.27

12.05

5.1

3.6

130.99

131.98

g/l

0.76

1062

7508

Pneumothorax

285

1837

1.61

12.05

4.3

3.2

127.48

129.17

g/l

0.53

276

1780

In situ neoplasms

1505

12464

1.22

11.97

3.5

3.2

125.55

127.56

g/l

2.97

1455

12111

Inflammatory bowel disease, strict (require KELA)

749

5722

1.33

11.93

3.9

3.6

130.81

131.69

g/l

0.46

722

5573

Pre-eclampsia

489

3495

1.42

11.90

4.0

3.0

126.13

129.67

g/l

3.12

473

3394

Metatarsalgia

319

2110

1.55

11.80

3.3

3.0

130.73

129.21

g/l

0.61

311

2046

Acquired absence of organs, not elsewhere classified

287

2.68

11.79

6.7

3.1

118.64

128.16

g/l

2.27

280

Enthesopathies of lower limb, excluding foot

739

5647

1.33

11.73

4.1

3.3

131.40

129.53

g/l

1.47

713

5512

Osteonecrosis

250

1574

1.65

11.73

5.4

3.0

122.46

129.21

g/l

4.50

241

1531

Motor disorders, excluding more controls

189

2.95

11.70

10.0

18.1

130.80

127.17

g/l

0.53

184

Other disorders of lacrimal gland

1300

10636

1.24

11.67

4.4

3.2

127.91

128.47

g/l

0.42

1245

10349

Keratitis

1266

10329

1.24

11.66

4.1

3.4

128.57

129.95

g/l

1.33

1226

10050

Excessive vomiting in pregnancy

208

1245

1.71

11.62

2.9

131.08

129.83

g/l

0.41

202

1209

Other condition

509

3692

1.41

11.56

4.4

3.4

127.56

130.73

g/l

2.56

493

3583

Other specified/unspecified bacterial intestinal infections

263

1683

1.62

11.51

5.6

3.1

125.53

128.99

g/l

1.64

255

1635

Other/unspecified synovitis and tenosynovitis

386

2671

1.48

11.42

3.5

3.0

129.24

129.59

g/l

0.11

373

2591

Other and unspecified injuries of lower leg

262

1674

1.61

11.37

3.9

3.5

131.81

129.78

g/l

0.76

256

1623

Oxicams

1003

4504

1.28

11.33

3.1

4.1

131.03

126.14

g/l

9.16

982

4404

Maternal care for other conditions predominantly related to pregnancy

439

3022

1.43

11.33

3.1

3.3

130.17

130.49

g/l

0.12

428

2938

Bronchiectasis

319

2139

1.54

11.30

3.2

3.1

126.12

127.18

g/l

0.39

310

2082

Pre-eclampsia or poor fetal growth

697

5280

1.33

11.27

4.2

3.0

126.87

130.04

g/l

3.55

672

5143

Ventricular septal defect, a heart condition

436

2.26

11.21

9.2

11.4

129.56

128.81

g/l

0.10

428

Wet age-related macular degeneration

784

5875

1.32

11.20

3.3

3.0

125.64

126.04

g/l

0.20

761

5697

Ulcerative colitis, NAS

458

3280

1.43

11.20

4.7

3.4

127.47

131.21

g/l

2.81

436

3183

Cluster headache, strict, including avohilmo

165

941

1.82

11.14

3.3

3.1

133.13

132.77

g/l

0.07

160

914

Other intracranial haemorrhages

156

883

1.87

11.10

4.6

3.2

126.69

127.54

g/l

0.17

150

860

Iridocyclitis

794

6186

1.31

11.02

4.8

3.3

126.15

129.94

g/l

4.87

775

6013

Varicella [chickenpox]

165

946

1.81

10.99

10.1

4.0

129.61

133.73

g/l

1.55

158

930

Vascular dementia (undefined)

196

1169

1.73

10.97

4.1

3.1

123.92

123.25

g/l

0.16

190

1132

Varicella [chickenpox], including avohilmo

186

1104

1.74

10.90

10.2

4.4

130.34

133.14

g/l

0.98

177

1088

Pain associated with micturition

427

3044

1.44

10.81

5.2

3.1

128.34

128.88

g/l

0.20

409

2948

Oligomenorrhoea

108

542

2.07

10.78

5.8

3.0

130.19

128.07

g/l

0.51

108

532

Any event in hilmo or specialist outpatient

+∞

10.75

3.9

0.0

132.54

—

g/l

—

Spondyloarthritis

606

4567

1.35

10.71

4.3

3.3

126.58

129.91

g/l

3.09

586

4441

Other inflammatory liver diseases

247

1585

1.61

10.68

3.8

3.2

123.06

129.77

g/l

3.90

237

1542

Inguinal hernia

2277

13045

1.17

10.68

3.8

3.5

129.97

130.91

g/l

1.07

2225

12690

Striking against or struck by other objects

1142

9298

1.24

10.59

3.8

131.94

131.42

g/l

0.32

1108

9062

Pedal cyclist injured in other and unspecified transport accidents

394

2780

1.45

10.58

3.8

3.4

127.09

131.11

g/l

3.27

383

2703

Burns and corrosions of external body surface, specified by site

374

2614

1.47

10.57

3.6

3.8

129.54

131.68

g/l

0.98

367

2540

Arthropathic psoriasis

389

2741

1.45

10.55

3.8

3.3

130.02

130.15

g/l

0.04

382

2661

Other disorders of conjunctiva

543

4046

1.37

10.54

5.0

3.3

129.82

128.01

g/l

1.07

523

3924

Hyperkinetic disorders

341

2274

1.48

10.54

5.3

4.8

133.42

134.16

g/l

0.26

328

2227

Superficial injury of shoulder and upper arm

429

3075

1.43

10.52

3.7

3.3

130.92

130.45

g/l

0.17

418

2989

Primary gonarthrosis, bilateral

2053

14764

1.18

10.52

3.0

3.4

128.79

127.91

g/l

1.03

1983

14371

Idiopathic pulmonary fibrosis

336

2314

1.50

10.51

4.2

3.1

128.17

126.84

g/l

0.51

325

2248

Dental caries, including avohilmo

2920

13096

1.15

10.47

3.8

3.3

128.39

128.98

g/l

0.68

2830

12777

Necrosis of pulp, including avohilmo

1967

16657

1.18

10.43

4.0

3.4

131.78

130.77

g/l

1.22

1912

16219

Other and unspecified psoriasis

257

1675

1.59

10.40

3.5

3.3

127.72

129.28

g/l

0.49

250

1629

Cluster headache, wide,, including avohilmo

173

1022

1.75

10.34

3.2

3.1

132.86

132.33

g/l

0.11

168

994

Skin changes due to chronic exposure to nonionizing radiation

1651

12653

1.20

10.34

3.6

3.2

126.30

126.83

g/l

0.45

1600

12279

Melanocytic naevi of trunk

420

3012

1.43

10.29

4.4

3.2

127.28

130.15

g/l

1.84

408

2916

Pain and other conditions associated with female genital organs and menstrual cycle

532

3294

1.37

10.17

3.1

131.76

128.21

g/l

3.89

523

3220

Meniscus derangement

2016

11469

1.18

10.17

3.2

131.25

130.31

g/l

1.03

1944

11205

Lyme disease

759

9638

0.78

10.15

2.1

3.5

134.03

129.27

g/l

8.76

741

9363

Lyme disease, including avohilmo

759

9638

0.78

10.15

2.1

3.5

134.03

129.27

g/l

8.76

741

9363

Weight loss

396

2827

1.44

10.08

4.1

3.7

127.15

128.13

g/l

0.38

370

2745

Sulfasalazine

926

7430

1.26

10.02

3.5

3.1

127.26

130.43

g/l

4.26

896

7242

Other noninfective disorders of lymphatic vessels and lymph nodes

146

834

1.83

9.98

5.2

3.1

126.59

128.85

g/l

0.63

141

811

Other benign neoplasms of skin

1368

11437

1.21

9.95

3.9

3.3

128.26

128.32

g/l

0.03

1334

11108

948

7136

1.26

9.92

3.4

3.0

124.52

126.23

g/l

1.71

913

6922

Diffuse brain injury

124

674

1.91

9.85

2.7

3.1

128.56

129.25

g/l

0.13

119

657

Habit and impulse disorders

284

2.46

9.85

2.1

3.3

132.00

134.33

g/l

0.33

275

Inflammatory diseases of female pelvic organs

1848

10793

1.18

9.84

3.3

3.0

129.07

127.73

g/l

2.01

1788

10503

Alzheimer’s disease (Late onset), excluding more controls

564

2746

1.36

9.83

2.5

2.9

127.04

125.20

g/l

1.17

549

2671

Adult respiratory distress syndrome

293

2.49

9.83

6.6

3.1

119.10

128.52

g/l

2.07

285

Other spirochaetal diseases

771

9733

0.78

9.83

2.2

3.5

133.86

129.27

g/l

8.33

752

9456

Suggestive for eosinophilic asthma

332

2306

1.48

9.82

3.4

3.1

132.45

129.31

g/l

1.84

325

2235

Actinic keratosis

1610

12431

1.19

9.81

3.6

3.2

126.23

126.80

g/l

0.50

1560

12065

Algoneurodystrophy

113

598

1.97

9.81

3.4

2.9

131.82

131.23

g/l

0.11

108

582

Drug-induced osteoporosis with pathological fracture

411

2.24

9.79

8.6

3.5

119.49

126.90

g/l

2.44

400

Later onset COPD

1221

8113

1.23

9.79

4.3

3.1

126.05

126.67

g/l

0.42

1178

7864

Pedal cyclist injured in transport accident

743

5834

1.29

9.72

3.3

3.6

129.29

130.91

g/l

1.24

720

5682

Other disorders of veins

1446

11972

1.20

9.72

3.4

3.1

129.97

128.55

g/l

1.68

1413

11644

Glaucoma

2245

16594

1.16

9.67

3.5

3.3

125.86

127.97

g/l

4.34

2173

16131

conjunctival haemorrhage

308

2120

1.50

9.65

5.0

3.1

128.17

128.22

g/l

0.01

295

2056

Spirochaetal infections, other/unspecified, including avohilmo

772

9716

0.78

9.60

2.1

3.5

134.07

129.30

g/l

8.98

753

9440

Rheumatism, unspecified

411

2971

1.41

9.58

3.1

2.9

128.70

127.71

g/l

0.42

388

2890

Sequelae of injuries of lower limb

313

2160

1.49

9.54

3.6

3.2

128.89

130.65

g/l

0.63

304

2099

Other symptoms and signs involving the urinary system

387

2779

1.43

9.51

3.8

3.2

127.51

129.60

g/l

1.08

379

2689

Other specified/unspecified inflammatory spondylopathies

142

814

1.80

9.44

3.9

2.9

129.53

131.75

g/l

0.55

137

790

Follicular cysts of skin and subcutaneous tissue

639

4946

1.31

9.44

3.9

3.4

128.91

130.07

g/l

0.64

616

4808

Rare circulating lymphoid malignancy, including Hilmo

125

696

1.89

9.39

18.1

3.8

115.60

130.94

g/l

9.64

125

680

Dislocation, sprain and strain of joints and ligaments of knee

1977

15437

1.17

9.39

3.1

3.4

134.23

130.98

g/l

8.28

1928

15028

Dermatitis due to substances taken internally

195

1221

1.65

9.39

4.2

3.3

125.21

129.44

g/l

1.76

188

1188

Right bundle-branch block

136

775

1.82

9.34

6.9

2.7

128.73

128.57

g/l

0.03

130

750

Contusion of ankle

138

789

1.81

9.32

4.8

3.6

133.39

131.91

g/l

0.33

132

768

Malignant neoplasm of endocrine gland

242

1595

1.56

9.29

5.3

3.1

127.01

130.91

g/l

1.89

233

1544

Anterior Iridocyclitis

686

5370

1.30

9.28

5.1

3.3

126.09

129.99

g/l

4.49

668

5210

Malignant neoplasm of endocrine gland, including Hilmo

273

1845

1.52

9.28

4.9

3.2

127.35

130.96

g/l

1.83

261

1786

Exclusion endpoint for clefts

369

2.23

9.27

11.3

8.9

127.83

131.78

g/l

0.71

363

Chondropathies

488

3646

1.36

9.27

3.5

3.4

132.77

130.85

g/l

1.09

471

3541

Mandibular retrognathia

192

1197

1.64

9.21

4.5

4.3

136.73

131.94

g/l

2.62

186

1164

Caries of dentine, including avohilmo

3088

14000

1.14

9.20

3.9

3.5

128.57

128.96

g/l

0.41

2991

13669

Other and unspecified vascular occlusions

389

2820

1.42

9.15

4.7

3.0

123.57

127.28

g/l

2.62

378

2735

Other spirochaetal diseases, including avohilmo

790

9837

0.79

8.97

2.2

3.5

133.88

129.28

g/l

8.58

770

9559

Abnormal results of function studies

311

2175

1.47

8.89

5.0

3.5

127.43

130.09

g/l

1.22

304

2107

Other coagulation defects

255

1717

1.53

8.86

5.5

3.2

124.17

129.43

g/l

2.91

248

1668

Hydrocephalus

297

2067

1.48

8.82

3.0

3.2

130.24

127.39

g/l

1.53

288

2006

Hyperhidrosis

477

2.01

8.80

3.0

2.8

129.98

g/l

0.00

462

Implicit parasitic Sepsis, including avohilmo

106

3.46

8.78

5.0

2.3

130.48

128.76

g/l

0.14

101

Menorrhagia

988

4477

1.24

8.77

3.6

3.0

127.61

126.57

g/l

0.83

956

4381

Temporomandibular joint disorders, including avohilmo

1291

10507

1.20

8.73

3.4

3.3

131.93

130.20

g/l

2.43

1250

10231

Coeliac disease

387

2819

1.40

8.70

5.0

3.3

125.84

130.49

g/l

4.40

372

2734

Vascular dementia (mixed)

105

571

1.96

8.66

2.4

3.1

127.52

124.26

g/l

0.77

105

551

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

326

2292

1.44

8.65

6.1

4.9

131.15

130.50

g/l

0.21

321

2231

Injury of eye and orbit

453

3386

1.36

8.59

4.1

3.5

132.15

131.63

g/l

0.19

445

3291

Impingement syndrome of shoulder

792

6369

1.26

8.55

3.6

3.2

131.88

129.59

g/l

2.10

756

6201

Crohn's disease of large intestine

165

1015

1.68

8.55

4.0

3.2

127.82

132.54

g/l

1.84

157

987

Seborrhoeic dermatitis

365

2645

1.41

8.55

3.9

3.3

129.22

130.17

g/l

0.34

351

2561

Acute and subacute iridocyclitis

640

5026

1.29

8.49

5.2

3.3

126.46

130.03

g/l

3.56

622

4880

Blepharochalasis

1083

9008

1.22

8.47

3.5

3.2

128.60

127.13

g/l

1.45

1052

8743

Malignant neoplasm of rectum, including Hilmo

470

3549

1.35

8.47

2.7

3.3

123.75

130.48

g/l

8.13

457

3447

Other and unspecified disorders of vitreous body

1530

12809

1.18

8.46

3.2

3.3

130.25

128.13

g/l

3.47

1481

12444

Accidental poisoning by and exposure to alcohol

324

2.24

8.41

6.2

3.4

133.41

132.21

g/l

0.17

314

222

1465

1.55

8.39

3.7

2.8

127.32

126.29

g/l

0.28

215

1419

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

107

585

1.90

8.38

9.7

7.2

128.92

131.71

g/l

0.56

107

572

Malignant neoplasm of stomach, including Hilmo

241

1631

1.52

8.28

2.9

3.0

116.91

130.18

g/l

14.89

236

1577

Malignant neoplasm of stomach

211

1389

1.57

8.28

3.0

116.77

130.10

g/l

12.99

206

1347

Other symptoms and signs involving the nervous and musculoskeletal systems

1430

12204

1.18

8.21

4.4

3.5

131.13

128.98

g/l

3.28

1370

11880

Other diseases of upper respiratory tract

4224

19984

1.11

8.21

3.6

3.5

130.16

128.92

g/l

2.91

4100

19468

Otalgia

277

1925

1.47

8.20

5.4

4.0

129.53

129.12

g/l

0.11

272

1877

Abnormal weight loss

360

2628

1.41

8.14

3.7

3.6

127.46

128.05

g/l

0.19

336

2554

Other injuries of spine and trunk, level unspecified

179

2.73

8.12

4.7

3.4

124.40

130.02

g/l

0.77

174

Psoriatic arthropathies, ICD10

349

2535

1.41

8.07

3.9

3.3

129.87

130.20

g/l

0.10

343

2464

Non-Hodgkin lymphoma, all

187

1208

1.61

8.07

3.8

3.0

113.82

129.74

g/l

14.50

182

1170

Colon adenocarcinoma

489

3743

1.34

8.03

2.7

3.2

120.57

129.74

g/l

13.62

477

3637

Gonarthrosis, primary, with knee surgery

2278

15643

1.14

8.03

3.1

3.4

127.38

127.91

g/l

0.53

2210

15230

Embolic stroke

194

1263

1.59

8.02

3.5

3.1

125.85

127.05

g/l

0.27

188

1225

Gestational [pregnancy-induced] hypertension

562

4354

1.30

8.02

4.3

2.9

127.71

130.08

g/l

1.91

548

4228

Other specified disorders of muscle

111

626

1.85

8.00

5.5

2.8

129.78

130.93

g/l

0.21

106

608

Behavioural syndromes associated with physiological disturbances and physical factors

3400

20732

1.12

7.98

3.4

3.5

131.90

129.58

g/l

7.72

3306

20163

Other and unspecified immunodeficiencies with predominantly antibody defects

242

2.44

7.97

23.4

3.6

123.69

130.58

g/l

1.36

236

Retinal haemorrhage

113

644

1.85

7.97

5.0

3.0

124.01

127.93

g/l

1.08

113

628

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1834

15404

1.16

7.95

4.1

3.5

130.98

129.79

g/l

1.44

1770

14992

Exposure to other and unspecified man-made environmental factors

380

2.11

7.92

2.5

3.1

136.75

131.05

g/l

1.30

374

Visual field defects

313

2244

1.43

7.90

4.5

3.2

127.87

128.13

g/l

0.07

300

2180

Other obstetric conditions, not elsewhere classified

608

2987

1.29

7.88

3.9

2.9

130.88

132.18

g/l

0.84

586

2911

Other psoriatic arthropathies

340

2470

1.41

7.87

3.9

3.3

129.96

130.28

g/l

0.09

334

2401

Other specified congenital malformation syndromes affecting multiple systems

307

2.24

7.86

11.4

10.0

127.58

131.58

g/l

0.61

302

Rash and other nonspecific skin eruption

327

2363

1.42

7.82

3.8

3.5

128.13

128.61

g/l

0.15

319

2294

Car occupant injured in noncollision transport accident

123

719

1.77

7.80

3.6

3.1

133.08

132.08

g/l

0.16

118

701

Contact with other sharp object(s)

210

1396

1.54

7.78

3.4

3.7

133.69

133.52

g/l

0.03

205

1358

Anomalies of dental arch relationship, including avohilmo

570

4025

1.30

7.76

4.9

3.7

132.15

131.18

g/l

0.50

559

3916

Malignant neoplasm of oesophagus, including Hilmo

153

953

1.68

7.75

2.8

3.1

117.99

131.50

g/l

9.28

147

927

Coxarthrosis, primary, with hip surgery

1845

14962

1.15

7.68

3.3

127.34

127.49

g/l

0.10

1793

14542

Implicit parasitic Sepsis

3.46

7.67

5.4

2.4

128.28

128.73

g/l

0.03

Other extrapyramidal and movement disorders in other diseases

886

7308

1.23

7.61

3.4

128.94

128.47

g/l

0.26

866

7103

Viral warts, including avohilmo

671

5375

1.26

7.53

5.7

3.5

129.22

131.14

g/l

1.40

655

5231

Seropositive rheumatoid arthritis

837

6830

1.23

7.52

3.4

3.1

122.86

128.23

g/l

10.48

812

6666

Acute nasopharyngitis (common cold)

376

2772

1.37

7.48

4.0

3.4

131.84

133.52

g/l

0.68

362

2702

Effects of foreign body entering through natural orifice

829

6804

1.23

7.46

3.6

3.8

131.78

131.36

g/l

0.21

803

6621

Other strabismus

654

5210

1.27

7.44

5.7

3.9

131.07

130.46

g/l

0.30

637

5072

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

457

3493

1.32

7.41

3.0

128.93

129.07

g/l

0.05

438

3400

Malignant neoplasm of thyroid gland, including Hilmo

235

1619

1.49

7.36

3.1

2.9

128.24

130.97

g/l

1.06

227

1566

Malignant neoplasm of ovary, including Hilmo

209

1409

1.53

7.34

2.7

2.8

118.23

128.43

g/l

9.40

203

1366

Prolonged pregnancy

149

2007

0.63

7.34

2.3

3.3

132.60

130.90

g/l

0.48

143

1958

Central retinal artery occlusion

106

610

1.84

7.32

3.9

3.1

124.02

125.86

g/l

0.33

106

590

Hypoparathyroidism

136

835

1.70

7.28

6.5

3.0

123.21

127.66

g/l

1.96

131

805

Acute laryngitis and tracheitis

312

2223

1.40

7.25

4.1

3.9

131.72

132.96

g/l

0.42

300

2172

Alzheimer’s disease (Atypical or mixed)

499

3841

1.31

7.23

2.8

3.2

128.94

124.52

g/l

4.71

485

3732

Postprocedural musculoskeletal disorders, not elsewhere classified

272

1937

1.45

7.22

3.1

125.83

128.16

g/l

0.89

260

1887

Complications of other internal prosthetic devices, implants and grafts

159

1018

1.62

7.15

4.7

3.0

122.87

128.61

g/l

2.57

154

988

Occlusion and stenosis of arteries, not leading to stroke

315

2.16

7.06

3.0

2.9

122.78

126.34

g/l

0.59

304

Oesophageal obstruction

144

906

1.65

7.02

4.1

2.9

120.28

128.71

g/l

4.33

139

883

Noninflammatory disorders of female genital tract

1145

4839

1.20

6.99

3.4

3.1

129.06

126.97

g/l

2.80

1106

4733

Lymphoid leukaemia

222

1536

1.49

6.96

11.5

3.5

119.12

128.03

g/l

7.72

216

1487

Drug-induced neutropenia

251

1775

1.45

6.93

3.9

3.3

114.77

129.07

g/l

17.30

246

1720

Hypoplasia of dental enamel, prenatal

4.62

6.93

57.4

17.0

111.85

124.25

g/l

1.51

Other neurotic disorders

165

1074

1.58

6.88

4.2

2.9

129.82

129.03

g/l

0.17

160

1045

Malignant neoplasm of thyroid gland

215

1477

1.49

6.87

3.2

2.9

128.02

130.93

g/l

1.11

208

1430

Contusion of other and unspecified parts of foot

154

984

1.60

6.87

3.2

3.9

130.37

131.82

g/l

0.35

149

958

Foreign body entering into or through eye or natural orifice

273

1960

1.43

6.86

4.0

3.7

132.33

131.36

g/l

0.30

267

1904

Fibrosis of liver

177

2.62

6.86

4.4

3.8

115.86

129.15

g/l

2.60

171

Polymyalgia rheumatica

531

4201

1.29

6.85

3.5

3.0

124.83

126.97

g/l

1.63

516

4079

Other congenital malformations

247

1741

1.45

6.80

6.7

4.8

128.94

130.75

g/l

0.59

242

1695

Contact with heat and hot substances

178

1180

1.55

6.80

3.1

4.2

129.78

130.57

g/l

0.17

173

1151

Polyp of the female genital tract

900

4222

1.22

6.78

2.8

3.0

128.19

126.29

g/l

1.91

877

4134

Unspecified contracted kidney

130

2.91

6.78

8.1

3.3

113.56

129.98

g/l

2.98

125

Acute lymphadenitis

173

1140

1.55

6.76

4.0

3.8

128.38

131.43

g/l

0.97

168

1109

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

226

1571

1.47

6.74

3.9

2.8

124.29

129.12

g/l

2.78

221

1517

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

259

2.22

6.69

12.2

5.0

131.11

130.22

g/l

0.12

251

Infections of genitourinary tract in pregnancy

229

1599

1.46

6.63

3.0

129.47

128.88

g/l

0.16

223

1551

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

581

2899

1.27

6.63

4.0

2.9

130.88

132.21

g/l

0.84

559

2824

Complications predominantly related to the puerperium

584

4674

1.26

6.60

2.9

3.1

131.35

129.25

g/l

1.81

570

4549

Renal cell carcinoma of kidney

131

819

1.66

6.58

4.5

2.7

118.21

129.38

g/l

5.75

126

796

Ptosis of eyelid

421

3255

1.32

6.54

4.7

3.2

128.30

127.92

g/l

0.14

412

3142

Carcinoma in situ of skin of other and unspecified parts of face

364

2764

1.35

6.53

3.6

3.1

123.43

126.03

g/l

1.51

351

2683

Non-allergic asthma

294

2156

1.39

6.50

3.2

4.1

128.47

128.99

g/l

0.15

288

2093

Carcinoma in situ of other and unspecified digestive organs

177

1190

1.54

6.47

4.0

3.0

124.66

128.88

g/l

1.55

171

1159

Congenital malformation of biliary tract

3.87

6.46

18.5

12.9

117.45

127.50

g/l

1.05

Thyrotoxicosis with diffuse goitre

396

3034

1.32

6.44

3.4

3.2

131.07

128.57

g/l

1.53

383

2950

Other maternal disorders predominantly related to pregnancy

1367

7380

1.17

6.43

3.1

130.82

128.66

g/l

3.47

1332

7178

270

2.14

6.37

4.1

2.7

127.64

132.66

g/l

0.86

263

Otitis media, unspecified

318

2173

1.37

6.37

5.6

4.2

130.56

131.53

g/l

0.34

303

2113

Nonsuppurative otitis media

648

4563

1.24

6.36

5.2

3.7

129.40

131.58

g/l

1.62

630

4438

Diseases of middle ear and mastoid

1836

13252

1.14

6.35

4.5

3.5

130.90

130.67

g/l

0.16

1785

12893

Calculus of lower urinary tract

213

1490

1.48

6.34

4.0

3.3

131.52

128.03

g/l

1.51

208

1445

Artificial joint operation, meniscal resection

3484

20358

1.10

6.32

3.1

3.4

129.39

129.21

g/l

0.17

3378

19824

Other abnormal uterine and vaginal bleeding

690

4046

1.24

6.31

3.0

127.53

126.16

g/l

1.01

661

3964

Pilonidal cyst

235

1666

1.44

6.31

4.0

3.5

134.03

135.64

g/l

0.42

227

1629

Congenital malformations of the musculoskeletal system, not elsewhere classified

233

2.25

6.30

13.3

5.3

131.68

129.85

g/l

0.27

225

Meralgia paraesthetica

123

765

1.67

6.29

3.0

3.1

131.43

129.61

g/l

0.42

118

746

Herpesviral [herpes simplex] infections, including avohilmo

737

6090

1.22

6.23

3.8

3.3

129.03

130.33

g/l

0.87

719

5920

Burn and corrosion of hip and lower limb, except ankle and foot

488

1.84

6.18

4.8

3.7

130.91

130.37

g/l

0.08

475

Burns classified according to extent of body surface involved

204

2.37

6.17

6.0

5.6

122.60

130.14

g/l

1.08

199

Voice disturbances

875

7361

1.20

6.16

4.0

3.4

129.58

128.51

g/l

0.76

848

7156

Schizoid personality disorder

353

2.00

6.12

2.9

3.3

128.12

132.90

g/l

1.00

345

Otitis externa, unspecified

359

2737

1.33

6.12

3.8

3.7

131.81

130.21

g/l

0.67

344

2661

Lateral epicondylitis

377

2898

1.32

6.02

3.1

132.92

130.78

g/l

1.12

365

2822

Other and unspecified mononeuropathies of upper limb

105

635

1.71

6.01

3.3

3.1

133.12

130.44

g/l

0.53

100

622

Other and unspecified injuries of ankle and foot

127

803

1.62

6.01

3.8

4.1

132.15

130.73

g/l

0.31

122

780

Uterine polyps

842

4104

1.21

6.00

3.1

128.38

126.23

g/l

2.16

820

4018

Autoimmune hepatitis, wide definition

150

987

1.56

5.99

3.7

3.0

124.25

131.28

g/l

3.03

144

958

Caries of enamel

2879

20689

0.91

5.97

4.0

3.4

130.32

130.38

g/l

0.05

2814

20107

Trigeminal neuralgia

196

1363

1.47

5.96

3.0

2.9

131.77

128.81

g/l

1.20

187

1331

Other meningitis

321

2.03

5.96

2.5

3.0

127.68

130.65

g/l

0.55

313

Hydrocele

438

3445

1.29

5.95

4.5

3.7

125.50

129.86

g/l

3.23

424

3364

Acute appendicitis, with complications

634

5194

1.24

5.93

3.1

3.5

129.50

129.89

g/l

0.17

611

5059

Biological medication for rheuma

497

3962

1.27

5.93

3.6

129.46

131.93

g/l

1.61

482

3862

Scoliosis

241

1737

1.41

5.92

5.1

3.4

127.92

129.08

g/l

0.34

234

1687

Impacted cerumen

253

3437

0.72

5.92

3.3

3.4

129.29

128.11

g/l

0.36

244

3333

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

538

4331

1.26

5.91

4.2

3.5

130.86

131.49

g/l

0.24

515

4219

Parkinson's disease, including avohilmo

617

5053

1.24

5.90

3.3

3.2

128.02

127.33

g/l

0.36

602

4904

UC patients in KELA-register (code 208), prior to 1994

153

1019

1.55

5.85

4.3

3.1

127.10

130.04

g/l

0.73

143

992

Injury of heart

4.25

5.82

4.7

2.7

125.06

128.26

g/l

0.17

Plantar fascial fibromatosis

291

2169

1.36

5.81

2.9

3.0

130.51

129.42

g/l

0.40

280

2107

Hodgkin lymphoma, hilmo

103

627

1.71

5.79

3.8

3.4

122.66

129.90

g/l

2.45

612

Hypogonadotropic hypogonadism

107

657

1.69

5.79

3.1

4.0

143.49

136.20

g/l

1.95

100

642

Paralytic strabismus

255

1870

1.40

5.77

4.5

3.2

127.53

128.71

g/l

0.35

243

1811

173

1177

1.49

5.75

2.5

2.9

132.01

132.16

g/l

0.03

173

1146

Other bursitis of elbow

198

2.34

5.73

3.6

2.9

128.77

133.07

g/l

0.57

193

Vulvovaginal ulceration/inflammation in other diseases

166

1125

1.50

5.69

3.3

2.8

129.77

129.91

g/l

0.03

159

1096

Outcome of delivery

170

1522

0.68

5.65

1.9

3.0

134.95

130.53

g/l

2.49

170

1487

Anankastic personality disorder

108

667

1.66

5.65

3.1

3.0

131.66

132.98

g/l

0.25

101

646

Other and unspecified injuries of wrist and hand

124

793

1.61

5.64

3.8

127.85

129.24

g/l

0.25

116

771

Erosion of teeth , including avohilmo

781

6555

1.20

5.64

5.5

3.6

130.08

131.47

g/l

0.92

762

6381

Pediculosis, acariasis and other infestations

190

1329

1.46

5.61

4.4

3.4

130.71

131.56

g/l

0.20

184

1297

Other hammer toe(s) (acquired)

597

4449

1.24

5.56

3.4

3.1

126.11

126.91

g/l

0.39

572

4348

Other keratitis

355

2742

1.32

5.55

4.7

3.2

128.71

130.72

g/l

0.89

344

2665

Rheumatoid arthritis, including avohilmo

1285

11238

1.15

5.54

3.5

3.3

124.53

128.22

g/l

7.92

1248

10918

Specific developmental disorder of motor function

279

2.04

5.53

10.0

15.2

130.80

129.33

g/l

0.19

270

Malignant neoplasm of rectum

366

2845

1.31

5.52

2.7

3.2

122.52

130.69

g/l

9.54

355

2761

Disorders of refraction and accommodation

835

7036

1.19

5.51

5.9

3.9

129.74

130.86

g/l

0.78

810

6854

Atopic dermatitis, strict definition with reimbursement

797

6445

1.20

5.50

3.8

132.62

131.84

g/l

0.47

775

6285

Degenerative macular diseases

451

3604

1.27

5.45

3.7

3.0

128.05

127.28

g/l

0.31

440

3495

Injury of muscle and tendon at wrist and hand level

440

3501

1.28

5.44

2.8

3.4

133.07

130.63

g/l

1.42

426

3403

Benign lipomatous neoplasm

984

8456

1.18

5.43

4.0

3.4

130.81

129.13

g/l

1.62

942

8218

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

233

1700

1.40

5.42

4.1

3.1

129.35

131.27

g/l

0.64

228

1644

Oter anti-inflammatory and antirheumatic agents, non-steroids

915

4267

1.19

5.42

3.1

4.0

128.30

125.87

g/l

2.40

889

4174

Other injuries of lower limb, level unspecified

223

2.21

5.40

3.0

3.8

120.70

130.06

g/l

1.64

218

Other specified/unspecified necrotizing vasculopathies

335

1.97

5.37

7.0

3.1

117.42

128.01

g/l

2.98

326

Otitis externa

735

6171

1.20

5.36

3.7

3.6

131.14

129.94

g/l

0.75

710

6008

Colonic or urogenital fistula

885

7550

1.18

5.35

3.6

3.5

129.08

129.83

g/l

0.43

852

7342

Haemorrhage in early pregnancy

606

4843

1.22

5.35

2.7

3.2

131.33

129.05

g/l

2.04

591

4709

Hallux valgus (acquired)

1078

6652

1.17

5.34

2.8

3.1

128.12

128.06

g/l

0.03

1038

6494

Other disorders of bladder

421

3348

1.28

5.29

5.1

3.2

127.65

129.44

g/l

0.87

401

3247

Preterm labour and delivery

577

4734

1.23

5.28

3.0

3.2

129.19

128.53

g/l

0.33

566

4618

Adenocarcinoma and Papillary adenocarcinoma of kidney

324

1.99

5.28

6.1

2.8

119.13

132.44

g/l

4.09

315

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

376

2952

1.30

5.27

2.6

3.3

123.73

130.53

g/l

6.89

365

2867

Dental pulpitis, including avohilmo

3057

17936

1.10

5.26

3.4

3.5

133.38

130.45

g/l

10.35

2962

17476

Localized swelling, mass and lump of skin and subcutaneous tissue

1064

9219

1.16

5.25

5.1

3.4

128.60

129.09

g/l

0.30

1032

8966

Other disorders of the genitourinary system

414

3288

1.28

5.25

3.9

3.0

127.02

126.54

g/l

0.18

403

3186

Injury of muscle and tendon at shoulder and upper arm level

1298

11415

1.15

5.21

3.2

3.4

131.86

129.97

g/l

2.23

1249

11104

Ulcerative colitis (strict definition, require KELA)

493

3994

1.25

5.18

4.2

3.5

130.58

131.50

g/l

0.37

472

3888

Giant cell arteritis

164

1139

1.49

5.18

4.2

2.9

126.13

126.59

g/l

0.10

158

1105

Early lumbar disc prolapse, operated

227

1657

1.39

5.18

3.7

3.2

136.25

135.10

g/l

0.30

213

1616

Corneal ulcer

579

4771

1.23

5.17

4.2

3.2

129.37

130.68

g/l

0.70

561

4639

Left hemicolectomy

579

1.70

5.16

4.4

3.1

118.17

127.02

g/l

2.61

565

Personal history of malignant neoplasm

238

1756

1.38

5.14

4.6

2.7

126.93

129.35

g/l

1.07

232

1707

Other specified/unspecified systemic involvement of connective tissue

176

1236

1.46

5.14

3.4

3.0

123.84

128.02

g/l

1.77

170

1201

Other and unspecified urticaria

558

4583

1.23

5.13

4.8

3.7

129.19

129.77

g/l

0.24

540

4453

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

476

3851

1.25

5.08

4.2

3.5

130.64

131.55

g/l

0.35

458

3750

Lesion of radial nerve

131

872

1.55

5.07

3.5

2.9

129.52

129.35

g/l

0.03

126

851

Demyelinating diseases of the central nervous system

223

1632

1.39

5.07

4.3

3.0

132.54

131.30

g/l

0.39

215

1588

Persons encountering health services in circumstances related to reproduction

1422

10771

0.88

5.06

4.6

3.9

130.83

132.06

g/l

1.18

1376

10521

Other specified and unspecified retinal disorders

133

891

1.54

5.03

5.4

2.8

126.83

128.01

g/l

0.24

127

866

Benign neoplasm of mouth and pharynx

357

2803

1.30

5.01

3.5

3.2

128.69

129.03

g/l

0.10

346

2718

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

187

1309

1.43

4.97

6.2

5.5

131.90

g/l

0.00

182

1275

Other peripheral vertigo

318

2465

1.32

4.96

3.3

3.0

132.31

127.88

g/l

3.65

309

2397

Parkinson's disease

585

4857

1.22

4.95

3.3

3.2

128.02

127.36

g/l

0.34

570

4714

Premature rupture of membranes

268

2519

0.75

4.95

2.5

3.1

132.34

130.45

g/l

0.87

258

2455

Motor disorders

298

1.95

4.92

10.0

16.2

130.80

129.06

g/l

0.23

291

Mental and behavioural disorders due to cocaine

7.13

4.85

2.5

5.4

132.18

127.78

g/l

0.14

Parkinson's disease, strict definition

547

4524

1.23

4.84

3.3

3.2

128.50

127.33

g/l

0.72

533

4391

Monoplegia

354

1.87

4.83

3.3

2.9

132.73

128.66

g/l

0.73

346

Colon adenocarcinoma, helper endpoint

489

4001

1.24

4.82

2.7

3.2

120.57

127.60

g/l

8.45

477

3884

Other and unspecified injuries of neck

146

2.39

4.81

4.0

3.0

131.88

132.07

g/l

0.02

140

Methotrexate

420

3375

1.26

4.80

3.5

2.9

123.57

129.61

g/l

7.16

405

3275

Ehlers-Danlos syndrome, including avohilmo

152

2.33

4.77

17.4

3.4

130.91

132.21

g/l

0.14

145

Perforation of tympanic membrane

324

2530

1.30

4.76

4.7

3.2

128.70

129.47

g/l

0.22

314

2458

Malignant neoplasm of head and neck, including Hilmo

347

2736

1.29

4.73

3.3

3.4

124.87

130.90

g/l

5.05

336

2664

Cerebral palsy

290

1.94

4.71

6.3

8.3

130.44

130.74

g/l

0.03

282

Viral infections of the central nervous system, including avohilmo

235

1758

1.36

4.71

3.9

3.4

127.51

130.50

g/l

1.21

230

1710

Multiple sites

10.53

4.70

5.6

6.5

121.00

134.54

g/l

—

Mantle cell lymphoma, including Hilmo

366

1.85

4.68

4.0

2.7

116.92

131.29

g/l

4.05

357

Malignant neoplasm of breast, HER2-negative, including Hilmo

1174

6590

1.15

4.66

2.4

3.1

125.36

129.36

g/l

8.72

1136

6407

Malignant neoplasm of breast, including Hilmo

1174

6590

1.15

4.65

2.4

3.1

125.36

129.36

g/l

8.72

1136

6407

Viral infections of the central nervous system

220

1633

1.37

4.65

4.1

3.3

126.55

130.67

g/l

1.92

215

1590

Nonsuppurative otitis media, including avohilmo

884

6587

1.17

4.60

4.5

3.6

130.90

131.42

g/l

0.28

864

6416

Calcific tendinitis of shoulder

171

1221

1.43

4.58

4.3

2.9

133.44

129.77

g/l

1.36

163

1186

Intussusception

426

1.75

4.57

2.2

3.2

128.15

129.50

g/l

0.20

415

Primary coxarthrosis, bilateral

1090

9574

1.15

4.56

3.4

3.3

127.10

127.33

g/l

0.13

1057

9306

Other peripheral vascular diseases

246

1863

1.34

4.54

3.5

2.8

125.44

129.69

g/l

2.23

234

1811

Adenocarcinoma and papilloma adenocarcinoma of rectum

355

2823

1.28

4.54

2.6

3.2

123.49

130.58

g/l

7.00

344

2739

ILD medications: acetylcysteine

163

2.27

4.54

3.5

2.5

118.43

125.07

g/l

0.97

158

Unspecified maternal hypertension

130

2.40

4.53

1.9

2.8

126.83

134.93

g/l

0.97

125

Palmar fascial fibromatosis [Dupuytren]

546

4543

1.22

4.52

3.3

128.67

128.71

g/l

0.01

533

4404

Unspecified/other endometriosis

200

1436

1.38

4.49

2.9

3.0

131.54

128.29

g/l

1.43

193

1402

Hypertrophy of breast in women and men

498

4105

1.22

4.47

3.1

3.2

129.87

128.99

g/l

0.40

478

3986

Inflammatory diseases of prostate (prostatitis)

465

3816

1.24

4.47

3.6

3.4

134.31

131.00

g/l

2.34

454

3719

Spontaneous rupture of synovium and tendon

266

2046

1.32

4.42

3.5

3.0

131.13

128.91

g/l

0.85

254

1981

Carcinoma in situ of skin of scalp and neck

126

863

1.52

4.41

4.3

3.1

121.07

126.09

g/l

1.61

126

838

Overexertion and strenuous or repetitive movements

301

2353

1.30

4.41

3.7

3.3

128.74

131.16

g/l

0.99

296

2287

Acute lymphocytic leukaemia, including Hilmo

114

2.52

4.39

49.9

7.6

111.04

129.91

g/l

5.68

109

Acute lymphocytic leukaemia, helper endpoint

114

2.52

4.39

49.9

7.6

111.04

129.91

g/l

5.68

109

Acute lymphocytic leukaemia

114

2.52

4.39

49.9

7.6

111.04

129.91

g/l

5.68

109

Benign neoplasm of urinary organs

167

1200

1.43

4.39

4.5

3.1

125.78

127.52

g/l

0.47

162

1163

Deep bite

319

2200

1.29

4.39

8.3

4.3

130.96

131.13

g/l

0.05

313

2134

Transient global amnesia

316

2492

1.29

4.38

2.7

3.1

132.84

127.46

g/l

4.42

311

2419

Distal bite

102

659

1.57

4.36

11.0

6.9

133.20

130.88

g/l

0.55

637

Peritonsillar abscess

596

5011

1.20

4.34

3.3

3.4

131.84

131.46

g/l

0.15

582

4883

Thyrotropin deficiency

200

2.10

4.34

6.4

3.6

131.30

132.09

g/l

0.08

195

Puerperal sepsis

307

2411

1.29

4.30

3.2

130.92

128.40

g/l

1.43

301

2342

Urethritis and urethral syndrome

426

1.72

4.29

3.6

2.8

124.98

129.81

g/l

1.09

412

Salpingitis and oophoritis

446

3656

1.23

4.27

4.3

3.0

127.59

127.67

g/l

0.03

435

3559

Malignant neoplasm of breast, ER-positive, including Hilmo

928

6003

1.16

4.25

2.4

3.0

125.49

129.08

g/l

6.10

888

5834

Tumor necrosis factor alpha inhibitors

426

3477

1.24

4.25

3.6

3.7

129.64

131.82

g/l

1.17

411

3390

Malignant neoplasm of breast

1151

6541

1.14

4.24

2.4

3.1

125.36

129.31

g/l

8.38

1114

6358

Malignant neoplasm of breast, HER2-negative

1150

6538

1.14

4.23

2.4

3.1

125.34

129.32

g/l

8.52

1113

6355

Polyhydramnios

646

1.56

4.17

3.6

3.3

127.77

130.26

g/l

0.58

630

Malignant neoplasm of breast, HER-positive

925

5999

1.16

4.17

2.4

3.0

125.47

129.08

g/l

6.15

885

5830

Nummular dermatitis

288

2260

1.30

4.16

4.6

3.2

126.93

129.64

g/l

1.19

281

2189

Hypermetropia

217

1636

1.35

4.15

8.4

4.6

126.95

129.50

g/l

1.04

211

1589

Spondylopathies in diseases classified elsewhere

290

1.89

4.14

6.3

2.9

118.29

126.52

g/l

1.72

280

Spinal osteochondrosis

211

2.04

4.12

2.3

2.8

132.32

132.94

g/l

0.06

205

Ehlers-Danlos syndrome

130

2.33

4.10

20.1

3.4

131.86

132.42

g/l

0.05

123

Conductive hearing loss, unspecified

259

2009

1.31

4.08

5.8

3.5

127.02

129.63

g/l

1.03

251

1957

Spondylopathies (FG)

384

3121

1.24

4.02

3.9

3.3

129.93

131.79

g/l

0.87

374

3052

Sleep disorders

3155

20191

1.08

3.99

3.2

3.4

132.23

129.61

g/l

9.11

3070

19635

Urethral stricture

207

1565

1.35

3.98

3.8

3.1

131.26

129.22

g/l

0.58

201

1517

APECED

14.96

3.97

8.5

12.8

127.17

132.60

g/l

—

Beta thalassaemia

14.70

3.95

11.7

12.0

131.67

124.40

g/l

—

Brachial plexus disorders

235

1805

1.32

3.95

2.9

3.0

131.75

130.66

g/l

0.30

224

1759

Selective deficiency of immunoglobulin M [IgM]

11.44

3.95

9.1

7.3

130.86

121.33

g/l

—

Temporal arteritis

140

999

1.45

3.93

4.0

2.9

127.55

126.56

g/l

0.23

134

972

Panniculitis, unspecified

223

1.98

3.90

3.4

2.8

118.50

130.08

g/l

2.40

216

MS-disease / Multiple Sclerosis

181

1343

1.37

3.88

4.5

3.1

133.30

131.69

g/l

0.51

174

1303

Glaucoma suspect

1305

11705

1.12

3.87

3.4

3.3

126.44

127.76

g/l

1.31

1259

11368

Diastasis of muscle

147

2.21

3.87

3.1

3.2

133.00

130.11

g/l

0.27

139

Hidradenitis suppurativa

635

1.54

3.87

3.5

128.64

132.74

g/l

0.94

619

Achilles tendinitis

313

2502

1.27

3.86

4.0

3.4

132.24

129.54

g/l

1.24

298

2433

Osteitis due to dental implant

197

2.07

3.85

3.4

3.3

130.45

128.04

g/l

0.25

191

Adalimumab

266

2085

1.29

3.85

3.7

130.27

132.22

g/l

0.69

255

2028

Degenerative diseases of the nervous system

1517

9856

1.12

3.84

2.8

3.2

127.68

126.11

g/l

2.11

1485

9559

Benign neoplasm of meninges

338

2732

1.26

3.82

3.5

3.0

128.02

127.77

g/l

0.08

328

2644

Pervasive developmental disorders excl. Autism + Asperger

221

1.95

3.79

3.2

14.0

139.52

130.02

g/l

3.25

215

Bronchitis, not specified as acute or chronic

268

2109

1.29

3.78

4.7

3.2

128.53

129.54

g/l

0.29

258

2054

Other diseases of hard tissues of teeth

2094

9928

1.10

3.77

4.1

3.1

129.45

129.22

g/l

0.17

2020

9709

Causalgia

298

1.81

3.76

3.2

3.0

135.89

130.55

g/l

0.95

292

Giant cell arteritis with polymyalgia rheumatica

140

1008

1.43

3.75

4.0

2.9

127.55

126.51

g/l

0.24

134

979

Maternal care related to the fetus and amniotic cavity and possible delivery problems

754

5103

0.86

3.74

2.8

3.2

130.71

129.44

g/l

0.95

731

4970

Other hearing loss

1053

9062

1.13

3.71

3.3

126.37

127.24

g/l

0.60

1018

8811

Other/unspecified enthesopathies of lower limb, excluding foot

197

1493

1.34

3.69

5.1

3.1

130.95

129.20

g/l

0.50

192

1451

Malignant neoplasm of ovary

146

1059

1.41

3.68

3.0

2.9

117.78

128.71

g/l

7.23

141

1027

Disorders of puberty

219

1.93

3.68

12.6

6.4

130.61

133.27

g/l

0.34

211

Unspecific neurodegenerative disorder

1724

10753

1.11

3.67

2.7

3.3

128.20

126.15

g/l

3.78

1673

10418

Myopia

332

2686

1.25

3.66

5.4

3.6

131.09

131.82

g/l

0.24

321

2611

FESS (DNB20)

240

3056

0.78

3.63

2.6

3.3

132.70

130.88

g/l

0.63

225

2971

Glucosamine medication

1731

12606

1.10

3.62

2.8

3.3

127.77

126.77

g/l

1.12

1681

12243

Mixed conductive and sensorineural hearing loss

413

3432

1.22

3.58

3.8

3.3

126.90

128.19

g/l

0.57

396

3335

Drug-induced Cushing's syndrome

5.89

3.57

1.4

2.9

121.56

127.61

g/l

—

Alcohol induced polyneuropathy

238

1.91

3.57

6.3

3.3

128.86

130.47

g/l

0.14

233

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

174

2.07

3.55

7.3

3.6

120.62

129.43

g/l

1.57

169

Infections with a predominantly sexual mode of transmission

738

6406

1.16

3.55

3.9

3.3

128.61

132.10

g/l

4.01

718

6238

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

225

1751

1.31

3.54

4.1

3.3

122.06

130.41

g/l

6.65

217

1700

Chronic rhinitis, nasopharyngitis and pharyngitis

999

8872

1.13

3.54

3.6

131.94

129.54

g/l

3.10

982

8640

Other salmonella infections, including avohilmo

124

881

1.44

3.52

5.7

2.8

129.82

130.04

g/l

0.04

119

851

Scleritis and episcleritis

172

1289

1.36

3.52

5.5

3.2

127.30

130.64

g/l

1.29

165

1253

Defect, injury or illness of neck

114

2.34

3.50

3.3

3.4

133.68

130.21

g/l

0.36

109

Varicose veins

2156

15013

1.09

3.49

3.3

3.2

128.10

128.20

g/l

0.08

2075

14602

Other inflammation of eyelid

453

3804

1.20

3.49

3.4

130.35

128.76

g/l

0.84

440

3680

Ganglion

566

4842

1.18

3.45

3.5

3.0

131.88

129.94

g/l

1.25

549

4724

Childhood allergy (age < 16)

284

1869

1.26

3.43

5.2

5.8

133.11

134.11

g/l

0.33

279

1827

Disorders in reading

247

1.84

3.41

28.7

6.7

131.91

135.69

g/l

0.47

242

Normal-pressure hydrocephalus

187

1432

1.34

3.40

2.5

3.0

131.55

126.02

g/l

3.56

182

1392

Ethmoidectomy

254

3184

0.79

3.40

2.8

3.3

132.62

130.80

g/l

0.65

238

3096

Protein-energy malnutrition of moderate and mild degree

250

1.87

3.39

9.7

5.5

121.97

127.76

g/l

1.04

243

Pyoderma

386

1.66

3.35

7.3

3.6

125.42

129.88

g/l

0.90

375

Acute epiglottitis

294

1.76

3.35

3.4

2.8

126.08

131.95

g/l

0.95

286

malignant neoplasm of male genital organs, including Hilmo

1096

5886

1.13

3.32

3.4

3.5

127.61

133.34

g/l

11.62

1068

5734

Injury of muscle and tendon at hip and thigh level

308

2507

1.24

3.30

3.4

3.5

130.62

131.08

g/l

0.12

298

2442

Maternal care for known or suspected fetal abnormality and damage

181

2002

0.76

3.28

2.2

3.3

132.59

130.54

g/l

0.67

176

1952

Other (seronegative) rheumatoid arthritis, wide

601

5196

1.17

3.27

3.5

3.2

124.37

127.88

g/l

3.79

585

5046

Malignant otitis externa

4.17

3.26

4.4

2.6

118.55

135.17

g/l

1.40

Other/unspecified rheumatoid arthritis

398

3332

1.21

3.23

3.7

3.0

122.50

127.44

g/l

5.20

388

3226

Vasomotor and allergic rhinitis

1091

9569

1.12

3.23

3.6

3.7

133.11

130.27

g/l

4.28

1069

9330

Scabies

132

964

1.39

3.22

4.0

3.3

130.01

132.56

g/l

0.62

127

942

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

7.06

3.21

1.7

7.3

128.71

132.25

g/l

—

Other/unspecified enthesopathies, not elsewhere classified

257

2059

1.27

3.20

3.2

3.0

129.28

129.15

g/l

0.03

250

1997

Postmenopausal bleeding

828

3813

1.15

3.19

3.1

127.13

125.60

g/l

1.22

798

3736

Rapidly progressive nephritic syndrome

3.24

3.19

30.2

3.1

115.00

126.18

g/l

1.52

Migraine with aura, drug-induced

195

1.93

3.19

2.0

2.6

127.31

131.30

g/l

0.48

189

Other abnormal products of conception

616

3486

1.16

3.18

2.3

3.2

132.05

130.44

g/l

1.18

600

3385

Separation of retinal layers (serosa)

133

977

1.39

3.17

5.2

3.2

131.45

131.65

g/l

0.03

128

954

Carcinoma in situ of breast, other/unspecified

327

0.38

3.15

2.5

2.4

124.69

126.76

g/l

0.17

320

Perforation of oesophagus

120

2.25

3.15

2.7

2.9

125.16

128.63

g/l

0.28

115

Fall on and from ladder

262

2112

1.26

3.14

3.2

3.4

131.58

129.82

g/l

0.64

256

2055

Peripheral retinal degeneration

693

1.47

3.13

3.2

2.7

135.67

128.69

g/l

2.41

674

Acetic acid derivatives and related substances

1033

4766

1.13

3.13

2.8

4.1

131.24

126.52

g/l

8.78

997

4662

Congenital dyserythropoietic anaemia

6.91

3.10

6.3

2.7

113.29

131.46

g/l

—

Other and unspecified mononeuropathies, also in other diseases

678

1.47

3.10

4.0

2.8

127.42

128.41

g/l

0.16

662

Other and unspecified glaucoma

259

2089

1.26

3.10

3.5

2.9

125.34

127.14

g/l

0.67

250

2032

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

404

1.62

3.08

3.7

3.0

112.33

128.34

g/l

6.65

388

Aortic hypoplasia

4.07

3.08

8.1

24.0

117.64

121.09

g/l

0.23

D07AA Corticosteroids, weak (group I)

414

3486

1.20

3.06

5.0

4.3

130.05

129.97

g/l

0.02

403

3394

Abscess of tendon sheath

128

2.15

3.04

3.5

2.5

129.62

132.20

g/l

0.17

122

Bitten or struck by other mammals

299

2448

1.23

3.03

3.7

3.5

131.88

130.93

g/l

0.30

287

2383

Atopic dermatitis, strict definition

736

6336

1.14

3.03

3.8

4.2

132.86

131.55

g/l

0.90

718

6173

Q fever

9.10

3.03

12.2

7.8

128.00

137.20

g/l

—

Benign neoplasm: Cerebral meninges

303

2490

1.23

3.02

3.4

3.0

128.42

127.73

g/l

0.23

294

2413

Dentofacial anomalies [including malocclusion]

2132

15479

1.08

2.98

3.7

3.5

132.13

130.47

g/l

3.16

2072

15073

Unspecified urinary incontinence

276

2250

1.24

2.97

3.3

2.8

125.16

127.64

g/l

1.09

257

2174

Nephropathy induced by other drugs, medicaments and biological substances

3.53

2.96

13.6

3.7

110.50

129.72

g/l

2.57

Postpartum haemorrhage due to anatomy

1365

0.70

2.96

3.6

2.6

131.28

132.39

g/l

0.20

1328

Malignant neoplasm of vulva, including Hilmo

322

1.68

2.95

3.7

2.4

124.37

127.26

g/l

0.42

311

Kyphoscoliotic heart disease

4.55

2.94

4.1

2.8

126.33

132.26

g/l

—

Contraceptive management

901

7049

0.89

2.94

4.2

3.5

132.45

132.57

g/l

0.05

873

6894

Radial styloid tenosynovitis [de Quervain]

142

1065

1.35

2.94

2.5

2.7

129.44

130.31

g/l

0.17

136

1037

Other disorders of white blood cells

171

1320

1.32

2.94

6.2

3.1

123.58

129.10

g/l

2.09

164

1284

Convalescence

141

1058

1.35

2.93

6.5

2.4

123.01

131.50

g/l

3.77

135

1021

Other salmonella infections

105

754

1.42

2.89

5.8

2.9

127.97

129.78

g/l

0.33

100

732

Disorders of puberty, all

253

1.74

2.88

13.3

7.6

130.30

131.45

g/l

0.13

244

Nonspecific lymphadenitis

158

1209

1.33

2.87

8.1

3.4

130.43

130.68

g/l

0.05

150

1177

All dysplastic lesions of the cervix uteri, vagina or vulva

605

5150

1.15

2.86

3.4

3.0

128.91

129.78

g/l

0.48

592

5004

Excessive attrition of teeth

1905

17480

1.08

2.84

4.6

3.4

131.82

130.37

g/l

2.12

1852

17015

Abuse of non-dependence-producing substances

4.28

2.82

4.9

2.9

132.89

122.17

g/l

—

Scleritis

256

1.74

2.81

5.5

3.0

127.74

130.71

g/l

0.43

250

Use of levodopa decarboxylase inhibitor

515

4465

1.17

2.81

3.0

3.2

128.31

127.20

g/l

0.64

501

4332

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

818

7302

1.13

2.80

3.4

3.2

122.99

127.97

g/l

9.04

793

7092

Other orthopaedic follow-up care

155

1188

1.32

2.79

3.4

2.6

128.55

131.76

g/l

0.96

147

1150

Q fever, including avohilmo

7.24

2.77

12.2

7.2

128.00

139.18

g/l

—

Other disorders of patella

446

3822

1.18

2.76

3.1

3.2

132.34

131.14

g/l

0.52

432

3742

Flat foot [pes planus] (acquired)

276

2268

1.23

2.76

3.1

3.2

128.11

128.75

g/l

0.19

269

2217

Murder, homicide, or other assault by handgun discharge

6.93

2.73

1.3

4.8

131.33

127.18

g/l

—

Other puerperal infections

138

1042

1.34

2.72

2.1

3.0

133.14

131.00

g/l

0.59

132

1016

Pediculosis, acariasis and other infestations, including avohilmo

470

4050

1.17

2.71

3.5

3.6

132.58

131.65

g/l

0.42

457

3941

Sicca syndrome [Sjögren]

242

1967

1.25

2.71

5.7

2.9

125.76

127.91

g/l

0.87

231

1912

Autoimmune hyperthyroidism

159

1228

1.31

2.71

3.2

2.6

131.52

130.40

g/l

0.25

149

1192

Other nutritional anaemias

229

1.78

2.70

6.5

3.1

103.54

127.38

g/l

8.64

222

Failure in dosage during surgical and medical care

3.76

2.70

4.5

4.1

121.90

130.03

g/l

—

Acne, including avohilmo

469

3262

1.17

2.69

4.4

3.7

131.77

133.32

g/l

0.82

460

3178

Mantle cell lymphoma

246

1.76

2.68

4.2

2.9

113.80

131.89

g/l

4.15

241

Visual impairment including blindness (binocular or monocular)

235

1909

1.25

2.67

5.6

3.2

123.12

127.38

g/l

2.25

223

1853

Other diseases of blood and blood-forming organs

221

1784

1.26

2.67

4.1

3.1

133.04

129.43

g/l

1.01

211

1726

Thyrotoxicosis with toxic multinodular goitre

192

1526

1.28

2.66

3.2

2.9

129.70

126.94

g/l

1.13

187

1483

Abrasion of teeth

904

10030

0.90

2.65

2.9

3.4

130.78

129.63

g/l

0.91

873

9761

Use of antiglaucoma preparations and miotics

283

2347

1.22

2.64

4.5

2.9

123.58

126.81

g/l

1.55

268

2283

Disease of hard tissues of teeth, NOS

1950

9476

1.08

2.64

3.0

3.1

132.11

129.57

g/l

5.15

1868

9264

Drug-induced acute pancreatitis

3.35

2.64

44.8

2.5

120.18

130.11

g/l

0.66

Internal derangement of knee

1170

10576

1.10

2.58

3.2

131.38

130.57

g/l

0.57

1134

10334

Insomnia

3028

19887

1.06

2.55

3.2

3.4

132.39

129.57

g/l

10.04

2947

19342

L02BB Anti-androgens

343

2907

1.20

2.54

3.2

3.5

119.38

127.94

g/l

9.33

334

2816

Injury of nerves at lower leg level

203

1.79

2.54

2.9

129.09

129.33

g/l

0.02

198

Nasal polyp

630

5575

1.14

2.54

3.0

3.4

132.76

129.74

g/l

2.98

614

5411

Defects in post-translational modification of lysosomal enzymes

7.97

2.53

1.0

3.1

140.20

125.13

g/l

—

Benign neoplasm: Liver/bile ducts (ICD-9)

5.84

2.52

2.5

2.4

117.50

126.50

g/l

—

Ankyloglossia

255

1.68

2.52

7.8

11.5

134.90

130.86

g/l

0.54

248

Hypertrophy of breast

384

3279

1.18

2.52

2.7

3.1

130.12

128.44

g/l

0.88

368

3186

Benign mammary dysplasia

394

3376

1.18

2.51

3.2

3.0

126.90

126.64

g/l

0.09

382

3281

Fibrosis and sclerosis of liver

4.86

2.50

3.0

2.8

111.57

136.82

g/l

—

Other/unspecified seropositive rheumatoid arthritis

829

7462

1.12

2.49

3.4

3.3

122.90

127.94

g/l

9.42

804

7250

Triptan medication for migraine, min. 3 purchases

1435

9878

1.09

2.48

3.1

3.3

133.13

130.63

g/l

4.98

1400

9620

Sequelae of injuries of neck and trunk

658

1.41

2.47

2.3

3.1

129.79

130.31

g/l

0.08

643

Tooth agenesis EXCLUDE clefts and syndromes

605

1.42

2.46

5.2

5.7

132.44

131.38

g/l

0.20

584

Need for immunization against other single infectious diseases

3.69

2.45

6.3

6.4

126.33

127.43

g/l

—

Glycosuria

3.98

2.45

3.5

10.5

132.13

123.86

g/l

—

Other nonthrombocytopenic purpura

237

1.72

2.44

5.0

3.0

128.31

128.64

g/l

0.04

230

Pedestrian injured in transport accident

206

1669

1.25

2.42

3.5

3.3

128.15

129.94

g/l

0.49

194

1620

Rat-bite fevers, including avohilmo

5.55

2.41

6.5

3.2

127.17

124.69

g/l

—

malignant neoplasm of male genital organs

1056

5787

1.11

2.41

3.3

3.5

127.54

133.25

g/l

11.23

1028

5636

Testicular dysfunction

124

945

1.34

2.41

4.1

3.6

138.38

136.18

g/l

0.40

118

920

Seropositive rheumatoid arthritis, wide

837

7561

1.11

2.37

3.4

3.3

122.86

127.97

g/l

9.69

812

7344

Single spontaneous delivery

978

5688

0.90

2.37

2.4

3.2

129.11

126.26

g/l

4.34

946

5523

Malignant neoplasm of cervix uteri, including Hilmo

462

1.48

2.36

4.6

2.7

124.45

128.68

g/l

0.94

445

Mucosal proctocolitis

340

2894

1.19

2.36

4.4

3.3

128.35

131.77

g/l

1.73

328

2818

Lethal midline granuloma

5.72

2.36

6.8

2.9

119.50

129.79

g/l

—

Exposure to high and low air pressure and changes in air pressure

4.33

2.34

1.0

2.3

136.71

139.17

g/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

392

3378

1.17

2.34

3.9

3.5

131.93

131.50

g/l

0.13

378

3287

Malignant neoplasm of prostate, including Hilmo

1054

5669

1.10

2.34

3.3

3.5

127.65

133.00

g/l

10.01

1026

5525

Allergic rhinitis

789

7015

1.12

2.33

4.0

133.30

131.42

g/l

1.63

776

6835

Retained placenta and membranes, without haemorrhage

259

2155

1.21

2.32

3.0

3.1

127.63

128.73

g/l

0.36

250

2097

Early lumbar disc prolapse operation

234

1929

1.22

2.31

3.6

3.3

136.59

135.87

g/l

0.18

220

1886

Other menopausal disorders

577

3638

0.88

2.30

2.8

3.1

130.03

126.38

g/l

4.36

558

3561

Crowding of teeth, including avohilmo

204

1370

1.24

2.29

8.5

5.0

132.38

132.72

g/l

0.08

197

1338

Carcinoma in situ of skin of upper limb, including shoulder

104

782

1.37

2.29

4.8

3.1

123.98

125.28

g/l

0.27

760

Infections with a predominantly sexual mode of transmission, including avohilmo

964

8022

1.10

2.29

3.7

3.3

130.42

132.36

g/l

1.86

940

7813

Abnormality of white blood cells, not elsewhere classified

203

1.75

2.28

5.4

3.8

122.83

129.37

g/l

0.79

197

Congenital malformations of eye, ear, face and neck

161

1278

1.28

2.27

5.2

4.7

129.97

131.42

g/l

0.35

156

1246

Lactose intolerance

549

1.43

2.27

3.2

3.3

124.86

129.73

g/l

0.97

532

Pustulosis palmaris et plantaris

117

894

1.33

2.24

2.7

2.9

131.40

129.49

g/l

0.40

112

866

Victim of lightning

4.84

2.24

2.0

2.7

131.00

128.21

g/l

—

Malignant neoplasm of vulva

259

1.65

2.24

4.3

2.4

121.88

127.53

g/l

0.82

248

Disorders of sphingolipid metabolism and other lipid storage disorders

2.45

2.23

4.1

2.9

137.93

126.22

g/l

0.91

Rickettsioses, including avohilmo

3.01

2.22

7.8

3.8

133.70

132.03

g/l

—

Nanophthalmos, microphthalmos and macrophthalmos

5.14

2.22

3.5

16.3

135.33

126.27

g/l

—

Female genital prolapse

819

4108

1.11

2.20

2.7

3.0

127.71

126.04

g/l

1.57

798

4021

Other and unspecified spinal muscular atrophies

190

1.76

2.20

4.1

3.5

127.41

127.77

g/l

0.03

185

Testicular hypofunction

109

828

1.34

2.20

4.4

3.7

137.03

135.82

g/l

0.18

104

810

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

277

2339

1.20

2.18

3.4

3.2

127.72

129.00

g/l

0.41

267

2273

Disorders of breast

1337

10888

1.08

2.17

3.2

3.0

128.44

127.54

g/l

0.91

1295

10596

Open bite that required surgery (Lefort1 or BSSO)

123

1.92

2.16

2.0

2.9

139.48

132.76

g/l

1.11

117

Endometriosis

859

4522

1.11

2.16

2.8

3.0

129.41

126.80

g/l

3.45

836

4428

Follow-up care involving plastic surgery

716

0.66

2.15

3.6

2.4

127.14

131.05

g/l

0.71

688

Iliotibial band syndrome

198

1.72

2.15

5.2

3.4

124.55

129.66

g/l

0.65

190

HSIL lesion of the vulva

357

1.53

2.15

2.9

2.5

123.11

129.19

g/l

1.51

347

Routine general health check-up of defined subpopulation

267

1.60

2.15

3.4

2.3

131.31

132.18

g/l

0.11

258

Disorders of conjunctiva

2815

20671

1.06

2.15

3.9

3.5

130.95

129.58

g/l

2.66

2736

20117

Etanercept

169

1360

1.26

2.15

3.6

3.7

125.45

131.44

g/l

2.62

161

1325

Vestibular neuronitis

272

2297

1.20

2.15

3.2

3.1

130.87

128.99

g/l

0.78

266

2232

Conjunctivitis (acute, non atopic), including avohilmo

3363

21302

0.95

2.14

3.7

3.5

131.53

129.50

g/l

5.72

3265

20734

Other disorders of prostate

118

911

1.32

2.14

3.6

3.4

129.46

128.16

g/l

0.24

118

891

Other secondary gout

2.28

2.14

4.0

3.3

117.50

128.58

g/l

1.30

Bladder disorders in in diseases classified elsewhere

4.55

2.13

2.8

2.9

137.33

122.60

g/l

—

Torsion of testis

308

1.56

2.13

3.5

5.3

142.64

138.14

g/l

0.48

301

Melanoma in situ of lip

6.20

2.12

3.8

1.7

107.60

130.64

g/l

—

Seropositive rheumatoid arthritis, strict definition

440

3859

1.15

2.11

3.1

123.36

128.59

g/l

5.54

427

3740

Myeloproliferative diseases

270

2284

1.20

2.11

2.6

3.0

125.64

128.15

g/l

0.89

256

2218

Dextrocardia

3.88

2.09

6.9

13.7

122.57

132.95

g/l

—

Malignant neoplasm of head and neck

263

2221

1.20

2.08

3.0

3.2

123.88

131.21

g/l

5.32

255

2159

Diseases of external ear

1180

10909

1.09

2.06

3.7

3.6

130.15

129.08

g/l

0.90

1142

10608

Whooping cough, including avohilmo

247

1.61

2.05

5.8

2.6

127.90

133.27

g/l

0.87

236

Rat-bite fevers

5.47

2.05

6.8

2.4

128.20

126.91

g/l

—

Pedal cyclist injured in noncollision transport accidents

322

2771

1.17

2.02

3.1

3.5

130.33

131.27

g/l

0.34

312

2692

Abnormal findings on antenatal screening of mother

125

977

1.29

2.01

2.1

3.1

133.33

131.26

g/l

0.68

120

953

Postpartum care and examination

163

1267

0.80

2.00

6.6

2.8

128.87

131.34

g/l

0.92

155

1235

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

4.94

1.99

11.8

3.3

134.40

129.36

g/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

147

1178

1.27

1.98

4.1

3.0

132.01

129.98

g/l

0.53

140

1143

Lichen planus

391

3420

1.15

1.98

3.7

3.2

127.68

128.09

g/l

0.14

380

3317

Episcleritis

137

1089

1.27

1.97

5.5

3.2

127.55

130.21

g/l

0.77

130

1060

Unspecified visual impairment (binocular)

340

1.51

1.97

3.3

4.3

123.80

128.98

g/l

0.94

333

Moderate visual impairment, binocular

839

0.70

1.96

6.6

3.4

118.45

125.89

g/l

1.84

819

Tooth eruption problems

304

2517

1.17

1.96

8.8

4.0

128.65

132.86

g/l

2.87

289

2457

Cysts of oral region, not elsewhere classified

174

1423

1.24

1.96

3.8

3.3

128.96

130.32

g/l

0.31

164

1382

Interstitial emphysema and related conditions originating in the perinatal period

2.95

1.95

17.4

24.1

118.00

123.24

g/l

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

233

1956

1.20

1.95

2.8

3.0

134.57

132.37

g/l

0.99

228

1901

Rickettsioses

2.90

1.95

8.6

3.9

134.00

131.50

g/l

—

Lactose intolerance, other/unspecified

481

1.42

1.95

3.3

3.1

123.02

129.48

g/l

1.29

466

Congenital obstruction of the pelviureteric junction

174

1.74

1.94

5.4

2.9

128.17

130.36

g/l

0.18

169

Other female pelvic inflammatory diseases

386

3376

1.15

1.94

3.6

2.9

129.99

127.80

g/l

1.29

368

3283

Dementia in Alzheimer disease

699

5293

1.11

1.94

2.6

3.2

127.68

124.88

g/l

2.98

687

5139

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

201

1670

1.22

1.94

2.6

3.2

132.95

129.42

g/l

1.38

191

1625

Congenital malformations of genital organs

196

1610

1.22

1.94

4.0

4.7

127.79

130.59

g/l

1.06

187

1563

Mental and behavioural disorders of puerperium, not classified elsewhere

143

1.79

1.93

2.1

2.9

129.72

129.59

g/l

0.01

136

Malignant neoplasm of cervix uteri

292

1.54

1.92

3.0

2.4

126.20

129.61

g/l

0.49

284

Lumbosacral root disorders, not elsewhere classified

264

0.48

1.92

2.2

2.9

126.85

128.81

g/l

0.09

255

Family history of malignant neoplasm

253

2145

1.19

1.91

2.8

2.4

130.49

132.06

g/l

0.56

242

2087

Malignant neoplasm of retroperitoneum and peritoneum

183

1.71

1.91

2.0

2.6

112.30

130.50

g/l

4.92

178

Benign neoplasm of middle ear and respiratory system

244

2067

1.19

1.90

3.2

127.64

129.00

g/l

0.42

235

2003

Night blindness

4.76

1.90

25.4

7.4

100.80

122.67

g/l

—

Guillain-Barre syndrome

360

1.49

1.89

5.4

2.8

130.42

129.54

g/l

0.10

351

Traumatic amputation of forearm

4.00

1.87

6.2

3.2

115.33

124.83

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

391

3436

1.15

1.87

3.7

3.3

131.75

129.49

g/l

1.25

373

3332

Other specified/unspecified disorders of bone/cartilage

606

1.36

1.86

4.9

2.9

129.44

131.61

g/l

0.35

594

Other prurigo

255

1.58

1.86

6.6

2.9

121.97

129.49

g/l

1.13

247

Cervical polyps

245

2078

1.19

1.86

2.7

3.1

129.32

126.21

g/l

1.61

236

2037

Supervision of normal pregnancy

307

2033

0.86

1.84

2.1

3.0

134.37

130.06

g/l

3.62

297

1987

Drug phototoxic response

3.85

1.84

1.3

4.6

139.50

127.44

g/l

—

Mouth breathing

1257

11691

1.08

1.84

4.2

3.8

131.67

130.52

g/l

1.00

1216

11390

Myotonic disorders

154

1.75

1.83

2.6

3.8

127.88

129.95

g/l

0.16

149

Pregnancy examination and test

276

1458

1.18

1.82

2.4

3.0

132.36

130.99

g/l

0.53

264

1422

Need for immunization against single bacterial diseases

2.39

1.82

23.3

23.0

128.67

129.56

g/l

0.04

Iron deficiency

470

1.40

1.82

3.9

5.1

130.13

130.39

g/l

0.04

457

Pustular psoriasis

128

1022

1.27

1.81

2.7

2.9

130.76

129.22

g/l

0.33

122

989

Burn and corrosion of respiratory tract

3.68

1.81

2.0

10.4

116.50

138.22

g/l

—

Toxic effect of other inorganic substances

4.48

1.80

1.2

6.2

137.00

130.00

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

303

3240

0.86

1.80

2.9

3.2

132.36

130.09

g/l

1.20

289

3169

Operations 1 for CAVS

2.16

1.80

4.5

8.7

121.53

124.05

g/l

0.13

Drug-induced autoimmune haemolytic anaemia

3.23

1.80

6.3

2.3

127.71

129.00

g/l

—

Coxibs

998

4821

1.09

1.79

2.7

4.2

131.56

126.56

g/l

9.68

963

4714

Tetraplegia

171

1.71

1.78

4.9

132.04

129.37

g/l

0.24

166

Other congenital malformations of intestine, including avohilmo

242

1.58

1.78

20.7

4.7

129.76

130.44

g/l

0.07

236

Persistent hyperplasia of thymus

3.72

1.77

3.5

2.2

130.83

135.37

g/l

—

Other congenital malformations of intestine

187

1.66

1.76

25.0

5.2

127.37

130.72

g/l

0.33

181

Other and unspecified disorders of psychological development

188

1.64

1.75

4.5

12.1

127.65

130.45

g/l

0.22

183

Guttate psoriasis

283

1.52

1.75

3.9

3.0

130.31

130.47

g/l

0.02

276

Polycythaemia vera

112

886

1.29

1.75

3.1

2.7

131.21

130.09

g/l

0.17

107

859

Tonsillectomy and adenotomy

1448

9431

1.07

1.74

4.1

4.0

133.52

132.28

g/l

1.30

1404

9188

Dyslexia and other symbolic dysfunctions, not elsewhere classified

2.20

1.71

4.5

4.4

136.31

128.71

g/l

0.92

Gestational diabetes (for exclusion)

655

4086

1.11

1.70

3.0

3.1

132.24

130.69

g/l

1.21

639

3975

Other congenital malformations, including avohilmo

320

2792

1.15

1.70

5.9

4.3

129.80

130.33

g/l

0.16

312

2718

Delivery

1002

5704

0.92

1.68

2.5

3.2

129.01

126.27

g/l

4.07

966

5539

Exfoliative dermatitis

254

1.55

1.67

3.4

3.3

128.37

130.68

g/l

0.28

246

Long labour

345

3327

0.88

1.67

3.5

3.2

132.47

130.04

g/l

1.45

326

3249

Congenital deformities of feet

453

1.39

1.67

3.5

4.8

129.73

131.04

g/l

0.19

441

Sixth [abducent] nerve palsy

108

857

1.28

1.66

4.4

3.3

128.53

128.39

g/l

0.02

100

833

Alzheimer disease, including avohilmo

1495

9726

1.07

1.66

2.6

3.2

127.84

125.88

g/l

3.08

1453

9430

Retinal detachment with retinal break

421

3753

1.13

1.65

4.5

3.2

127.35

129.46

g/l

1.08

409

3644

Malignant neoplasm of other and unspecified female genital organs

371

1.44

1.65

3.1

2.4

114.27

127.82

g/l

5.65

356

Muscular dystrophy

175

1.66

1.65

4.6

5.1

136.82

130.98

g/l

0.76

169

Other secondary gonarthrosis

166

1382

1.22

1.63

4.2

3.2

126.18

128.13

g/l

0.55

159

1345

Colorectal neuroendocrine tumor and carcinoma

305

1.48

1.62

4.0

2.6

127.55

131.46

g/l

0.43

297

Other congenital malformations of ear

159

1.67

1.62

2.5

5.6

140.88

131.42

g/l

1.21

153

Malignant neoplasm of prostate

1018

5589

1.08

1.62

3.3

3.5

127.65

132.87

g/l

9.34

990

5445

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

820

6215

1.09

1.61

3.5

3.3

122.76

130.25

g/l

17.65

790

6035

Malignant neoplasm of other connective and soft tissue, including Hilmo

130

1058

1.25

1.60

4.6

3.2

124.31

130.43

g/l

2.48

124

1028

Myeloproliferative diseases (CML excluded)

239

2057

1.18

1.60

2.5

3.0

126.71

128.14

g/l

0.38

226

1998

Essential (haemorrhagic) thrombocythaemia

115

924

1.26

1.59

2.1

2.8

126.96

130.90

g/l

1.11

109

893

Pulmonary artery stenosis

2.91

1.59

5.0

30.0

127.00

121.81

g/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1495

12322

0.94

1.59

3.2

3.3

129.45

128.97

g/l

0.38

1435

11991

Disorders of vagus nerve

2.89

1.59

22.4

4.7

125.43

123.26

g/l

—

Polyglandular dysfunction, other/unspecified

3.68

1.57

5.6

3.8

130.00

127.00

g/l

—

Seronegative rheumatoid arthritis

336

2964

1.14

1.57

3.2

3.1

124.89

128.38

g/l

2.22

326

2896

Congenital malposition of the kidney

3.16

1.57

4.5

3.6

108.67

126.67

g/l

—

Other and unspecified rosacea

247

2134

1.17

1.56

6.1

3.1

132.00

129.17

g/l

1.24

239

2070

Underdevelopment of the second kidney

3.11

1.56

10.3

7.3

103.83

131.33

g/l

—

Artificial joint re-operation

225

1933

1.18

1.56

3.8

2.9

121.28

127.71

g/l

4.46

214

1882

Alzheimer disease

1327

8909

1.07

1.54

2.7

3.2

127.87

125.54

g/l

3.76

1297

8647

Crushing injury of head

2.62

1.54

1.6

10.0

124.67

127.53

g/l

—

Carcinoma in situ of oral cavity and pharynx

2.62

1.54

2.2

3.1

131.00

131.92

g/l

—

Endometriosis ASRM stages 1,2

355

3145

1.13

1.53

2.7

3.1

132.09

129.30

g/l

2.07

347

3048

Persons encountering health services in other circumstances

1197

11094

1.07

1.53

4.8

3.2

128.47

129.75

g/l

1.12

1145

10763

Ulcerative rectosigmoiditis

214

1832

1.18

1.52

4.9

3.1

130.17

131.47

g/l

0.34

206

1780

Malignant neoplasm of rectosigmoid junction

429

1.39

1.51

3.3

2.8

125.09

130.15

g/l

0.82

415

Use of benzatropine

3.58

1.51

6.8

4.1

124.40

120.69

g/l

—

Secondary sideroblastic anaemia

2.24

1.50

5.8

3.1

114.36

129.58

g/l

1.55

Alcoholic myopathy

3.04

1.50

4.3

3.7

143.83

129.95

g/l

—

Carcinoma in situ of skin

293

2575

1.15

1.49

3.6

3.0

125.21

127.32

g/l

0.89

284

2501

Poor fetal growth

195

1657

1.18

1.49

4.3

3.2

128.59

131.52

g/l

1.15

184

1611

Contact with sharp glass

735

1.28

1.48

4.1

3.8

128.94

133.57

g/l

0.96

716

Radiodermatitis

2.33

1.46

2.0

2.4

127.90

131.28

g/l

—

HSIL lesion of the cervix uteri, vagina or vulva

381

3402

1.12

1.45

3.6

3.1

128.73

129.92

g/l

0.52

373

3304

Benign neoplasm of ovary

451

4070

1.11

1.45

2.6

3.1

125.63

126.79

g/l

0.58

434

3950

Memory loss

291

2562

1.15

1.45

3.4

3.2

130.13

126.57

g/l

2.19

286

2484

Other disorders of penis

315

2784

1.14

1.44

4.6

4.4

130.78

131.40

g/l

0.16

307

2722

Assault by drugs, medicaments and biological substances

2.60

1.44

4.9

4.2

132.86

126.93

g/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

120

983

1.24

1.43

3.3

128.34

128.86

g/l

0.09

114

961

Use of entacapone

197

0.49

1.42

3.8

3.2

123.80

127.79

g/l

—

190

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1423

14414

0.94

1.42

3.3

3.4

131.03

129.61

g/l

1.72

1384

14037

Bartonellosis, including avohilmo

3.30

1.41

4.0

1.5

118.80

135.41

g/l

—

Neuroendocrine tumor and carcinoma of pancreas

159

1.64

1.41

3.4

2.6

122.88

131.82

g/l

1.09

153

Pectus carinatum

2.81

1.41

7.7

7.8

128.33

133.26

g/l

—

Endometriosis of pelvic peritoneum

339

2740

1.13

1.39

2.7

3.2

132.50

127.45

g/l

5.33

333

2680

All dysplastic lesions of the vagina

513

1.33

1.38

3.7

2.6

124.12

128.94

g/l

1.22

496

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

436

3936

1.11

1.38

3.4

3.2

130.63

132.65

g/l

1.07

422

3833

Other acquired deformities of ankle and foot

168

1.60

1.36

3.0

3.2

132.50

127.50

g/l

0.87

160

Use of galantamine

226

2591

0.86

1.36

2.2

3.0

131.04

125.45

g/l

3.66

215

2524

Androgenic alopecia

160

1.60

1.35

3.4

2.5

123.72

129.42

g/l

0.62

155

Chronic laryngitis and laryngotracheitis

332

3719

0.89

1.35

4.0

3.3

128.54

128.38

g/l

0.04

308

3608

Injury of muscle and tendon at lower leg level

451

4089

1.11

1.35

3.7

3.5

132.10

130.99

g/l

0.48

435

3988

L01XX Other antineoplastic agents

187

1606

1.18

1.34

3.3

2.9

121.17

127.93

g/l

3.19

174

1559

Procreative management

885

6789

1.08

1.34

5.5

4.0

129.40

132.26

g/l

3.09

856

6627

Epidermolysis bullosa

2.68

1.34

7.2

12.9

113.50

128.21

g/l

—

Atrophic disorders of skin

424

3833

1.11

1.34

3.8

3.0

126.74

129.00

g/l

1.54

419

3729

Malignant neoplasm of base of tongue, including Hilmo

210

1.53

1.34

5.7

3.2

119.13

131.00

g/l

1.80

205

Foreign body or object entering through skin

165

1402

1.19

1.33

3.2

3.5

130.42

131.93

g/l

0.33

160

1368

Rhabdomyosarcoma

3.06

1.33

52.4

16.8

111.60

130.94

g/l

—

Other otitis externa (chronic)

190

1634

1.17

1.33

4.3

3.4

132.70

129.09

g/l

1.53

184

1585

Restless leg syndrome

413

3732

1.11

1.33

3.1

131.08

128.89

g/l

1.31

401

3618

Perineal laceration during delivery

284

2022

1.14

1.32

2.0

3.0

134.74

130.95

g/l

3.16

277

1971

Disorders of synovium and tendon in diseases classified elsewhere

483

1.33

1.31

3.3

3.0

127.54

132.25

g/l

0.89

471

Type 1 diabetes, wide definition, subgroup 2

293

0.60

1.31

9.8

3.1

122.44

124.96

g/l

0.15

284

Obstructive hydrocephalus

337

1.40

1.30

3.5

3.9

129.59

128.64

g/l

0.10

328

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

2.61

1.29

4.5

2.5

120.33

130.88

g/l

—

Benign lipomatous neoplasm of other sites/unspecified

264

2331

1.14

1.29

3.4

3.0

129.30

128.10

g/l

0.40

253

2261

Medical abortion

1717

8834

1.05

1.28

3.0

128.33

127.55

g/l

0.77

1662

8587

Patellar tendinitis

269

1.43

1.28

3.1

3.5

134.03

134.63

g/l

0.05

262

Undescended testicle

211

1.50

1.27

3.6

11.9

126.10

131.57

g/l

0.68

204

Other disorders of skin and subcutaneous tissue related to radiation

2.33

1.27

2.1

3.1

128.13

129.81

g/l

—

Allergic conjunctivitis

1506

15241

0.95

1.27

3.3

3.4

131.07

129.65

g/l

1.80

1464

14838

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1017

7967

0.94

1.26

3.0

3.1

128.98

128.87

g/l

0.06

978

7763

Alzheimer’s disease (Early onset)

104

1262

0.82

1.25

2.5

3.0

127.90

125.69

g/l

0.63

104

1226

Triptan medication for migraine, single purchase ok

2205

14299

1.05

1.25

3.2

3.5

132.92

130.58

g/l

5.69

2145

13935

Migraine, single triptan purchase ok & required. ICD-code if available is included

2205

14299

1.05

1.25

3.2

3.5

132.92

130.58

g/l

5.69

2145

13935

Lesion of sciatic nerve

133

1118

1.20

1.25

3.0

2.9

126.57

126.39

g/l

0.03

126

1089

Heterophoria

199

1726

1.16

1.25

6.8

3.7

130.73

130.56

g/l

0.04

192

1678

Brain glioblastoma

332

1.39

1.23

2.3

2.9

138.11

131.69

g/l

1.90

325

Atopic dermatitis

1534

12838

0.95

1.23

3.7

3.6

131.93

131.10

g/l

0.81

1490

12500

Leiomyoma of uterus

1742

9307

1.05

1.22

3.1

3.0

128.33

127.06

g/l

1.74

1681

9063

Postpartum hemorraghe, parous women as controls

376

3480

0.90

1.22

2.7

2.8

130.98

131.22

g/l

0.08

365

3387

Horner syndrome

282

1.42

1.21

3.3

3.2

127.03

129.18

g/l

0.23

274

Intracranial injury with prolonged coma

2.74

1.19

2.4

2.5

135.20

130.75

g/l

—

Other inflammation of vagina/vulva

579

1.27

1.18

1.8

2.9

130.40

129.90

g/l

0.07

565

Lagophthalmos

327

1.38

1.17

3.5

3.0

122.86

126.50

g/l

0.47

316

Myasthenia gravis, drug-induced

2.52

1.17

4.1

3.3

115.29

130.70

g/l

—

Thyroiditis, unspecified

292

1.40

1.17

3.4

2.8

132.53

128.97

g/l

0.48

282

Polypectomy (DHB20)

197

1720

1.16

1.17

3.1

3.2

130.65

130.16

g/l

0.11

191

1672

Spasmodic torticollis

653

1.26

1.16

2.7

3.3

135.41

128.77

g/l

2.16

634

Other superficial mycoses, including avohilmo

257

2282

1.13

1.16

3.2

3.4

133.95

131.87

g/l

0.84

247

2222

Undescended testis, unilateral

159

1.55

1.15

4.1

12.0

123.42

132.00

g/l

1.01

154

Adrenogenital disorders

1.77

1.15

4.0

3.5

124.60

128.35

g/l

0.21

Exophthalmic conditions

234

1.45

1.15

2.8

2.9

131.24

130.35

g/l

0.09

227

HSIL lesion of the vagina

259

1.42

1.15

3.7

2.6

121.56

128.68

g/l

1.23

253

Persons with potential health hazards related to communicable diseases

820

8670

0.93

1.15

7.2

3.8

126.36

131.92

g/l

9.76

796

8448

Benign neoplasm: Pancreas

746

1.24

1.14

4.0

2.9

125.78

128.04

g/l

0.48

727

Benign neoplasm: Skin, unspecified

109

910

1.21

1.12

4.7

2.9

128.08

128.92

g/l

0.14

103

885

Habitual aborter

217

1.44

1.12

2.8

3.4

130.29

130.24

g/l

0.00

212

Supervision of high-risk pregnancy

296

1987

0.89

1.12

2.3

3.0

133.54

129.96

g/l

2.42

287

1941

Ovarian hyperstimulation (induction)

209

1.45

1.12

1.9

3.4

128.87

132.78

g/l

0.47

202

Profound mental retardation

2.55

1.12

6.4

6.5

123.80

128.14

g/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

210

1.46

1.11

4.6

8.6

136.03

131.55

g/l

0.48

203

Complications of labour and delivery

1358

7935

0.95

1.10

2.9

3.1

129.95

128.09

g/l

2.76

1322

7725

Ectropion of eyelid

142

1217

1.18

1.10

3.6

3.0

124.85

125.11

g/l

0.05

137

1182

Scar conditions and fibrosis of skin

811

1.22

1.10

5.4

3.6

128.55

130.11

g/l

0.34

791

Other congenital malformations of spinal cord

2.27

1.10

21.3

5.5

123.71

129.36

g/l

—

Erectile dysfunction

269

2410

1.13

1.09

6.3

3.6

126.39

128.69

g/l

0.80

258

2347

Optic atrophy

410

1.32

1.08

7.0

4.6

129.42

129.17

g/l

0.03

402

Other lesions of median nerve

678

1.24

1.08

3.1

2.8

129.55

127.15

g/l

0.43

657

Medical treatment for female infertility

279

3079

0.89

1.07

2.4

3.2

132.33

130.98

g/l

0.56

268

2993

Fourth [trochlear] nerve palsy

544

1.27

1.07

4.4

3.1

129.29

127.53

g/l

0.23

532

Wilms' tumor, including Hilmo

138

1.58

1.07

7.5

4.6

114.48

128.87

g/l

2.33

133

Maternal care for cervical incompetence

702

0.78

1.07

2.2

2.5

134.89

128.63

g/l

1.73

682

Kissing spine

2.17

1.06

2.4

3.7

134.71

129.53

g/l

—

Other papulosquamous disorders

239

1.41

1.04

3.4

3.1

129.15

129.82

g/l

0.06

233

Postpartum haemorrhage

376

3398

0.91

1.03

2.7

3.1

130.98

130.05

g/l

0.37

365

3322

Carcinoma in situ of cervix uteri

182

1595

1.15

1.03

4.1

2.8

127.97

129.99

g/l

0.61

176

1553

Hydatidiform mole

213

0.60

1.01

2.6

3.2

129.77

129.30

g/l

0.04

207

Benign neoplasm: Pharynx, unspecified

173

1.48

1.01

5.1

3.0

134.36

130.82

g/l

0.32

168

Use of bromocriptine

0.00

1.01

0.0

2.8

—

128.10

—

Drug-induced aplastic anaemia

2.07

1.01

5.4

2.7

117.86

126.47

g/l

—

Optic atrophy, wide definition

433

1.29

1.00

7.1

4.5

129.64

128.63

g/l

0.14

424

Complications specific to multiple gestation

1.89

1.00

1.1

2.8

138.78

127.88

g/l

—

conjunctival scars

2.05

1.00

4.0

6.2

127.00

131.00

g/l

—

Traumatic spondylopathy

1.89

1.00

2.3

2.8

141.56

129.90

g/l

—

Special screening examination for other diseases and disorders

303

2743

1.11

0.99

4.1

2.8

125.09

131.02

g/l

4.91

291

2664

Maxillary retrognathism

310

1.34

0.99

3.7

6.5

140.29

133.21

g/l

1.24

297

Chondrosarcoma, including Hilmo

116

0.50

0.98

5.3

2.9

119.83

130.56

g/l

—

111

Hyperfunction of pituitary gland, other and/or unspecified

2.01

0.98

4.0

3.1

123.00

126.78

g/l

—

Cellulitis of external ear

242

1.39

0.97

2.3

3.0

137.48

129.68

g/l

1.02

236

Malignant neoplasm of tongue

489

1.27

0.97

3.0

2.8

121.54

131.08

g/l

2.09

475

Atrophy of thyroid (acquired)

2.37

0.97

3.8

3.4

124.00

127.26

g/l

—

Postpartum hemorraghe, all women as controls

376

3999

0.91

0.97

2.7

3.1

130.98

130.63

g/l

0.12

365

3896

L02BX Other hormone antagonists and related agents

200

1778

1.14

0.97

3.2

3.5

116.82

128.54

g/l

9.93

195

1722

Unspecified parasitic disease, including avohilmo

175

1.47

0.96

10.0

3.2

124.48

130.09

g/l

0.79

170

Embedded teeth, including avohilmo

180

1586

1.14

0.96

5.6

3.7

126.24

133.13

g/l

4.19

168

1545

Endometriosis ASRM stages 3,4

523

4864

1.08

0.95

2.9

3.0

129.11

128.02

g/l

0.65

508

4726

Ménière disease

277

2508

1.11

0.95

3.0

128.82

127.76

g/l

0.39

266

2433

Pectus carinatum, including avohilmo

2.26

0.94

7.7

6.9

128.33

132.11

g/l

—

Brain glioblastoma, helper endpoint

349

1.32

0.94

2.3

3.1

138.11

128.56

g/l

3.53

340

Inguinal or femoral hernia, bilateral

357

3276

1.10

0.93

3.4

3.5

129.45

129.66

g/l

0.06

351

3179

Inguinal hernia, bilateral

350

3209

1.10

0.93

3.4

3.5

129.56

129.79

g/l

0.06

344

3115

Disorders of orbit

115

985

1.18

0.93

3.1

2.9

130.57

129.24

g/l

0.29

108

952

Benign lipomatous neoplasm of of intra-abdominal organs

1.72

0.92

3.0

3.4

123.00

128.95

g/l

0.41

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

236

1.38

0.92

4.4

7.9

136.00

132.07

g/l

0.44

228

All dysplastic lesions of the cervix uteri

476

4347

1.08

0.92

3.2

3.0

128.98

130.13

g/l

0.59

464

4219

Pleural plaque

327

2994

1.10

0.91

3.5

3.3

129.59

126.99

g/l

1.36

318

2903

Flatulence and related conditions

194

1.42

0.90

4.5

2.7

126.67

127.32

g/l

0.05

189

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

229

0.64

0.90

1.9

3.6

136.47

134.49

g/l

0.19

224

Unspecified severe protein-energy malnutrition

1.92

0.89

5.1

4.8

127.00

127.45

g/l

—

Other congenital malformations of skin, including avohilmo

153

1739

0.87

0.89

4.5

3.8

131.92

130.20

g/l

0.46

147

1692

Other and unspecified disorders of skin and subcutaneous tissue

133

1523

0.87

3.5

3.0

124.30

129.18

g/l

1.67

122

1481

Other congenital malformations of peripheral vascular system

247

1.36

0.87

4.4

7.4

128.88

130.44

g/l

0.14

240

Sequelae of infectious and parasitic diseases, including avohilmo

200

1790

1.12

0.87

5.0

3.1

125.60

129.85

g/l

1.94

200

1740

Allergic colitis

352

1.29

0.86

10.9

8.9

130.56

130.89

g/l

0.04

342

Occupational exposure to risk-factors

808

1.19

0.86

3.4

3.2

131.26

129.31

g/l

0.35

789

Small kidney of unknown cause

1.82

0.85

6.6

3.8

119.13

130.35

g/l

—

Donors of organs and tissues

240

1.35

0.84

2.8

2.2

130.53

133.84

g/l

0.35

233

Functional disorders of polymorphonuclear neutrophils

0.00

0.83

0.0

3.2

—

134.21

—

LSIL lesion of the cervix uteri, vagina or vulva

270

2460

1.10

0.83

3.1

128.36

129.76

g/l

0.57

265

2388

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

320

1.30

0.83

4.0

3.4

139.95

135.53

g/l

0.60

311

Pityriasis rosea

147

1.46

0.82

2.8

3.3

142.24

132.31

g/l

1.24

142

Malignant neoplasm of other and unspecified parts of tongue

357

1.28

0.81

2.9

2.8

125.87

130.66

g/l

0.64

348

Photocontact dermatitis [berloque dermatitis]

1.91

0.81

4.8

136.17

124.30

g/l

—

Other diseases of peritoneum

117

1017

1.16

0.81

4.4

2.8

127.22

127.81

g/l

0.10

111

986

Gastroenterology and urology devices associated with adverse incidents

2.46

0.81

4.8

4.0

116.20

137.09

g/l

—

Brain mixed glioma, helper endpoint

0.00

0.81

0.0

4.2

—

133.42

—

Benign neoplasm: Skin of eyelid, including canthus

463

4325

1.08

0.80

3.6

3.2

128.69

127.73

g/l

0.41

450

4191

Brain mixed glioma

0.00

0.80

0.0

2.7

—

132.67

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

2.37

0.80

2.6

3.0

129.00

132.70

g/l

—

Alzheimer’s disease (Early onset), excluding more controls

104

845

1.17

0.80

2.5

2.8

127.90

125.13

g/l

0.83

104

822

Intentional self-harm by hanging, strangulation and suffocation

124

0.55

0.80

1.7

3.8

145.29

132.08

g/l

—

119

Disorders of brain, other and unspecified

209

1.37

0.78

4.1

2.9

122.93

128.08

g/l

0.56

203

Spirochaetal infections, other/unspecified

210

2319

0.90

0.78

2.2

3.4

133.95

128.67

g/l

3.70

205

2252

Myocardial infarction, unclassifiable

802

6810

1.06

0.77

4.8

3.2

121.75

126.66

g/l

8.28

768

6617

Chronic suppurative otitis media, including avohilmo

208

1883

1.11

0.76

4.5

4.1

130.09

129.37

g/l

0.18

202

1828

Malignant neoplasm of bronchus and lung, including Hilmo

712

5628

1.06

0.76

3.6

3.3

122.70

130.16

g/l

15.65

691

5461

Rosacea

328

3032

1.09

0.76

6.4

3.3

131.26

129.39

g/l

0.89

319

2939

Inhalation and ingestion of food causing obstruction of respiratory tract

228

1.34

0.75

3.6

5.1

132.67

128.14

g/l

0.71

222

Contact with machinery

329

3047

1.09

0.74

3.8

3.6

133.60

131.60

g/l

0.78

314

2968

Chronic suppurative otitis media

174

1563

1.12

0.74

4.4

3.5

130.08

129.64

g/l

0.10

169

1517

Noise effects on inner ear

1064

0.86

0.74

3.9

3.4

134.52

130.03

g/l

1.03

1038

Other and unspecified cicatricial alopecia

1.63

0.73

2.0

2.6

130.89

128.44

g/l

—

Ectopic pregnancy

340

3154

1.08

0.72

2.4

3.3

128.34

128.58

g/l

0.07

330

3071

Polyneuropathy due to other toxic agents

2.01

0.72

32.8

2.8

121.60

126.37

g/l

—

Aphakia

327

1.27

0.72

5.1

2.9

128.95

128.79

g/l

0.02

315

1.97

0.71

14.0

4.1

129.60

138.69

g/l

—

Alzheimer’s disease, strict definition

909

7668

0.95

0.71

2.4

3.2

126.93

125.20

g/l

1.75

888

7439

Other predominantly sexually transmitted diseases, not elsewhere classified

348

3233

1.08

0.71

3.4

3.0

129.35

132.27

g/l

1.59

336

3143

Other osteochondropathies

170

1531

1.12

0.70

2.9

3.5

133.57

131.66

g/l

0.46

161

1494

Parapsoriasis

428

1.23

0.70

2.9

3.4

138.33

130.34

g/l

2.14

418

Other disorders of cornea

274

2526

1.09

0.70

3.5

3.1

125.36

129.24

g/l

1.87

266

2456

Benign neoplasm of breast

287

2651

1.09

0.70

2.7

2.8

127.15

127.27

g/l

0.03

282

2565

Use of anticholinesterases

1357

10091

1.04

0.70

2.5

3.2

128.87

125.81

g/l

6.61

1318

9781

N06DA Anticholinesterases

1357

10091

1.04

0.70

2.5

3.2

128.87

125.81

g/l

6.61

1318

9781

Alzheimer’s disease (Late onset)

846

7281

0.95

0.69

2.4

3.2

126.79

124.98

g/l

1.78

825

7062

Primary open-angle glaucoma

1138

10531

1.04

0.68

3.3

3.2

125.73

126.82

g/l

0.90

1098

10228

Other disorders of amniotic fluid and membranes

186

1980

0.90

0.68

2.9

3.2

132.69

130.44

g/l

0.93

179

1930

Other disturbances of cerebral status of newborn

1.88

0.68

1.8

22.6

138.20

122.57

g/l

—

Lipodystrophy, not elsewhere classified

1.86

0.68

1.2

2.1

126.20

135.79

g/l

—

Deviated nasal septum

1041

9990

1.04

0.67

3.4

3.5

132.93

130.44

g/l

3.15

1016

9718

Palatinal maxillary operation

111

1.46

0.67

22.3

10.5

128.00

130.90

g/l

0.25

105

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

1.84

0.66

8.6

15.1

108.20

125.52

g/l

—

Brain glioblastoma and astrocytoma

404

1.23

0.66

2.3

2.7

137.63

132.95

g/l

1.20

394

Lichen planus, including avohilmo

552

5228

1.06

0.66

3.4

3.3

128.30

128.64

g/l

0.14

539

5082

Other and unspecified hereditary haemolytic anaemias

1.81

0.66

2.4

4.1

110.80

129.31

g/l

—

Unspecified human immunodeficiency virus [HIV] disease

212

0.70

0.65

1.9

3.7

136.47

134.58

g/l

0.17

207

LSIL lesion of the vagina

269

1.28

0.65

3.7

2.9

128.88

130.46

g/l

0.21

263

Delivery, wide proxy

885

4905

0.95

0.65

2.5

3.1

128.24

125.82

g/l

2.91

851

4765

Endometriosis of rectovaginal septum and vagina

178

1616

1.11

0.65

2.6

2.9

131.62

126.21

g/l

3.53

173

1581

Benign leiomyoma with endometriosis

354

3785

0.93

0.65

2.8

3.0

126.72

126.85

g/l

0.04

346

3674

Other specified diseases of spinal cord, drug-induced

0.00

0.63

0.0

3.6

—

128.90

—

Pleural plaque with presence of asbestos

207

2255

0.91

0.63

3.7

3.6

129.00

127.12

g/l

0.60

199

2191

Antenatal screening

353

2116

0.93

0.63

2.7

3.0

132.97

130.03

g/l

2.12

345

2066

Mumps

533

0.82

0.63

2.9

2.8

132.95

132.49

g/l

0.05

522

Toxic erythema

1.72

0.62

2.6

2.5

118.60

128.43

g/l

—

Palindromic rheumatism

210

0.70

0.62

3.6

3.1

135.73

128.88

g/l

0.65

203

Other congenital malformations of integument

0.00

0.62

0.0

12.5

—

132.84

—

Chronic bullous disease of childhood

0.00

0.62

0.0

2.8

—

133.15

—

Malignant melanoma of skin, including Hilmo

438

4131

1.06

0.62

3.0

3.2

127.55

130.55

g/l

1.89

422

4002

Polydactyly

0.00

0.62

0.0

22.3

—

121.20

—

Unspecified pneumoconiosis

0.00

0.62

0.0

5.1

—

123.21

—

Sequelae of tuberculosis

436

1.21

0.61

4.7

2.9

119.85

124.03

g/l

0.78

423

Other and unspecified pemphigoid

237

1.29

0.61

3.9

3.1

127.73

126.59

g/l

0.11

231

Varicose veins of other sites

177

1615

1.10

0.60

2.7

3.4

132.50

131.07

g/l

0.31

169

1569

Sequelae of infectious and parasitic diseases

190

1739

1.10

0.60

5.0

3.1

125.58

129.96

g/l

1.94

190

1690

Other and/or unspecified nontoxic goitre

210

1931

1.09

0.60

2.7

3.0

128.93

127.07

g/l

0.62

202

1876

Use of memantine

1094

8491

1.04

0.60

2.4

3.2

128.34

125.24

g/l

5.52

1066

8239

Use of other anti-dementia drugs

1094

8491

1.04

0.60

2.4

3.2

128.34

125.24

g/l

5.52

1066

8239

Asymptomatic human immunodeficiency virus [HIV] infection status

114

0.60

0.59

2.0

4.0

145.71

135.58

g/l

—

114

Chalazion

300

2800

1.08

0.59

2.9

3.3

131.74

129.89

g/l

0.77

286

2714

Venous complications and haemorrhoids in the puerperium

184

1.32

0.59

2.5

2.4

132.58

128.83

g/l

0.40

179

Benign neoplasm: Spinal meninges

256

1.27

0.59

4.4

2.8

123.16

127.40

g/l

0.68

248

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

1.72

0.58

11.5

3.8

141.17

131.47

g/l

—

Follow-up examination after treatment for malignant neoplasms

285

2658

1.08

0.58

2.9

2.8

124.82

127.69

g/l

1.27

268

2573

Traumatic amputation of wrist and hand

118

1058

1.12

0.57

3.7

3.8

131.40

129.51

g/l

0.34

111

1032

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

215

1986

1.09

0.57

6.2

3.1

130.90

129.16

g/l

0.58

205

1930

Sequelae of tuberculosis, including avohilmo

449

1.19

0.57

4.7

2.9

120.02

124.06

g/l

0.77

435

Other inflammation of eyelid, including avohilmo

1186

12256

0.97

0.56

3.2

3.4

131.83

130.04

g/l

2.15

1153

11932

Carcinoma in situ of breast, intraductal

173

1887

0.91

0.56

2.2

2.9

125.31

127.17

g/l

0.51

165

1827

Hereditary lymphedema, including avohilmo

1.63

0.56

6.5

3.2

128.00

132.50

g/l

—

Viral infections of central nervous system, not elsewhere classified/unspecified

213

1.29

0.55

1.9

3.1

126.48

132.30

g/l

0.69

207

Hypersensitivity pneumonitis due to organic dust

377

1.21

0.55

3.4

3.0

131.00

128.98

g/l

0.23

369

Scabies, including avohilmo

348

3274

1.07

0.55

3.4

3.8

133.21

132.04

g/l

0.47

340

3191

Foreign body on external eye

410

3879

1.06

0.55

3.7

134.20

132.90

g/l

0.55

394

3787

Glaucoma, exfoliation

366

3453

1.06

0.54

3.6

3.0

126.69

126.24

g/l

0.15

349

3354

Pemphigus

158

0.68

0.54

3.2

3.0

129.00

128.33

g/l

0.04

153

Benign neoplasm of eye and adnexa

265

2835

0.93

0.53

3.6

3.1

127.75

128.36

g/l

0.17

253

2750

Mumps, including avohilmo

543

0.84

0.52

2.9

2.8

133.22

132.42

g/l

0.09

532

Disorders of tooth development and eruption

403

3102

1.06

0.52

5.5

3.1

129.77

131.69

g/l

0.92

394

3037

Colitis due to radiation

261

1.25

0.51

5.2

3.1

124.53

127.20

g/l

0.33

251

Pollen allergy

359

3745

0.94

0.51

4.5

4.4

134.31

132.34

g/l

1.01

349

3656

Osteomalacia

171

1.31

0.51

4.7

2.6

134.27

131.76

g/l

0.18

166

Abnormal spermatozoa

379

4000

0.94

0.51

3.4

3.8

131.06

129.14

g/l

0.99

361

3891

Spontaneous abortion

1030

6665

1.04

0.51

2.9

3.1

129.39

128.43

g/l

0.80

997

6487

Primary angle-closure glaucoma

131

1192

1.11

0.51

4.4

2.9

124.56

126.47

g/l

0.38

124

1160

Malignant neoplasm of breast, ER-negative, including Hilmo

562

5025

1.05

0.51

2.6

3.0

124.76

128.38

g/l

3.99

547

4881

Drug-induced interstitial lung disorders, unspecified

1.62

0.51

2.4

3.7

132.00

129.24

g/l

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

455

1.18

0.50

6.0

3.0

117.02

125.64

g/l

2.66

445

Benign neoplasm: Choroid

158

1718

0.91

0.50

3.4

3.0

128.89

128.15

g/l

0.17

151

1667

Tinnitus

686

6594

1.04

0.49

3.6

3.4

132.14

129.43

g/l

2.69

664

6417

Hereditary spherocytosis

1.56

0.49

1.7

5.2

126.86

127.61

g/l

—

Anisometropia and aniseikonia

709

1.14

0.49

8.8

4.1

131.03

128.41

g/l

0.49

691

Diseases caused by chlamydiae, including avohilmo

217

1.26

0.49

4.1

3.1

134.48

132.72

g/l

0.14

212

Use of donepezil

778

7155

1.04

0.48

2.7

3.1

129.23

125.16

g/l

7.12

749

6945

Chronic diseases of tonsils and adenoids

2356

15168

0.98

0.48

3.8

3.6

132.13

130.06

g/l

4.26

2282

14772

Gluteal tendinitis

899

0.89

0.48

3.2

2.7

130.17

128.03

g/l

0.44

870

Maternal care for known or suspected malpresentation of fetus

261

1984

0.94

0.47

2.8

3.2

131.68

131.10

g/l

0.17

253

1935

Single delivery by caesarean section

298

1805

0.94

0.46

2.6

3.7

131.38

129.06

g/l

1.18

283

1757

Malignant melanoma, including Hilmo

531

5088

1.05

0.46

2.9

3.2

127.95

130.51

g/l

1.70

513

4931

Lichen ruber planus, wide definition including periferal and oral lichen planus

648

6235

1.04

0.46

3.2

3.3

128.72

128.69

g/l

0.01

632

6060

HSIL lesion of the cervix uteri

314

2967

1.06

0.46

3.7

3.1

129.60

130.33

g/l

0.24

306

2886

Endometriosis of ovary

378

3380

1.06

0.46

3.0

3.1

128.87

126.64

g/l

1.41

367

3305

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

123

1123

1.10

0.45

5.6

3.2

125.93

132.47

g/l

2.53

123

1099

Chronic conjunctivitis

648

1.13

0.45

5.4

4.2

126.42

129.31

g/l

0.54

631

Dysplasia of cervi uteri

487

3272

1.05

0.45

2.9

3.1

128.95

127.74

g/l

0.63

473

3203

Raynaud syndrome

183

1966

0.93

0.44

2.8

3.1

130.52

129.72

g/l

0.20

177

1908

Blepharospasm

229

0.77

0.44

6.2

3.1

137.67

128.22

g/l

1.39

223

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

1.62

0.44

8.0

18.3

126.40

129.28

g/l

—

Carcinoma in situ of other and unspecified genital organs

406

1.17

0.43

3.3

2.4

117.94

128.56

g/l

2.97

395

Plasmodium vivax malaria

0.00

0.43

0.0

3.7

—

134.19

—

Plasmodium vivax malaria, including avohilmo

0.00

0.43

0.0

3.7

—

134.19

—

Eclampsia

1.59

0.43

4.4

2.0

115.80

138.00

g/l

—

Coccidioidomycosis

0.00

0.43

0.0

2.7

—

124.40

—

Coccidioidomycosis, including avohilmo

0.00

0.43

0.0

2.7

—

124.40

—

Graves disease, strict definition

224

2103

1.07

0.42

2.7

3.0

132.75

129.26

g/l

1.63

215

2039

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.42

0.0

4.5

—

133.60

—

Cyclic neutropenia

1.55

0.42

2.0

3.0

121.20

133.61

g/l

—

Use of selegiline

111

1213

0.91

0.42

2.9

3.1

128.37

127.32

g/l

0.23

106

1177

Leiomyosarcoma

186

1.26

0.42

2.7

122.70

129.24

g/l

1.02

180

268

2534

1.06

0.41

4.2

3.5

117.92

129.42

g/l

10.57

262

2470

Non-small cell lung cancer, including Hilmo

479

4310

1.05

0.41

3.4

3.2

122.41

130.18

g/l

11.41

468

4184

Chronic hepatitis NAS

278

1.20

0.41

7.5

3.0

111.55

130.09

g/l

3.89

272

Respiratory tuberculosis, clinically confirmed

288

1.19

0.40

3.6

3.2

124.50

126.70

g/l

0.19

279

Bilateral sagittal split ramus osteotomy operation

550

1.13

0.40

2.5

3.0

139.79

133.01

g/l

1.89

533

Infliximab

353

1.17

0.40

2.2

3.5

134.46

135.74

g/l

0.16

343

Sequelae of other and unspecified infectious and parasitic diseases

121

1114

1.09

0.39

5.7

3.2

126.29

132.52

g/l

2.31

121

1090

Mandibular retrognathia AND surgery (BSSO)

419

1.15

0.39

2.3

3.1

142.65

132.43

g/l

3.48

408

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

429

1.15

0.39

1.9

2.7

120.20

129.50

g/l

2.29

416

Intestinal helminthiases, other/unspecified, including avohilmo

1.33

0.38

1.7

2.8

131.22

128.66

g/l

—

Adenomyosis (Endometriosis of uterus)

320

3043

1.05

0.38

2.5

3.0

128.91

125.86

g/l

2.00

315

2981

Injury of cranial nerves

125

1.30

0.38

1.5

3.1

132.44

131.83

g/l

0.04

120

Benign neoplasm: Bone and articular cartilage, unspecified

143

1.28

0.38

2.1

3.0

131.94

132.07

g/l

0.01

137

Carcinoma in situ of cervix uteri, endocervix

152

1.26

0.37

2.1

3.2

133.32

130.52

g/l

0.29

147

Presbycusis

492

4679

1.04

0.37

2.7

3.1

124.51

125.77

g/l

0.64

471

4559

Conjunctivitis

2364

18694

1.02

0.37

3.7

3.6

131.09

129.61

g/l

2.66

2299

18191

Perioral dermatitis

394

1.15

0.36

9.8

3.1

133.00

128.80

g/l

0.98

381

Glaucoma secondary to eye inflammation

190

1.23

0.36

3.4

3.9

130.04

130.36

g/l

0.02

182

Special screening examination for infectious and parasitic diseases

438

3321

0.96

0.35

2.3

2.8

137.73

135.43

g/l

1.28

430

3243

Obstructed labour due to maternal pelvic abnormality

302

2884

1.05

0.34

2.7

3.2

132.61

128.18

g/l

3.59

294

2811

Sequelae of injuries of upper limb

245

2329

1.06

0.34

3.2

3.4

130.92

130.96

g/l

0.01

236

2264

Other sexually transmitted chlamydial diseases, including avohilmo

146

1559

0.93

0.33

3.0

133.40

135.72

g/l

0.51

146

1520

Erysipeloid, including avohilmo

101

1.32

0.33

2.5

3.2

129.77

128.69

g/l

0.07

Fenamates

435

3072

0.96

0.33

3.5

4.1

129.59

125.40

g/l

3.50

420

3005

Vasomotor rhinitis (mode)

164

1741

0.94

0.32

2.8

3.2

132.97

129.27

g/l

1.51

157

1687

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

202

1.20

0.32

4.1

3.2

127.42

129.66

g/l

0.14

196

Pregnancy with abortive outcome

1754

8969

1.02

0.32

2.8

3.0

127.78

127.53

g/l

0.19

1704

8719

Postmenopausal atrophic vaginitis

708

3748

1.03

0.31

2.9

3.1

128.48

125.77

g/l

2.90

684

3671

Spermatocele

229

2180

1.05

0.31

3.6

3.7

130.83

129.73

g/l

0.28

218

2127

LeFortI or BSSO operation

666

1.10

0.31

2.4

3.2

140.26

132.53

g/l

2.63

648

Other sexually transmitted chlamydial diseases

924

0.92

0.31

3.0

131.51

136.25

g/l

0.94

896

Primary open-angle glaucoma, strict

906

8832

1.02

0.29

3.2

125.62

126.73

g/l

0.77

875

8579

Epiphora

526

1.11

0.29

2.4

2.9

134.62

126.93

g/l

2.86

509

Sudden idiopathic hearing loss

282

2705

1.05

0.29

3.6

3.2

127.02

129.08

g/l

0.73

268

2628

Malignant neoplasm of other and ill-defined digestive organs

205

1.18

0.28

1.8

2.7

121.83

129.68

g/l

1.05

197

Deep endometriosis

204

1945

1.05

0.27

2.5

2.7

131.84

128.10

g/l

2.20

198

1894

Otosclerosis

177

1861

0.95

0.27

3.4

3.1

129.52

128.04

g/l

0.37

168

1808

Other and unspecified degenerative diseases of nervous system

780

1.08

0.27

2.7

3.2

130.85

125.84

g/l

1.53

759

Leiomyosarcoma, including Hilmo

235

1.16

0.26

3.1

2.5

122.15

130.06

g/l

1.30

229

Other disorders of thyroid

301

1.14

0.26

3.7

2.7

127.71

126.76

g/l

0.10

295

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

181

0.82

0.26

2.4

2.6

122.60

131.02

g/l

0.79

175

Nail dystrophy

142

1.21

0.25

3.1

3.2

141.41

130.07

g/l

1.79

137

Acute thyroiditis

1.27

0.25

2.3

2.9

135.17

129.97

g/l

0.44

Congenital malformations of ovaries, fallopian tubes and broad ligaments

859

1.07

0.25

2.4

2.9

128.50

130.58

g/l

0.46

831

Injury of muscle and tendon at ankle and foot level

497

0.90

0.25

3.6

3.3

132.93

130.13

g/l

0.42

486

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

1.30

0.25

1.9

3.3

123.00

131.60

g/l

—

Scarlet fever

1.28

0.24

3.3

4.5

131.00

139.20

g/l

0.55

Excessive earwax

2170

19893

0.99

0.23

2.9

3.5

130.26

128.86

g/l

2.18

2102

19371

Non-small cell lung cancer

322

3081

1.04

0.23

3.5

3.2

122.71

130.00

g/l

7.08

312

2989

Macular pucker

512

4993

1.03

0.23

4.3

3.1

127.95

127.94

g/l

0.01

499

4835

Benign neoplasm: Cranial nerves

701

0.92

0.23

4.1

3.0

133.85

128.46

g/l

1.44

684

Other obstructed labour

134

1273

1.05

0.22

3.0

126.32

128.87

g/l

0.71

128

1240

Plague

0.00

0.22

0.0

3.6

—

136.09

—

Rabies

0.00

0.22

0.0

6.4

—

123.70

—

Other fluke infections

0.00

0.22

0.0

2.8

—

129.64

—

Xanthelasma of eyelid

199

0.85

0.22

6.1

2.5

126.24

129.29

g/l

0.19

194

Malignant neoplasm of trachea

0.00

0.22

0.0

1.5

—

138.55

—

Other fluke infections, including avohilmo

0.00

0.22

0.0

2.8

—

129.64

—

Rabies, including avohilmo

0.00

0.22

0.0

5.9

—

126.64

—

Familial dysautonomia

0.00

0.22

0.0

4.7

—

135.45

—

Congenital pneumonia

0.00

0.22

0.0

8.0

—

128.00

—

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.22

0.0

2.8

—

133.15

—

Intestinal helminthiases, other/unspecified

0.00

0.22

0.0

3.2

—

122.45

—

Echinococcosis, including avohilmo

0.00

0.22

0.0

6.6

—

122.91

—

Echinococcosis

0.00

0.22

0.0

6.6

—

122.91

—

Other assisted single delivery

252

0.87

0.22

2.3

3.2

129.50

129.22

g/l

0.02

242

Intentional self-harm by drowning and submersion

1.20

0.22

6.0

2.8

126.00

132.93

g/l

—

Spotted fever [tick-borne rickettsioses]

0.00

0.22

0.0

2.4

—

126.00

—

Chlamydial lymphogranuloma (venereum)

0.00

0.21

0.0

4.6

—

124.92

—

Neurological devices associated with adverse incidents

0.00

0.21

0.0

3.9

—

137.08

—

Strongyloidiasis

0.00

0.21

0.0

5.4

—

124.62

—

Strongyloidiasis, including avohilmo

0.00

0.21

0.0

5.4

—

124.62

—

Glanders and melioidosis, including avohilmo

0.00

0.21

0.0

2.0

—

129.23

—

Glanders and melioidosis

0.00

0.21

0.0

2.0

—

129.23

—

Chlamydial lymphogranuloma (venereum), including avohilmo

0.00

0.21

0.0

4.3

—

127.15

—

Lesion of plantar nerve

148

1415

1.05

0.20

5.8

2.9

133.32

128.44

g/l

2.45

139

1383

Acquired ichthyosis

0.00

0.20

0.0

2.9

—

146.57

—

Non-small cell lung cancer, adenocarcinoma

181

1739

1.04

0.20

3.6

3.0

124.14

129.95

g/l

3.14

175

1685

False labour

510

3088

1.03

0.20

2.4

3.2

133.52

130.43

g/l

3.22

496

3014

Ankylosis of joint

113

0.79

0.20

1.8

2.8

128.11

128.54

g/l

—

108

Non-small cell lung cancer, adenocarcinoma, helper endpoint

181

1880

0.96

0.19

3.6

3.0

124.14

127.46

g/l

1.30

175

1822

Benign neoplasm: Bronchus and lung

309

1.11

0.19

4.1

2.9

129.59

129.49

g/l

0.01

301

Labour and delivery complicated by fetal stress [distress]

332

2219

0.97

0.18

2.9

3.1

131.26

131.42

g/l

0.05

320

2170

Tarsal tunnel syndrome

214

1.13

0.18

3.2

2.5

125.67

129.09

g/l

0.40

209

Benign neoplasm: Skin of trunk

102

971

1.05

0.18

3.9

3.1

127.37

128.88

g/l

0.27

102

944

L02BG Aromatase inhibitors

794

7968

0.98

0.18

2.5

3.0

125.06

126.91

g/l

1.74

760

7753

Pigmented purpuric dermatosis

247

0.88

0.17

4.0

2.8

133.14

128.32

g/l

0.42

237

Benign neoplasm: Ciliary body

0.75

0.17

2.8

3.9

144.40

126.88

g/l

—

Haemorrhagic and haematological disorders of fetus and newborn

370

1.09

0.17

21.4

16.8

123.43

126.58

g/l

0.38

361

Other deformity of hallux (acquired)

186

1.14

0.17

1.7

2.9

129.29

127.54

g/l

0.11

178

Malignant neoplasm of respiratory system and intrathoracic organs

690

5624

1.02

0.17

3.7

3.3

122.73

130.20

g/l

14.60

666

5458

Multifocal fibrosclerosis

158

1.15

0.17

2.7

2.8

126.78

127.33

g/l

0.04

152

Female infertility

564

3315

1.02

0.17

2.6

3.1

130.26

127.86

g/l

1.87

549

3241

Other benign neoplasms of connective and other soft tissue

244

2374

1.03

0.15

3.1

126.88

129.49

g/l

1.01

233

2305

Malignant neoplasm, without specification of site

880

0.95

0.14

3.1

2.7

122.05

128.97

g/l

2.42

857

Heberden's nodes [with arthropathy]

208

1.11

0.14

4.8

2.7

130.91

127.53

g/l

0.28

202

Spinal enthesopathy

684

1.05

0.14

3.1

2.8

121.23

124.32

g/l

0.57

667

Propionic acid derivatives

1003

4986

1.01

0.13

3.1

4.4

130.69

126.65

g/l

6.50

978

4875

Postprocedural disorders of ear and mastoid process, not elsewhere classified

190

1.11

0.13

2.4

3.4

115.95

126.58

g/l

1.20

185

Unattended death

219

1.10

0.13

3.9

3.1

137.50

127.85

g/l

1.65

212

Cholesteatoma of external ear

200

0.89

0.13

6.9

3.4

130.89

129.07

g/l

0.14

195

Neuroendocrine tumor and carcinoma of lung

200

0.89

0.13

2.4

3.0

126.89

130.59

g/l

0.27

193

Disorder of thyroid, unspecified

307

1.08

0.12

3.8

2.7

128.88

126.46

g/l

0.31

298

Unspecified lump in breast

348

3545

0.98

0.12

3.8

2.9

127.39

127.49

g/l

0.03

336

3447

Hand

116

0.86

0.12

10.6

3.1

126.60

131.59

g/l

—

111

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

288

1.08

0.12

1.8

3.3

131.45

131.04

g/l

0.03

280

Maternal care for other known or suspected fetal problems

373

2297

1.02

0.12

3.1

131.15

131.37

g/l

0.07

355

2245

Other obstetric trauma

689

1.05

0.12

3.1

2.8

132.44

130.56

g/l

0.35

669

Sequelae of poliomyelitis

188

0.90

0.11

1.4

2.9

138.06

127.81

g/l

1.05

183

Anti-inflammatory and antirheumatic products, non-steroids

1002

4989

1.01

0.11

3.2

4.4

129.91

126.66

g/l

4.25

978

4878

Gastrointestinal stromal tumor and sarcoma

321

0.93

0.10

1.7

2.8

122.97

130.36

g/l

0.88

315

Dermatographic urticaria

134

1304

1.03

0.10

4.8

3.1

132.12

130.22

g/l

0.58

129

1272

Postpolio syndrome

1.07

0.09

2.2

3.1

124.40

127.83

g/l

—

Graves ophthalmopathy

487

1.05

0.09

3.1

2.8

133.00

128.96

g/l

0.64

477

Sequelae of poliomyelitis, including avohilmo

223

1.08

0.09

2.3

2.9

136.21

127.84

g/l

1.10

217

Other disorders of breast

274

2786

0.98

0.09

2.7

2.9

130.76

127.89

g/l

1.58

265

2710

Malignant melanoma

456

4505

1.01

0.09

2.8

3.2

127.94

130.45

g/l

1.44

438

4363

Other conditions related to polyarteritis nodosa

1.06

0.09

3.7

3.0

131.50

125.79

g/l

—

Retinal breaks without detachment

449

4437

1.01

0.08

3.8

3.3

129.58

129.57

g/l

0.00

435

4303

Von Willebrand disease

214

1.08

0.08

3.0

2.8

126.83

131.07

g/l

0.40

209

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.81

0.08

6.0

8.5

131.80

137.08

g/l

—

Other protozoal intestinal diseases

267

0.93

0.08

6.0

4.6

135.60

129.20

g/l

0.78

261

Benign neoplasm: Connective and other soft tissue, unspecified

244

1.07

0.08

3.3

2.9

133.27

128.45

g/l

0.54

239

Hallux rigidus

372

3674

1.01

0.08

2.4

3.2

129.02

127.96

g/l

0.43

362

3588

Glaucoma-related operations

161

1641

0.98

0.07

3.1

2.9

128.93

126.55

g/l

0.63

151

1593

Vascular dementia (sudden onset)

1.07

0.07

6.1

3.3

119.63

122.67

g/l

—

Malignant neoplasm of breast, HER-negative

506

4812

1.01

0.07

2.6

3.0

124.51

128.35

g/l

4.03

492

4673

L02BA Anti-estrogens

389

3847

1.01

0.07

2.4

3.0

124.58

127.46

g/l

2.19

377

3740

Deep bite that required surgery

204

0.93

0.07

3.2

2.8

143.58

133.77

g/l

2.19

197

Dermatophytosis, including avohilmo

2114

20614

1.00

0.07

3.1

3.4

130.96

130.25

g/l

0.74

2043

20060

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

281

0.95

0.06

10.3

18.5

124.93

125.59

g/l

0.06

275

Malignant neoplasm of hypopharynx, including Hilmo

172

0.93

0.06

2.0

2.9

122.44

131.08

g/l

0.66

167

Neonatal jaundice from other and unspecified causes

296

1.05

0.06

27.0

17.7

123.44

126.49

g/l

0.32

289

Frontotemporal dementia

151

0.92

0.05

3.4

2.8

131.64

127.97

g/l

0.32

145

Chronic myeloid leukaemia

120

0.91

0.05

4.3

2.6

113.82

130.83

g/l

1.74

115

Unspecified chronic bronchitis

817

0.98

0.05

6.5

2.8

129.47

126.42

g/l

0.60

796

Trichomoniasis, including avohilmo

191

0.94

0.05

3.7

2.7

126.89

128.43

g/l

0.14

185

Early syphilis, including avohilmo

282

0.96

0.04

2.6

3.1

120.67

133.42

g/l

1.37

272

Malignant neoplasm of parotid gland, including Hilmo

251

0.95

0.04

1.7

4.1

125.75

129.37

g/l

0.32

244

Medicines for HER+ breast cancer

982

9106

1.00

0.04

2.6

3.0

125.33

127.02

g/l

1.82

942

8864

Disorders of lacrimal system and orbit in diseases classified elsewhere

497

1.03

0.04

3.1

2.9

133.00

129.35

g/l

0.55

479

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

140

1418

0.99

0.04

2.4

2.8

128.29

127.51

g/l

0.15

129

1379

Other deformities of toe(s)

837

1.02

0.03

3.0

3.1

127.64

128.47

g/l

0.12

820

Maternal care for known or suspected abnormality of pelvic organs

432

2900

1.01

0.03

3.4

3.2

132.99

130.15

g/l

2.31

419

2829

Other protozoal intestinal diseases, including avohilmo

380

0.97

0.03

5.2

3.9

136.22

130.30

g/l

0.89

369

Corneal degeneration

400

0.97

0.02

2.4

2.9

122.69

126.67

g/l

0.45

390

Early syphilis

259

0.96

0.02

2.6

3.2

120.92

133.08

g/l

1.15

250

Malignant neoplasm of bronchus and lung

594

4983

1.00

0.02

3.7

3.3

122.68

130.15

g/l

12.95

577

4837

Gender identity disorders

158

0.95

0.02

3.6

5.3

140.40

134.05

g/l

0.45

153

Malignant melanoma of skin

343

3417

1.00

0.01

3.0

3.2

127.50

130.46

g/l

1.49

327

3316

Female infertility, cervical, vaginal, other or unspecified origin

510

3251

1.00

0.01

2.7

3.1

130.85

127.86

g/l

2.48

497

3179

Calcaneal spur

267

0.97

0.01

3.4

2.6

129.65

130.26

g/l

0.05

257

Pregnancy, childbirth and the puerperium

854

4450

1.00

0.01

2.4

3.2

126.60

125.64

g/l

0.69

823

4323

Use of rivastigmine

559

5563

1.00

0.01

2.3

3.1

127.18

125.43

g/l

1.30

547

5404

Malignant neoplasm of eye and adnexa

206

0.97

0.00

3.5

2.9

121.10

130.69

g/l

1.08

200

Other disorders of breast and lactation associated with childbirth

204

1.03

0.00

2.0

2.8

134.43

132.64

g/l

0.22

197

Benign neoplasm: Connective and other soft tissue of head, face and neck

343

0.99

0.00

2.7

2.8

127.97

128.80

g/l

0.07

336

Congenital malformations of anterior segment of eye

168

1.01

0.00

4.2

4.7

131.71

130.89

g/l

0.05

160

Exposure to excessive heat of man-made origin

199

1.01

0.00

9.1

4.0

123.40

128.16

g/l

0.42

190

Malignant neoplasm of parotid gland

211

0.99

0.00

1.6

3.0

126.29

129.21

g/l

0.23

204

Benign neoplasm: Vagina

261

1.00

0.00

2.8

2.4

130.73

127.33

g/l

0.33

256

Normotensive glaucoma

260

2599

1.00

0.00

2.7

2.9

125.79

127.35

g/l

0.53

249

2521

Graves ophthalmopathy, strict

439

1.00

0.00

3.0

2.8

132.18

128.97

g/l

0.40

429

Disorders of acoustic nerve

653

1.00

0.00

3.9

3.1

133.72

129.42

g/l

1.04

635

Chlamydia psittaci infection

0.00

0.0

3.4

—

138.20

—

Chlamydia psittaci infection, including avohilmo

0.00

0.0

3.4

—

138.20

—

Blastomycosis, including avohilmo

0.00

0.0

2.0

—

121.00

—

Blastomycosis

0.00

0.0

2.0

—

114.20

—

Other disorders of diminished melanin formation

0.00

0.0

2.0

—

140.40

—

Pseudomembranous colitis, drug-induced

0.00

0.0

2.1

—

137.13

—

Inhalation of gastric contents

0.94

0.00

5.4

2.8

156.40

134.08

g/l

—

Elastosis perforans serpiginosa

0.00

0.0

2.7

—

121.67

—

Bilateral

0.00

0.0

3.2

—

136.83

—

Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

0.00

0.0

1.4

—

152.60

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

1.8

—

133.17

—

Heredofamilial amyloidosis, unspecified

0.00

0.0

2.7

—

126.00

—

Disorders of other visual pathways

0.00

-0.00

0.0

47.3

—

130.86

—

Anhidrosis

0.00

-0.00

0.0

3.4

—

130.78

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

4.7

—

120.29

—

Deformity of orbit

0.00

-0.00

0.0

2.5

—

132.38

—

Chronic thyroiditis

0.89

-0.00

5.6

2.7

129.75

131.47

g/l

—

Intrauterine hypoxia

0.00

-0.00

0.0

6.0

—

131.75

—

Tetanus

0.00

-0.00

0.0

2.5

—

130.00

—

Benign neoplasm: Mesothelial tissue of pleura

0.00

-0.00

0.0

3.5

—

125.83

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

102

1020

1.00

-0.00

2.7

3.0

124.91

129.90

g/l

1.34

994

Alcohol-induced pseudo-Cushing syndrome

0.00

-0.00

0.0

1.6

—

124.20

—

Malignant neoplasm of placenta

0.00

-0.00

0.0

1.7

—

136.33

—

Other neonatal haemorrhages

0.00

-0.00

0.0

13.1

—

126.43

—

Trichuriasis

0.00

-0.00

0.0

2.8

—

124.44

—

Pulmonary haemorrhage originating in the perinatal period

0.00

-0.00

0.0

4.0

—

134.83

—

Taeniasis

0.00

-0.00

0.0

5.2

—

116.40

—

Tetanus, other/unspecified, including avohilmo

0.00

-0.00

0.0

2.5

—

130.00

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

10.4

—

124.80

—

Trichuriasis, including avohilmo

0.00

-0.00

0.0

2.8

—

124.44

—

Miliaria, unspecified

0.00

-0.00

0.0

3.2

—

133.33

—

Tetanus, other/unspecified

0.00

-0.00

0.0

2.5

—

130.00

—

Immobility syndrome (paraplegic)

0.00

-0.00

0.0

1.5

—

137.83

—

Delta-beta thalassaemia

0.00

-0.00

0.0

5.4

—

129.67

—

Scleritis and episcleritis (ICD-9) only

0.00

-0.00

0.0

4.8

—

123.11

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

-0.00

0.0

4.4

—

129.14

—

Tetanus, including avohilmo

0.00

-0.00

0.0

2.5

—

130.00

—

Frontotemporal dementia, wide, incl. Pick's disease

170

1.00

-0.00

3.4

3.3

132.12

127.14

g/l

0.46

164

Use of tolcapone

0.00

-0.00

0.0

3.7

—

135.33

—

Other specified/unspecified disorders of ear

0.95

-0.00

15.5

3.0

119.33

128.60

g/l

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

-0.00

0.0

5.3

—

122.50

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hemoglobin [Mass/volume] in Venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS